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ABSTRACT  STRUCTURE-FUNCTION RELATIONSHIPS IN BACTERIAL REGULATORY PROTEINS AND AN ENZYME INVOLVED IN ANTIBIOTIC BIOSYNTHESIS  by  Lanlan Han  The University of Wisconsin-Milwaukee, 2017 Under the Supervision of Professor Nicholas R. Silvaggi  The first part of my thesis is focused on a new family of two-component response regulator proteins: Aspartate-Less Regulators (ALR). They lack the catalytic aspartate residue that mimics the phosphorylation mechanism of typical two component response regulators. We are using biophysical tools to determine two proteins with redox-sensitive ALR domains: repressor of iron transport regulator (RitR) from Streptococcus pneumonia R6 and diguanylate cyclase Q15Z91 from Pseudoalteromonas atalantica. The structure of inactive RitR(C128S) monomer showed that the ALR domain and the DNA-binding domain 
are linked by an α-helix that runs the length of the entire protein, with C128 near the C-terminal end. Bioinformatic analysis of all streptococcal RitR homologs showed that Cys128 is strictly conserved, suggesting that RitR may be a novel redox sensor. Hydrogen peroxide was used to oxidize the cysteine thiol group to determine the structure of the oxidized, dimeric form of RitR. Oxidation of C128 to the disulfide caused a conformational change that caused the DBD to release from the ALR domain. Surprisingly, the freed DBD was observed bound to the ALR domain of the other, disulfide-linked molecule of RitR, recapitulating almost exactly the structure of the inactive, monomeric protein. An extended dimeric conformation was found in the RitR(L86A/V93A) variant. It binds to the target DNA according to gel filtration and differential scanning fluorimetry. The crystal structure 
 iii 
of the RitR(L86A/V93A) ALR domain showed an unprecedented conformational change for 
a response regulator protein, where helix α4 is disordered and the two protomers swap 
their α5 helices to form the dimer. Combining with the C128D mutant in vivo studies, it seems that oxidation of C128 is part of the activation mechanism, but there must be an additional factor that leads to dimerization of the ALR domains. The second ALR protein Q15Z91 has R61 replacing the phosphorylatable aspartate residue in the ALR domain. According to the structure of Q15Z91 with GTP and c-di-GMP, Purified Q15Z91 is an activated but product-inhibited dimer. Substitution on C142 that at the same position with 
that in RitR demonstrated that this C142 residue is also a redox sensor that involved in Q15Z91 activity regulation. 
The second part is a mechanistic enzymology project aimed at understanding the structure and mechanism of the novel pyridoxal-5’-phosphate (PLP)-dependent L-arginine hydroxylase/deaminase, MppP, from Streptomyces wadayamensis (SwMppP). SwMppP is predicted to be a type I/II aminotransferase based on primary sequence identity. However, NMR and ESI-MS results showed that SwMppP is not an aminotransferase, but rather a hydroxylase. The enzyme catalyzes the oxygen-dependent hydroxylation of L-arginine, 
forming 4-hydroxy-2-ketoarginine and the abortive side-product 2-ketoargine in a ratio of 1.7:1. This is exciting because SwMppP is the first PLP-dependent enzyme to react with oxygen in any context other than oxidative decarboxylation. The discovery of this new activity is especially surprising given that the tertiary structure of SwMppP is very similar to that of the prototypical aminotransferase, the E. coli aspartate aminotransferase (PDB 
entry 1ARS; RMSD of aligned Cα atoms is 3.7 Å). The major differences between the two enzymes are the disordered N terminus of SwMppP, and changes of a limited number of 
 iv 
amino acids near the PLP cofactor. The N-terminal helix transitions from a disordered, random-coil state to a helical conformation covering the active site only the substrate is bound. Specific roles of the un-conserved residues in the active site are being studied by mutagenesis. So far, most of the SwMppP mutants have lost the hydroxylase activity and only produce 2-ketoarginine. Our mechanistic studies have revealed that formation of the fully oxidized (hydroxylated) product requires 2 equivalents of dioxygen, while formation of 2-ketoarginine requires only one equivalent of dioxygen. Interestingly, the hydroxyl group of 4-hydroxy-2-ketoarginine comes from H2O, not dioxygen. Mutagenesis, structural and kinetic studies were used to understand how the residues in the active site stabilize the quinonoid form of the L-arginine-PLP complex to promote the reaction with dioxygen. Our structural and kinetic characterization of the wild-type and variant forms of SwMppP have allowed us to propose a model where the oxygen incorporated in the hydroxy-arginine product is derived from water rather than from dioxygen. In addition, SwMppP exhibits very high substrate specificity. Either change on the substrate length or guanidine group would result in no binding affinity or little activity. 
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Chapter 1 
Introduction to Bacterial Signal Transduction 
All cells sense and respond to environmental stimuli using signal transduction systems. In prokaryotes, these systems typically take the form of either one-component signal transduction (OCST) systems or two-component signal transduction (TCST) systems. OCST systems consist of one protein, which contains both input (sensory) and output (effector) domains, but lacks phosphotransfer domains15. The quorum-sensing protein TraR 16 from 
Agrobacterium tumefaciens is a one-component signaling system. When the autoinducer N-(3-oxo-octanoyl)-L-homoserine lactone binds to the N-terminal domain, TraR dimerizes and binds to DNA to activate expression of plasmid conjugal transfer genes 16, 17. In contrast, the more common TCST systems usually consist of five parts: (1) a sensory protein to detect the stimulus, (2) an autophosphorylated histidine kinase (HK; often part of the sensory protein), (3) a response regulator (RR) that accepts the phosphoryl group 
from the HK, (4) a target that the response regulator acts on, and (5) a phosphatase to restore the RR to its inactive state. The name “two-component” signal transduction system refers to the histidine kinase/response regulator pair. A typical TCST system is illustrated schematically in Figure 1-1. The sensor domain of the transmembrane histidine kinase protein triggers autophosphorylation of a specific histidine side chain of the HK domain in response to the stimulus, which can be the binding of some ligand 18, changes in pH 19, osmolality 20, temperature 21 and nutrients 22. The phosphoryl group on the HK is then transferred onto the conserved aspartate residue on the receiver (REC) domain of a cognate response regulator protein. This phosphotransfer reaction is catalyzed by the 
2 
response regulator itself and requires Mg2+.  
 
Figure 1-1: Schematic diagram of a typical two-component signal transduction system of the OmpR/PhoB family5.  The stimulus (black solid circle) is represented as a small molecule that is recognized by the sensor-kinase (blue); ligand binding triggers autophosphorylation of the histidine kinase domain. The inactive response regulator (white) encounters the phosphorylation HK and transfers the phosphate group to an aspartate residue in the receiver domain (REC) of the response regulator. Inactive (unphosphorylated) response regulator proteins can exist as monomeric or inactive dimeric conformations. Phosphorylation of the REC domain causes conformational changes that result in formation of the active dimer conformation of the RR (green). The response regulator in this example has a DNA-binding domain (DBD) as the output domain, and activation would result in either up- or down-regulation of transcription from a specific gene locus.  
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Signal transduction systems in prokaryotes were recently found to be more complicated than originally thought due to the discovery of auxiliary factors 23 and diverse phosphotransmission pathways, such as the ArcB-ArcA anoxic redox control system in E. 
coli 24, the CheA-CheY/CheB chemotaxis system in E. coli 25, the KinA/KinB-Spo0F-Spo0B-Spo0A sporulation control system in Bacillus subtilis 7, and Ser/Thr and Tyr phosphorylation systems mediated by bacterial eukaryotic-like serine/threonine and tyrosine kinases and the cognate PP2C phosphatases26-28. 
 
1.1 Histindine Kinase 
According to the domain compositions, HKs can be generally divided into two types: orthodox kinases and hybrid kinases. Orthodox histidine kinases typically contain a transmembrane domain, a four-helix coiled coil HAMP (histidine kinase, adenylyl cyclases, methyl-accepting chemotaxis proteins, and phosphatase) domain, a PAS (Per, ARNT and SIM) 29 domain, and a C-terminal transmitter domain. The transmitter domain contains the dimerization interface and the phosphorylatable histidine residue (DHp), and a catalytic  ATP/Mg2+ binding site (CA). EnvZ is an orthodox HK from E. coli that located in the inner membrane and contains two transmembran regions and a large cytoplasmic domain. It senses environmental osmolarity changes 1 and then phosphorylates the cognate RR protein OmpR, which ultimately regulates the expression of the outer membrane porins OmpF and OmpC 30 (Figure 1-2A). At high osmolality , OmpF is repressed and OmpC is the major outmembrane porin. It was also found that higher osmolality induces intra-helical H 
bonds, which enhances the H243 autophosphrylation and phosphoryl transfer to OmpR31. 
4 
HKs usually have two or more transmembrane regions that separate the periplasmic 
 
Figure 1-2: Prototypical histidine kinase with its cognate RR: Osmosis control (EnvZ 1-OmpR) (A), a typical hybrid histidine kinase system, ArcB-ArcA 2 (B) and the KinA/KinB-Spo0F-Spo0B-Spo0A system 7 (C), which is involved in phosphor-relay control. HPt: Histidine-containing phosphoryl transmitter domain. 
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sensor region from the cytoplasmic transmitter domain. Some orthodox HKs do not have a transmembrane region, like the chemotaxis kinase CheA 32 and the nitrogen regulatory kinase NtrB 33. PAS domains are common in sensor proteins and can sense diverse environmental or internal signals, including ligands, light, oxygen level and redox change34. The architecture of proteins containing PAS domains is diverse, but the overall structures of PAS domains are conserved35. Most PAS domains contain a central antiparallel β sheet 
with several α helices packed against one face35, as exemplified by VicK36 from 
Streptococcus mutans (Figure 1-3). The PAS domain contains a five-stranded central β sheet 
surrounded by five α helices. The uppermost HAMP domain consists four parallel α helices from two chains. Deletion of HAMP and PAS domains impaired the phosphatase activity of VicK37. The dimerization domain is usually composed of two long α helices. The phosphoryl receptor histidine locates in the helix (H217 in VicK). The loop connecting the two α helices determines the specificity of the receptor for one or more specific RR proteins 38. The main body of kinases CA domains is conserved, consisting of an α/β-sandwich fold with a five-
stranded mixed β sheet and three α helices, as observed in DesK39 and PhoQ40. This domain is structurally homologous to the ATPase domains of DNA gyrase B41, MutL42, and Hsp9043.  
6 
 
Figure 1-3: Schematic showing of VicK domain organization (A) and ribbon representation of VicK structure 
(PDB ID: 4I5S 36) (the transmembrane domain is not included in the structure) (B). The colors of different domains in chain A are matching the schematic from A. Chain B is colored in grey. The conserved H217 residues in the DHp domain are shown in stick with red carbon atoms. 
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Hybrid kinases are found in some prokaryotes and almost all eukaryotes 44. Hybrid kinases contain multiple phosphodonor and phosphoacceptor sites and undergo multi-step phospho transfer, such as ArcB 2, 24 (Figure 1-2B). ArcB from E. coli that is involved in anoxic redox control (Arc), is a typical HK of the hybrid kinase family. ArcB contains two N-terminal transmembrane regions, a kinase core, and a second His-containing phosphotransfer domain. Once the N-terminal transmembrane domain senses the stimulus, the signal is propagated into the transmitter domain by the HAMP domain, which triggers dimerization via the dimerization domain. The resulting four-helix bundle of the dimer is cross-phosphorylated on a conserved histidine residue of the dimerization domain using ATP and Mg2+. The complexity of hybrid kinase structures allows different regulatory pathways.  
 
1.2 Response regulators (RRs) 
1.2.1 Activation mechanism of phosphorylation dependent RRs 
In prokaryotic TCST systems, the most common and well-studied RRs are transcriptional regulators 15. They have DNA-binding domains that bind specific DNA sequences, and usually function as homodimers. The largest subgroup of DNA binding RRs is OmpR/PhoB family. The RRs in OmpR/PhoB family are characterized with a REC domain and a winged helix-turn-helix domain connected by a linker 45.  
X-ray crystal structures have been determined for a number of full-length RR proteins from the OmpR/PhoB family10, 46-48. In addition, the structures of some members of both 
8 
families have been determined in both the inactive, unphosphorylated and active, phosphorylated states. The latter is commonly approximated by BeF3 adducts that mimic the actual phosphorylated protein, owing to the difficulty of producing fully phosphorylated (i.e. homogenous) protein for crystallization studies. The ability to compare the structures of unphosphorylated and “phosphorylated” RRs has allowed some insight into the phosphorylation-induced activation mechanisms in these proteins14, 48.   
The REC domains of OmpR/PhoB subfamily adopt a sandwich (β/α)5 topology with a central five-stranded parallel β sheet surrounded by 3 and 2 α helices on both sides (e.g. PhoB in Figure 1-4). The phosphorylatable aspartate usually located in the loop between 
β3 and α3, and the other two acidic residues usually located in the loop between β1 and α1.  These three acidic triad residues are involved in the Mg2+ coordination and phosphoryl 
transfer from cognate HK. They dimerize through α4-β5-α5 interface upon phosphorylation.  
One well studied RR of OmpR/PhoB family is PhoB 5, which controls the cellular response to the phosphate-limitation in PhoR-PhoB5 (known as PhoP in some organisms) TCST system in E. coli and Bacillus subtilis. PhoR is an autophosphorylated transmembrane histindine kinase. It has a N-terminal transmembrane region and a cytoplasmic domain consisting of PAS domain, DHp domain and CA domain 49. PhoB (PhoP) is a transcriptional regulator that modulates the expression of pho regulon genes by binding to the “pho box” sequences of the promoters 50. Both the inactive monomeric structure 9 and the active dimeric structure 14 of PhoB were determined (Figure 1-4). Once the aspartate residue accepts the phosphoryl group from histidine kinase, a subtle structural rearrangement  
9  
 
Figure 1-4: PhoB dimerization is triggered by beryllium trifluoride, a phosphoryl analog. The left side shows the structure of the inactive PhoB monomer (PDB ID: 1B00 9), and the right side shows the BeF3-activated dimer (PDB ID: 1ZES 14). The acidic triad (E9, D10 and D53) and “switch” residues (T83 and Y102) are shown as sticks. The yellow-green sphere represents the magnesium ion required for the phosphotransfer reaction.  
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brings the α3 helix closer to the active site. The α4 helix and β5 strand undergo a more pronounced conformational change.  The side chain of T83 reorients and interacts with the phospho-Asp in the active site. In addition, the side chain of Y100 rotates around to fill the void left by the reorientation of T83. This reorientation of Y100 is thought to be an 
important factor in the formation of the α4-β5-α5 dimer interface 14. Thus, T83 and T100 have come to be thought of as the “switch residues” that are largely responsible for triggering dimerization by modulating the shape of the interacting surface of the REC domain.  
Comparisons of some full-length RRs structures in OmpR/PhoB family and the autophosphorylation rate, it was found that the interdomain interactions between REC domain and DBD of the inactive RRs affect the autophosphorylation rate51. According to the extent of interdomain interactions, OmpR/PhoB subfamily RRs are indeed divided into three subclasses (Figure 1-5) 12. As shown in Figure 1-5A, the α4-β5-α5 dimer interface of DrrB 3 REC domain interacts extensively with the DBD, which represents the “closed” subclass. DrrD 10 (Figure 1-5B) has less interdomain interactions and the DNA recognition helices are solvent accessible, which belongs to the “open” subclass. The representative of 
third subclasses is HP1043 11 (Figure 1-5C), which has little interdomain interactions and 
readily forms dimer through α4-β5-α5 dimer interface. 
11 
 
While DNA-binding effector domains are the most common, enzymatic domains (diguanylate cyclase, phosphatase, kinase etc), RNA binding domain and protein binding domain have also been observed in RRs 52. Some RRs only have a REC domain and the regulatory function resides in the REC domain. For example, CheY is a chemotaxis-related regulator with a REC domain that directly regulates the direction of motor rotation of bacterial flagella after phosphorylation by binding to the rotor protein FliM and FliN53, 54. 
The chemotaxis system in E. coli mainly contains a transmembrane methyl-accepting chemotaxis proteins (MCPs), an adaptor CheW and the TCST system CheA-CheY/CheB. 
 
Figure 1-5: Structural comparison of various classes of full-length OmpR/PhoB subfamily structures.  REC domains are colored in yellow, DBD colored in green. (A) The structure of DrrB (PDB ID: 1P2F 3), representing the “closed” subclass that has extensively interdomain interactions. (B) The structure of DrrD (PDB ID: 1KGS 10), representing the “open” subclass that has limited interdomain interactions (C) The structure of HP1043 (PDB ID: 2HQR 11), representing the “free” subclass that completely lacks the   
12 
MCPs, including Tar, Tsr, Tap, Trg, Aer 55, can bind various chemicals (e.g. sugars, amino acids, O2) and control the autophosphorylation of CheA via the adaptor protein CheW. CheA is a histindine kinase that lacks the periplasmic and transmembrane domains typically found in HKs 56, 57.  CheY, a response regulator with REC domain only and CheB, a glutamate methylesterase, compete for the phosphoryl group on CheA. Once phosphorylated, CheY binds to the switch protein on the flagella motor to change the rotation direction, while CheB controls the adaptation of the MCPs by demethylation. Demethylated MCPs are poor kinase activators58, which result in less activated CheA and less phosphorylated CheY.  
Comparison of the inactive and BeF3—activated mimic CheY structures59-61 shows that CheY has a similar activation mechanism to that postulated for PhoB (Figure 1-4, Figure 1-
 
Figure 1-6: Overlay of the inactive CheY (light pink) with BeF3 activated CheY dimer (green). Mn ions are represented in purple sphere. Acidic triad residues and switch residues are shown in stick. 
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6). Upon phosphorylation, the switch residue T87 of CheY rotates about to make a hydrogen bonding interaction with one of the fluoride atoms in the D57-BeF3 adduct, analogous to one of the phosphate oxygen atoms. The side chain of Y106 also undergoes a conformational change, rotating inward to fill the void left by T87, where its phenolic oxygen makes a hydrogen bonding interaction with the main chain carbonyl O atom of E89 and the ring itself is buried in a hydrophobic pocket formed by residues on β4 and α4.  
CheB has an N-terminal regulatory domain and a C-terminal methylesterase domain connected by a short linker. The regulatory domain of CheB is structurally homologous to CheY, but CheB contains a phosphorylation site and also an active site for auto-dephosphorylation on the REC domain 62. The N-terminal REC domain inhibits the methylesterase activity in the inactive state, but after phosphorylation, the methylesterase activity will be transiently activated 62. In addition, the inhibited full-length CheB structure 
is a “closed” conformation, because α4, α5 and β5 in the REC domain interact with the methylesterase domain and block the catalytic site 63. Phosphorylation of D56 changes the 
conformations of α4 and α5, which disrupts the interdomain interactions and opens access to the catalytic site. 
 
1.2.2 Conserved residues in phosphorylation-dependent RRs 
Comparison of response regulator sequences (Figure 1-7) demonstrates that the residues mentioned above, Ser/Thr and Tyr/Phe switch residues, the acidic triad residues including phosphorylatable aspartic acid are all highly conserved in phosphorylation-
14 
activated RRs. The acidic triad residues comprise a motif (Asp-Asp/Glu-Asp) that is essential for binding of the Mg2+ (or other divalent metal ions) required for phosphoryl group transfer. The conserved phosphorylatable aspartate residue plays a key role in activation. Substitution of this aspartate residue by glutamate, which has been used as a phospho-Asp mimic to examine activation in CheY 64, RcsB 65 and NtrC 66, resulted in constitutive activation. In contrast, substitution by asparagine or alanine in RcsB65 and NtrC 66 eliminated activation in these proteins. The switch residues Thr/Ser and Tyr/Phe are essential for forming the active dimer conformation in many RRs. Substitutions of these two switch residues (e.g. T87 into isoleucine or Y106 into trptophan) impairs activation in CheY and affects chemotaxis 67. Likewise, mutation of T87 to isoleucine prevents the side chain of Y106 from adopting the “inward-facing” conformation even when CheY is phosphorylated 67. 
 
 
 
Figure 1-7: Conserved residues in phosphorylation-activated response regulators. 
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In the REC domain of CheB 63, there is another important acidic residue E58. E58 is near the acidic triad and orients toward the metal-binding site. The E58K mutant of CheB exhibited a much slower rate of phosphoryl transfer from phospho-CheA and auto-dephosphorylation of CheB, which suggests that E58 contributes to the phosphoryl group transfer from CheA and autophosphotase activity of CheB. Phosphorylation-activated response regulators often have another conserved basic residue, a lysine, located near the phosphorylation site and interact with phospho-Asp. 
However, these highly conserved residues may have different roles in the transition to the activated state. In CheY, D57 is the conserved phosphorylatable residue68. In vivo, the CheY mutant D57N was phosphorylated at an alternative residue, S56, and still regulated the rotation of flagella69. However, a CheY D57E mutant, which in other systems has been thought to mimic phospho-Asp, exhibited no activity in vivo, although it was still phosphorylated by CheA. In NtrC (nitrogen regulatory protein C), the variant D54E mimics the phospho-Asp and has an NtrC+ phenotype 70.  In vitro phosphorylation studies verify 
that the NtrC D54E protein can still be phosphorylated even though not stable 71. Like CheY, NtrC also has a serine residue (S53) adjacent to the conserved phospho-acceptor residue 
D54. However, the NtrC D54N mutant does not have any active phenotype 70, 71. The conserved basic residue K109 in CheY interacts with the phospho-Asp and contributes to the phosphorylation by providing a simple electrostatic on-off switch 72-74. While mutating the analogous residue, K107 in CheB, to Arg does not affect the phosphorylation of D56, but it does slow down the dephosphorylation step 75. The analogous residue in NtrC, K103, is also not required for phosphorylation 71. 
16 
1.2.3 Atypical, phosphorylation-independent RRs containing the conserved Asp 
residue 
We talked about the phosphorylated RRs activation mechanism and the conserved residues above. For the remainder of this discussion, the phosphorylation-dependent response regulators will be referred to as “typical” or “canonical” RRs. Recently, a large group of RRs with atypical REC domains has been identified whose members respond to signals other than phosphorylation. For example, MarR from E. coli  that represses the transcription of many antibiotic-resistance operons was found to be derepressed by copper induced oxidation of the redox sensor C80 on MarR 76.  
The orphan regulator NblR from Synechococcus that lacks the cognate histidine kinase, has the conserved phosphorylatable Asp residue, but it is not required for NblR function77, 
78. Experiments with yeast and bacterial two-hybrid systems demonstrated that NblR does not interact with NblS (a conserved histidine kinase in Cyanobacteria), but rather with NarB (nitrate reductase).  
ChxR from Chlamydia trachomatis exists as a constitutively active homodimer without phosphorylation79. First, the structure of the ChxR REC differs from those of typical (phosphorylation-dependent) RRs in that ChxR lacks two helices (α2 and α3) found in the typical OmpR/PhoB-type regulators (Figure 1-8A) 8. Second, ChxR does not have both of 
the Thr/Ser and Tyr/Phe switch residues. The tyrosine residue on β5 is present, but the 
Ser/Thr on β4 is missing. Furthermore, the two residues in ChxR equivalent to the switch residues (L72 and Y90) are oriented similarly to those of inactive OmpR/PhoB family regulators, which indicate ChxR has a different activation/dimerization mechanism. Based 
17 
on small-angle X-ray scattering (SAXS) analysis of full-length ChxR (Figure 1-8B), ChxR belongs to the “free” subclass that lacks interdomain interaction between the REC domain and DBD 12. So ChxR can bind to DNA in a phosphorylation-independent manner. 
 
Figure 1-8: (A) The structure of ChxR REC domain (PDB ID: 3Q7R 8). Chain A colored in green, chain B colored in cyan. In comparison with typical OmpR/PhoB RRs, ChxR lacks α2, α3 and the second and third helices are labeled as “α4” and “α5”, respectively. (B) The model of full length ChxR dimer according to the best fit SAXS data 12 reflects a “free” conformation due to no interdomain interaction. (C) The structure of GlnR REC domain (PDB ID: 4O1H 13). Chain A colored in green, chain B colored in cyan. The putative acidic triad (except D50) and switch residues are all missing in GlnR. 
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Another atypical regulator, GlnR from Amycolatopsis mediterranei, represses the expression of the glutamine synthetase gene and is thus involved in regulating nitrogen metabolism. GlnR is an orphan RR, because the cognate HK is not identified 80. Like ChxR, GlnR also possesses the conserved phosphorylatable aspartate residue (D50), but functions as a homodimer without phosphorylation (Figure 1-8C). Interestingly, the other two acidic triad residues (E, D/E), the conserved Lys residue, and the switch residues (Ser/Thr, Tyr/Phe) are all not conserved in GlnR. In addition, Arg52 that located on the loop between 
β3 and α3 (Lβ3α3) is essential for maintaining dimerization by occupying the “phosphorylation pocket” and interacting with the conserved D50 13. 
 
1.2.4 Aspartate-Less Regulators (ALR) 
Among atypical RRs, there are many proteins lacking the phosphorylatable Asp residue, 
such as the atypical response regulator HP1043 from Helicobacter pylori. HP1043 regulates the transcription of tlpB gene that encoding a methyl-accepting chemotaxis protein and is essential for cell growth 81. In HP1043, a serine residue is substituted for the phosphorylatable Asp residue. The protein binds to DNA in a phosphorylation-independent way 11. This raises the question of whether the loss of the phosphorylatable Asp residue is a common evolutionary theme in bacterial signal transduction. We recently defined a new subfamily of RR proteins with aspartate-less receiver (ALR) domains 6. The ALR domains 
are common, accounting for ~4% of REC domain sequences in the Pfam database, and they 
are well distributed among bacteria, archaea, and eukaryotes. A large number (~28%) of ALR regulators have DNA-binding output domains. When compared to the entire class of 
19 
RRs, the ALR domain-containing response regulators are enriched for enzymatic output domains, such as diguanylate cyclase (GGDEF) domains, Ser-Thr kinase, and phosphatase domains. Although these atypical receiver domains have been known to exist for some time, the molecular details of their regulatory mechanisms have remained unclear. In the next two chapters, the structure-function relationships of two ALR proteins will be explored: RitR (Repressor of iron transport regulator, Chapter 2) and Q15Z91 (diguanylate cyclase, Chapter 3).  
 
1.2.4.1 Repressor of iron transport regulator (RitR)  
RitR is an orphan two-component signal transduction response regulator in 
Streptococcus pneumoniae R6. Analysis of the S. pneumoniae genome indicates that there are 13 pairs of TCST proteins (HK and RR) in this organism and a single orphan regulator, RitR 82-84. Searching the genome sequence, there is no kinase gene close to the ritR gene locus. Instead, the adjacent gene gnd encodes a 6-phosphogluconate dehydrogenase and is co-transcribed with ritR, as evidenced by Northern Blot analysis 85. RitR plays roles in iron uptake, the response to oxidative stress, and pathogenicity in a mouse lung model 85.  
Analysis of REC domain sequences shows that RitR belongs to the OmpR/PhoB subfamily of RRs, and suggests that RitR likely has a similar tertiary structure to other OmpR/PhoB family members. A representative sequence alignment with the typical response regulator PhoB (Figure 1-9) shows that the conserved, phosphorylatable Asp residue in RitR is replaced by asparagine (N53; highlighted in yellow in Figure 1-9).  
20 
Furthermore, RitR does not have any other residue near this position that would be capable of accepting a phosphate group, such as Ser56 in CheY. The absence of any obvious candidates for phosphorylation in the sequence suggests that RitR does not have a phosphorylatable site in the “active site”. Further underscoring the likely functional differences between RitR and other PhoB-type RRs is the substitution of a leucine residue in RitR for the Ser/Thr switch residue. 
The three-dimensional structure of the RitR receiver domain (PDB ID: 4LZL 6) was 
obtained by molecular replacement (Figure 1-10). The RitR REC domain is monomeric, which means that this structure represents an inactive (no DNA binding) conformation. It 
has the same (β/α)5 topology observed in other OmpR/PhoB family members, with only 
 
Figure 1-9: Sequence Alignment of RitR and PhoB. The acidic triad residues are colored magenta (Mg2+-binding) and red (phosphorylation site). The conserved Asp residue is replaced by Asn in RitR. The two switch residues are colored blue. The yellow boxes mark the differences in conserved residues between RitR and PhoB. 
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subtle differences (see below). 
The most obvious difference is the broken α4 helix (colored green in Figure 1-10A), the 
pieces of which are labeled α4a and α4b, respectively. The hydrophobic residues on the α4 
helix interact with residues on β3, β4 and β5, forming a hydrophobic core (as shown in Figure 1-10B). There are other RRs with unusual α4 helices, though none are “broken” like 
helix α4 of RitR. For example, DosR from Mycobacterium tuberculosis adopts an unusual 
(β/α)4 fold, where the canonical α4 helix and β5 strand have been lost 86 (Figure 1-11).  
 
Figure 1-10: The structure of the RitR receiver domain (this figure is downloaded from PLOS Pathogens 
11(4): e1004795 6). (A) Ribbon representation of the RitR REC domain with helices α1- α3 and α5 colored 
orange, the unusual α4 helix colored green, and the β-strands colored blue. N53 is shown in sticks. (B) Schematic view showing “hydrophobic interactions“ (yellow dotted lines) and the hydrogen-bonding network (green dotted lines) in the “hydrophobic gate” region of the structure.  
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Figure 1-11: The α4 helix of response regulator REC domains appears to be particularly malleable. The 
conserved residues equivalents are shown in stick. The typical topology where α4 is parallel to β5 and unbroken is exemplified by PhoB (PDB ID 1B00 9), Other RR proteins have unusual α4 helices. For example, 
helix α4 is broken into two pieces in RitR (PDB ID: 4LZL 6), while that of DrrD (PDB ID: 1KGS 10) is roughly perpendicular to strand β5. Finally, DosR (PDB ID:  3C3W 86) has a completely different topology where α4 is 
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missing entirely, as is strand β5. 
 
Helix α4 in DosR is positioned where the canonical helix α5 is located in other NarL 
subfamily RR proteins. The conserved Y101 and K104 residues that are normally located on strand β5 and the loop Lβ5α5, are instead located in linker helix α5 and far away from the phosphorylation site. In DrrD from Thermotoga maritima, helix α4 is roughly perpendicular rather than parallel to the other helices 3, as shown in Figure 1-11. 
In the so-called “active site,” the phosphorylatable aspartate is replaced with an asparagine residue and there is no bound metal (Figure 1-12A). In what would be the metal-binding site, E9 interacts with N53 and the conserved residue K103. The basic residue K10, which is normally one of the residues of the acidic triad, sits near the top of the putative phosphorylation site and disrupts the acidic environment that promotes metal binding. As shown in Figure 1-12B, not only is the acidic environment is disrupted, but also the cleft for Mg2+ binding is eliminated in RitR. As mentioned above, RitR lacks a cognate histidine kinase. The lack of a cognate HK protein, together with the lack of key residues found in phosphorylation-dependent RRs makes it clear that RitR must be activated by a different mechanism from the typical, phosphorylation-dependent proteins.  
Another feature of RitR is the only cysteine located in the linker region between REC domain and DBD. Bioinformatic results demonstrate that this cysteine128 is highly conserved in Streptococcus family. The specific role of this cysteine will be discussed in chapter 2. 
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Figure 1-12: Structure of the RitR “active site” (this figure is downloaded from PLOS Pathogens 11(4): 
e1004795 6). The stereoview of the 2|Fo|-|Fc| electron density in the RitR putative phosphorylation site 
(magenta mesh) contoured at 1.5 σ (A) shows the network of interactions and the lack of a large electron density peak that would indicate bound metal. Water molecules are shown as blue spheres. A comparison of the vacuum electrostatic surface potentials of the RitR and PhoB REC domains (B) highlights the differences in the surface properties of RitR that account for the loss of metal binding. The Mg2+ in PhoB is shown as a magenta sphere and highlighted with a white arrow. Both the electronegative environment and the physical cleft for Mg2+ binding are lost in the RitR putative phosphorylation site.  
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1.2.4.2 Diguanylate cyclase Q15Z91  
A search of response regulator sequences for ALR proteins that also possess a cysteine residue at the C-terminal end of the linker helix (α5) and an enzymatic output domain led to the identification of a protein known only by its Uniprot accession code, Q15Z91. This putative regulatory protein  from Pseudoalteromonas atlantica Tc6 contains an ALR domain linked to a diguanylate cyclase effector domain. This protein was chosen for study in order to explore the mechanism of ALR activation in the context of enzymatic activity rather than DNA binding. An enzymatic activity was preferred due to the facts that (1) it is simpler to conceptualize the active and inactive states of an enzymatic activity and (2) it is significantly easier to quantify enzymatic activity than DNA-binding.  A boon of the diguanylate cyclase domains in general is that the product, cyclic-di-guanosine monophosphate, is an important second messenger in biofilm formation. Thus, the biofilm phenotype is easily observed during heterologous expression in E . coli Origami™ 2 (DE3) cells, which will be discussed in detail in chapter 3.  
The diguanylate cyclase (DGC) domain of Q15Z91 catalyzes the condensation of two molecules of GTP to yield bis-(3’-5’)-cyclic dimeric guanosine monophosphate (c-di-GMP) (Scheme 1-1). A separate phosphodiesterase enzyme cleaves c-di-GMP to give 5’-phosphoguanosylyl-(3’-5’)-guanosine (pGpG). Cyclic di-GMP is an important second messenger that regulates biofilm formation, cell adhesion, and induction of virulence factors in some bacteria 87-89.  
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The diguanylate cyclases usually contain a conserved GG(D/E)EF motif for catalysis and an RxxD motif for regulation of the DGC activity by product inhibition. A well-studied diguanylate cyclase, PleD from Caulobacter crescentus, is activated by phosphorylation 90. As shown in Figure 1-13, PleD contains two CheY-like REC domains (a true receiver domain [D1] and an inactive “adapter” domain [D2]) and a DGC domain 91. The receiver and 
adapter domains of PleD share the (β/α)5 topology common to typical OmpR/PhoB RRs. Upon phosphorylation of D53 in the acidic pocket of the REC domain (D1), the conserved switch residues T83 and F102 undergo a conformational change that triggers a rearrangement of the D1 and D2 domains relative to one another. This rearrangement 
 
Scheme 1-1: Metabolism of cyclic-di-GMP. DGC: diguanylate cyclase; PDE-A: type A phosphodiesterase with EAL motif; PDE-B: type B phosphodiesterase with HD-GYP motif; pGpG: 5’-phosphoguanylyl-(3’-5’)-guanosine. 
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optimizes one face of the D1/D2 pair for dimerization between two PleD molecules 90, 92 (Figure 1-13A). Interestingly, the two REC domains (D1/D2) form an α4-β5-α5 dimer interface very similar to those seen in other OmpR/PhoB subfamily regulators, while the 
interactions between the PleD protomers includes residues from D1 domain (α1, β2, β3, 
α5) and D2 domain (α8 and α10).  
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Figure 1-13: The receiver (D1) and adapter (D2) domains of PleD rearrange after BeF3- treatment (A). BeF3- was used to mimic phosphorylation of D53. The DGC domains were omitted for clarity. The acidic triad residues are shown as sticks. The Mg2+ ions are shown as green spheres. The inactive form of PleD is shown on the left, and the BeF3 activated mimic structure is shown on the right. The D1 domain is colored cyan, and the D2 adapter domain is colored blue. In the activated PleD structure, the D1 and D2 domains of the second protomer in the dimer are colored grey. After D53 accepts the phosphoryl group, REC1 and REC2 form a tighter dimer interface. PleD dimerization (B) is promoted by phosphorylation and c-di-GMP binding immobilizes the DGC domain against the D1 and D2 domains. As above, the inactive PleD structure is shown on the left and the activated mimic on the right. The c-diGMP molecules are shown as sticks.  In the inactive structure, c-di-GMP is bound to both the inhibitory (I) and active (A) sites. In the BeF3 phospho-mimic structure of the PleD dimer, c-di-GMP is still bound in the inhibitory site, which restricts DGC domains from catalysis. Two GTP molecules (shown in stick) bind in each active site respectively. 
 The conserved DGC domain (GGEEF motif) consists of a five-stranded central β sheet 
surrounded by α helices, which is similar to the structure of adenylate cyclase and type I DNA polymerase. A single DGC domain binds only one GTP molecule, which means that a single domain contains only half of an active site.  As shown in Scheme 1-2, for reactions to happen, two GTP molecules need to get closer and well aligned. Thus, activity requires the antiparallel association of two DGC domains, each with GTP bound. The regulatory logic is clear: antiparallel association of two DGC domains is much more likely in the dimeric form of PleD, where it is a unimolecular process, than it is in the case of free PleD monomers. In the active site of PleD, the conserved residues G368, G269 and E371 make key interactions for binding GTP, while E370 is essential for catalysis 91. In PleD, inhibitory sites on the DGC domains, marked by an RxxD motif, bind intercalated c-di-GMP dimers that “pin” the DGC domains to the regulatory domains in the case of unactivated PleD, or to each other in an 
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unproductive back-to-back orientation in the case of activated (phosphorylated) PleD. This c-di-GMP dimer binding is the basis of the observed product inhibition that modulates DGC activity. Disruption of the inhibitory sites, for example by mutating the Arg or Gly residues of the RxxG motif, abrogates the product inhibition 93. This allosteric feedback inhibition is not affected by phosphorylation status (Fig1-15B).  
 
The diguanylate cyclase WspR from Pseudomonas aeruginosa is very similar to PleD in that it is also regulated by feedback inhibition, though the exact mechanism differs 4. WspR 
 
Scheme 1-2: Schematic representation of the diguanylate cyclase reaction where two GTP molecules are condensed to form c-di-GMP. The c-di-GMP contains two GMP moieties linked by O3’-P phosphodiester bonds. Four Mg2+ ions are shown as green spheres. The two GTP molecules are held in close proximity and with the proper alignment by four Mg2+ ions that are coordinated with the phosphate groups of GTP and the carboxyl groups of the conserved residues E370, E371, and D327. D327 is thought to promote deprotonation of the 3’-OH group of GTP to initiate the reaction. The deprotonated 3’-hydroxyl group 
would then attack the Pα-O bond, and release pyrophosphate (PPi). This is repeated in the other half of the active site so that a total of two molecules of PPi are released during each catalytic cycle.  
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contains a single CheY-like REC domain and a DGC domain (Figure 1-14A). These two 
domains are linked by a long helix α5 4. The REC domain has a similar structure to those of activated OmpR/PhoB RRs. The switch residue Y117 adopts an inward conformation, 
promoting association through the commonly observed α4-β5-α5 dimer interface (Figure 1-14B). However, no post-translational modification of WspR, such as phosphorylation, has been observed in the structure. In vitro activity study of Wsp and phosphorylated WspR showed that unphosphorylated WspR can catalyze c-di-GMP formation but phosphorylated WspR exhibited faster DGC activity 94. WspR from P. aeruginosa functions as a compact, c-di-GMP-free dimer. However, other WspR homologs, such as that from P. syringae, require phosphorylation-induced tetramerization for high cyclase activity 95. This activated cyclase activity was only obtained by phosphodiesterase treatment of WspR to remove c-di-GMP, followed by phosphorylation-induced tetramerization 95. Both WspR exhibit a product immobilization inhibition. WspR from P. aeruginosa is purified as a mixture of dimer and tetramer 4, 95. In the crystal lattice, WspR formed a distinct 222-symmetric tetramer, and 
the long helix α5 facilitates the antiparallel tetramer formation4, 95, as shown in Figure 1-
14A. Molecules of c-di-GMP dimers bind to the specific I sites (RxxD motif) that composed by two protomers from different dimers (e.g. chain A and chain C) in the tetramer and cross-link the DGC domains such that the active sites are forced apart for the cyclization of two GTP molecules. 
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Figure 1-14: The Wsp dimer (A), REC domain of WspR dimer (B) and tetramer (C) structure from 
Pseudomonas aeruginosa (PDB ID: 3BRE 4). Chain A is colored cyan, chain B is colored green, chain C is colored magenta, and chain D is colored yellow. Residues in phosphorylation site and switch residues are shown as sticks. The Mg2+ ions are represented with green spheres. The GTP binding active site are shown in red sphere in (A). Four c-di-GMP dimers in (C) are shown as sticks. In the crystal, two WspR dimers packed in an antiparallel way to form the inactive tetramer with c-di-GMP bound.  
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Both of these diguanylate cyclases, PleD and WspR, have the structural features required for phosphorylation-dependent activation. In the case of PleD, phosphorylation has been shown to be the primary regulatory factor, whereas with WspR, phosphorylation accelerates the DGC activity.  In contrast, Q15Z91 has lost these structural features, such as the conserved, phosphorylatable aspartate residue and the Mg2+-binding site. This prompted us to ask, “what is the mechanism of activation of Q15Z91?” Is it also controlled by the non-competitive allosteric product inhibition? These questions will be addressed in Chapter 3. 
In summary, ALRs exists in most classes of bacteria (averaging ~2 per genome), and are also prevalent in archaea, fungi, plants and possibly even insects and primitive animals. The key “invariant” catalytic and signaling residues required in canonical REC domains are found to be changed in many ALR sequences. Although these atypical REC domains has been known to exist for some time, it remain unknown that how they are regulated in the absence of the conserved Asp. Combining structural data with biochemical and genetic examination of two founding members of the ALR family, RitR and Q15Z91, we demonstrate that ALRs might have evolved to accommodate more diverse environmental signals, while largely retaining their time-tested ancestral post-input signaling mechanisms. This work also provides a foundation for future experimentation to decipher the largely unknown functional roles of these proteins. 
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Chapter 2  
The Atypical Response Regulator Protein Repressor of Iron Transport 
Regulator (RitR) Exhibits an Alternative Mechanism of Activation 
2.1 Background 
RitR is an orphan response regulator in S. pneumonia R6 that has been shown to down-regulate the expression of iron-transport proteins to avoid oxidative damage during aerobic growth 1, 2. RitR differs from typical two-component systems in that it lacks a cognate HK protein, the conserved phosphorylatable aspartate residue (D53) is substituted with asparagine, and the binding site for Mg2+, which is required for the phosphorylation reaction, is apparently disrupted in RitR.  Together, these differences suggest that RitR cannot be phosphorylated and, thus, must use a different mechanism of activation. So My work is using biophysical tools to determine the regulatory mechanisms of proteins with redox-sensitive ALR domains. 
 
2.2 Methods 
2.2.1 Cloning, expression, and purification of wild-type and mutant RitR  
The gene encoding wild-type RitR from Streptococcus pneumoniae strain R800 was cloned into the pE-SUMOkan expression vector (LifeSensors Inc, Malvern, PA) using primers containing BsaI and XbaI restriction sites. The His6-tagged SUMO-RitR fusion protein was expressed from E. coli BL21 Star (DE3) cells (Invitrogen Inc, Carlsbad, CA) carrying the pE-
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SUMO-RitR plasmid. Cultures were grown in Luria-Bertani medium with 50 µg/mL kanamycin at 37 °C with agitation at 250 rpm. When the cultures reached an OD600 of ~1.0, 
protein expression was induced with 0.4 mM IPTG. The temperature was then reduced to 16 °C and the cultures were grown overnight. Cells were harvested by centrifugation, resuspended in 5 mL/g of buffer A (25 mM TRIS pH 8.0, 300 mM NaCl, 10 mM imidazole) supplemented with 0.1 mg/mL DNAse I (Worthington Biochemical Corp., Lakewood, NJ). Cells were lysed using a Branson Sonifier S-450 cell disruptor (Branson Ultrasonics Corp., 
Danbury, CT) for a total of 5 min of sonication at 60% amplitude with 30 s pulses separated by 50 s rest periods. The temperature was maintained at or below 4 °C by suspending the steel beaker in an ice bath directly over a spinning stir bar. The lysate was clarified by 
centrifugation at 39,000 x g for 45 minutes and then applied to a 5 mL HisTrap column (GE Lifesciences, Piscataway, NJ) at a flow rate of 5 mL/min to isolate the His6-SUMO-RitR 
fusion protein. The protein was eluted by a 4-step gradient of buffer B (25 mM TRIS pH 8.0, 
300 mM NaCl, and 250 mM imidazole; 5, 15, 50, and 100% B). The His6-SUMO-RitR fusion protein eluted in the third and fourth steps and was ~90% pure, as judged on coomassie-stained SDS-PAGE gels.  Peak fractions were pooled and dialyzed overnight against 4 L of 25 mM TRIS pH 8.0, 150 mM NaCl, and ~3 µM SUMO protease (LifeSensors Inc). The dialysate was passed through the HisTrap column a second time to remove the cleaved His6-SUMO tag as well as the protease. The resulting RitR preparation was >95% pure according to SDS-PAGE results. The protein was desalted using a HiTrap Desalting column (GE Lifesciences) into storage buffer (pH 6.5, 25 mM TRIS, 150 mM NaCl, 100 mM Malic acid) and stored at -80 °C. All mutants mentioned in the chapter 2 were expressed and purified using the same protocol as the wild type RitR.  
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2.2.2 Preparation of purification of the oxidized RitR dimer (RitRox) 
RitRox was prepared by treating purified, wild-type RitR with 1 mM hydrogen peroxide for 3 h, followed by size exclusion chromatography to obtain the oxidized dimer. A HiPrep 26/60 Sephacryl S100 HR column was equilibrated with 2 column volumes of buffer C (pH 6.5, 20 mM TRIS, 150 mM NaCl, 100 mM malic acid, 1 mM H2O2). The first peak to elute from the column, which was consistent in size with the dimer (~60 kDa), contained the dimeric RitRox protein.   
 
2.2.3 Preparation of protein for structure determination 
The mutant SeMet labeled RitR(C128S) from T7 Express Crystal cells (New England BioLabs, Ipswich, MA) carrying the pE-SUMO-C128S plasmid. Cells were grown in SelenoMethionine Medium Complete (Molecular Dimensions, Newmarket, Suffolk, UK) with 50 µg/mL kanamycin. This selenomethionine-labelled RitR(C128S) mutant was purified using the same protocol described for RitR. But it was stored in 25 mM TRIS pH 8.0, 5 mM DTT for crystallization. The mutant RitR(C128D) was purified using the same protocol described for RitR. But it was stored in 10 mM ADA pH 7.0 buffer. 
Two forms of a RitR(L86A/V93A) ALR domain were devised to probe the structural consequences of this double mutation: one corresponding to the original RitR ALR domain structure, which ends well before the putative redox-active C128 residue (RitR(L86A/V93A) residues 1-124; RDLV) and a longer version that included the entire α5 helix (residues 1-132; RD2LV). Selenomethionine-labelled protein was prepared for both 
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double mutants from T7 Express Crystal cells (New England BioLabs, Ipswich, MA) carrying the pE-SUMO-RDLV or pE-SUMO-RD2LV plasmid. Cells were grown in SelenoMethionine Medium Complete (Molecular Dimensions, Newmarket, Suffolk, UK) with 50 µg/mL kanamycin. Both selenomethionine-labelled double mutant RitRL86A/V93A REC domains were purified using the same protocol described for RitR. 
 
2.2.4 Differential scanning fluorimetry  
Differential scanning fluorimetry (DSF) was used to search for buffer conditions where the relatively unstable WT RitR might be stable enough to crystallize. Wild-type RitR was 
diluted to 20 μM with water (1.1ml final volume) and 2µl of SYPRO Orange dye was added. This protein solution (10 µl) was mixed 1:1 with the Slice pH buffer screen (Hampton Research) in a 96-well PCR plate. The plate was heated from 20°C to 95°C in 1 oC steps in an Eppendorf RealPlex real-time PCR machine. At each temperature step, the fluorescence signal from the SYPRO Orange dye (ThermoFisher Scientific) in each well of the plate was monitored. Plotting the second derivative of the fluorescence intensity vs temperature plot gives a peak corresponding to the Tm of the protein in that buffer. Buffers showing at least a 2-3 °C upward shift in the Tm were investigated as storage buffers for RitR. 
DSF was also used to assess the ability of RitR and various mutants to bind to DNA by monitoring the ability of DNA to stabilize the proteins. To test the buffer and pH effects on the Tm, RitR and RitR(L86A/V93A) were incubated with a dsDNA oligo corresponding to the putative primary RitR binding site in S. pneumoniae R6 (BS3-3: 5'-
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ATGAAACTTTCTCATTATTTAATTGGCTTACTTCT-3') in different buffers at different pH. 
Firstly, 1500 μl solution containing 200 μM protein and 100 μM BS3-3  was incubated at 
room temperature for 2 hours. Then 2 μl of the protein/BS3-3 mixture was mixed with 18 
μl of different buffers at different pH containing the SYPRO Orange dye. Protein-only negative controls were prepared by mixing 200 μM RitR or RitR(L86A/V93A) protein with different buffers only containing SYPRO Orange dye. 
Finally, DSF was used to double check the gel shift results by looking at the shifts in Tm when different forms of RitR were incubated with BS3-3 in the binding buffer1 (20 mM HEPES pH 7.2, 5 mM MgCl2, 1 mM CaCl2, 0.1 mM EDTA) and with the optimal protein:DNA 
ratio for binding (protein:DNA = 4:1). The protein variants investigated included RitRox, RitR(L86A/V93A)ox and RitR(L86A/V93A/C128S)ox. Oxidized proteins were prepared by incubating with 1mM H2O2 at 4 oC overnight. Each RitR variant (RitR, RitRox, RitRL86A/V93A, RitR(L86A/V93A)ox, RitR(L86A/V93A/C128S), and RitR(L86A/V93A/C128S)ox) was mixed with BS3-3 at final concentrations of 400 µM protein and 100µM DNA in 25 mM TRIS pH 8.0, 150 mM NaCl buffer for 2 hours at room temperature. Then 2 μl of each protein/BS3-3 
mixture was mixed with 18 μl of different buffers (buffer 1: 20 mM TRIS pH 6.5, 150 mM NaCl, 100 mM Malic acid; buffer 2: binding buffer; or buffer 3: binding buffer supplemented with 150 mM NaCl) containing SYPRO Orange dye. The protein-only controls were 
prepared by mixing 400 μM protein with buffer with SYPRO™ orange fluorescent dye. 
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2.2.5 Site-directed mutagenesis  
The K10A, N53A, N53D, D81A, L86A, L90A, V93A, L86A/V93A, F96G, Y100A, Y102A, R113A, C128A, C128S, C128Dand Y163F mutants were prepared by the Ulijasz lab. Other mutants, L86A/V93A/C128S, RDLV and RD2LV, were constructed as part of this work. The full-length mutants were obtained by the Quick-ChangeTM mutagenesis method using the primers listed in Table 2-1. The Quick-ChangeTM protocol used the Pfusion DNA polymerase and the high fidelity (HF) master mix (New England Biolabs, Ipswich, MA). The PCR program included an initial denaturing step at 98 oC for 30s, followed by the cyclic portion of the program (denature at 98oC for 10 s, anneal at (Tm of primer pair – 2) oC for 25 s, extend for 210 s at 72 oC; 17 cycles), and a final extension step at 72 oC for 10 min. After 
PCR, DpnI (20 U) was added to the 50 μl PCR reaction to digest the methylated template DNA at 37 oC for 1 h.  The DpnI-treated PCR reaction (5 μl) was used to transform NEB5α competent E. coli (New England Biolabs, Ipswich, MA). Transformants were sequenced to confirm the presence of the mutation. The gene of two ALR domains of RitR(L86A/V93A) were amplified from pSUMO-RitR(L86A/V93A) plasmid. After BsaI and XbaI digestion, the genes were ligated into XbaI digested pSUMO kan plasmid. The success of ligation was checked by sequencing. 
Table 2-1: Primers used for mutagenesis 
Names Primer sequence sumo-RitRL86A_RD_Fwd GCGGTCTCAAGGTATGGGGAAACGGATTTTAT sumo-RitRL86A_RD_Rev GCTCTAGATTAAATGAAGTCCCGACCTCGG 
46 
sumo-RitR(C128S)_Fwd GACTTCATTGATCAACACAGCAGTCTGATGAAAGTTC sumo-RitR(C128S)_Rev GAACTTTCATCAGACTGCTGTGTTGATCAATGAAGTC sumo-RDLV_Rev GCTCTAGATTAAATGAAGTCCCGACCTCGG sumo-RD2LV_Rev GCTCTAGATTATTTCATCAGACTGCAGTGTTGATC sumo-RitR(C128D)_Fwd GACTTCATTGATCAACACGACAGTCTGATGAAAGTTC sumo-RitR(C128D)_Rev GAACTTTCATCAGACTGTCGTGTTGATCAATGAAGTC  
 
2.2.6 Determination of C128 pKa by DTNB assay 6, 7 
The thiol-reactive reporter compound 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) can be used to determine the number of free, solvent-exposed thiol groups in a protein or to estimate the pKa in cases where a single thiol group is present. The assay is based on the formation of 2-nitro-5 thiobenzoate (TNB-) upon reaction of DTNB with thiol groups. The ionized reporter group, TNB2- absorbs UV light at 412 nm (Scheme 2-1).  
Reactions contained 5 μM RitR and 20 μM DTNB in 50 mM CHB buffer (50 mM citric acid, 50 mM HEPES, 50 mM Bicine, 150 mM NaCl, with pH adjusted by titration with NaOH 
 
Scheme 2-1: The mechanism of DTNB assay  
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or HCl as appropriate) at pH values ranging from 4 to 9. The reactions were conducted at room temperature (~21 °C) in an EvolutionTM 300 UV-Vis spectrophotometer (Thermo Scientific). The absorption at 412 nm was recorded until it plateaued. Then the pH-dependent rate of each reaction k(pH) was determined by fitting the time course to the following equation:  
𝐴𝐴412(𝑡𝑡) = 𝐴𝐴412,0 + ∆𝐴𝐴412(1 − 𝑒𝑒−𝑘𝑘(𝑝𝑝𝑝𝑝)𝑡𝑡)    Equation 1 
Since k(pH) is directly dependent on the proportion of the cysteine thiolate group, the pKa of the C128 thiol was obtained by fitting the plot of k(pH) vs pH to the following equation: 
𝑘𝑘(𝑝𝑝𝑝𝑝) = 𝑘𝑘1+10𝑝𝑝𝑝𝑝𝑎𝑎,𝑡𝑡ℎ𝑖𝑖𝑖𝑖𝑖𝑖−𝑝𝑝𝑝𝑝     Equation 2 
where k(pH) is the observed rate constant at a particular pH value, and k is the maximal rate of TNB2- formation at high pH. 
 
2.2.7 Crystallization, structure determination, and model refinement 
Crystals of selenomethionine (SeMet)-substituted RitR(C128S) were grown by the vapor diffusion method with hanging drop geometry. Drops were comprised of equal parts protein solution (20 mg/ml RitR(C128S) in 25 mM TRIS, pH 8.0) and crystallization 
solution (25% (w/v) polyethylene glycol (PEG) 3350, 0.1 M ammonium acetate). Partially-hollow rods appeared after several days at 16oC. Crystals were prepared for flash-cooling 
by sequential soaks in solutions containing 25% PEG (w/v) 3350, 0.2 M ammonium 
acetate, and 5, 10, or 20% glycerol (v/v).  
48 
Crystals of RitR(C128D) were grown by the same method, except with hanging drops composed of 1 μl of protein solution (15.3 mg/mL RitR(C128D) in 10 mM ADA pH 7.0) and 
1 μl of crystallization solution (0.1 M HEPES pH 7.5, 22.5% Jeffamine ED-2001 pH 7.0). Long rod-shaped crystals grew after 3 days at 16 oC. Crystals were prepared for flash-cooling by sequential soaks in solutions containing 0.1 M HEPES pH 7.5, 22.5% Jeffamine ED-2001 pH 7.0, and 5, 10, or 20% glycerol (v/v). 
Crystals of RitRox were grown by the hanging-drop, vapor diffusion method with drops 
consisting of 2 μl of protein solution (6 mg/ml RitRox in pH 6.5, 20 mM TRIS, 150 mM NaCl, 100 mM malic acid, 1 mM H2O2) and 1 μl of crystallization solution (10% (w/v) PEG 3350, 0.3 M magnesium sulfate). Prism-shaped crystals appeared after several days at 16 oC. Crystals were prepared for flash-cooling by soaking in a solution containing 10% (w/v) 
PEG 3350, 0.3 M magnesium sulfate, and 20% glycerol (v/v).  
Crystals of RitR oxidized by treatment with CuCl2 rather than H2O2 were grown from 
drops containing 1 μl of protein solution (5 mg/mL RitRCuOX in pH 6.5, 25 mM TRIS, 150 mM NaCl, 100 mM Malic acid, 1 mM CuCl2) and 1 μl of microseeding solution (4% 
Tacsimate pH 6.0, 7.5% PEG 3350 containing microseeds derived from its own crystals). Single prism-shaped crystals grew after several days at 16 °C. Crystals were prepared for flash-cooling by sequential soaking in solutions containing 4% Tacsimate pH 6.0, 7.5% PEG 
3350, and 5, 10, or 20% glycerol (v/v). 
Crystals of selenomethionine-substituted RitR(L86A/V93A) REC domain, residues 1-
124 (RDLV), were grown in drops consisting of equal parts of protein solution (4.4 mg/ml 
RDLV in 10 mM TRIS pH 8.5, 50 mM Succinic acid) and crystallization solution (20% (w/v) 
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PEG  3350, 0.2 M magnesium sulfate, 0.1 M TRIS pH 8.5, 1 mM DTT). Small rods appeared after several days at 16 oC. Crystals were prepared for flash-cooling by sequential soaks in 
solutions containing 20% PEG (w/v) 3350, 0.2 M magnesium sulfate, 0.1 M TRIS pH 8.5, 
and 5, 10, or 20% glycerol (v/v).  
Crystals of SeMet-substituted RitR(L86A/V93A) REC domain, residues 1-132 (RD2LV), were grown by the hanging-drop, vapor diffusion method in drops comprised of equal parts of protein solution (19 mg/ml RD2LV in 10 mM glycine pH 8.8, 25 mM L-Arg) and 
crystallization solution (22.5% (w/v) polyethylene glycol (PEG) 3350, 12% Tacsimate pH 8.2). Small plate-shaped crystals appeared after several days at 16 oC. Crystals were prepared for flash-cooling by sequential soaks in solutions containing 22.5% (w/v) PEG 
3350, 12% Tacsimate pH 8.2, and 5, 10, or 20% glycerol (v/v).  
X-ray diffraction data for SeMet RitR(C128S) were collected at beamline 21-ID-F of the Life Science Collaborative Access Team (LS-CAT) at the Advanced Photon Source (APS), Argonne National Laboratory.  The RitR(C128D) data set was collected at LS-CAT beamline 21-ID-G. The RitRox data set was collected at LS-CAT beamline 21-ID-F. The SeMet RDLV data was collected at LS-CAT beamline 21-ID-G. The SeMet RD2LV data were collected at LS-CAT beamline 21-ID-D. All data sets were processed with HKL2000 8. 
The structure of RitR(C128S) was determined by the single-wavelength anomalous diffraction (SAD) method using 1.5 Å-resolution data collected from a single crystal of SeMet-substituted RitR(C128S) at 0.97889 Å, 61.0 eV below the tabulated K-edge wavelength for Se (0.97950Å). The program autoSHARP9 was used to solve the Se substructure, which contained 16 of the 18 Se atoms in the asymmetric unit, and to 
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calculate density-modified electron density maps. An initial model comprising ~90 % of the asymmetric unit contents was built using BUCCANEER10.  
The structure of RDLV was determined by the single-wavelength anomalous diffraction (SAD) method using 1.9 Å-resolution data collected from a single crystal of SeMet-substituted proteins at 0.97857 Å, 61.0 eV below the tabulated K-edge wavelength for Se (0.97950Å). The program autoSHARP9 was used to solve the Se substructure, which contained 16 of the 18 Se atoms in the asymmetric unit, and to calculate density-modified 
electron density maps. An initial model comprising ~90 % of the asymmetric unit contents was built using BUCCANEER10. The structure of RD2LV was determined by the single-wavelength anomalous diffraction (SAD) method using 2.6 Å-resolution data collected from a single crystal of SeMet-substituted proteins at 0.97872 Å, 61.0 eV below the tabulated K-edge wavelength for Se (0.97950Å). The program autoSHARP9 was used to solve the Se substructure, which contained 16 of the 18 Se atoms in the asymmetric unit, and to calculate density-modified electron density maps. An initial model comprising ~90 % of the asymmetric unit contents was built using BUCCANEER10. 
Chain A of this model was used as the search model for molecular replacement in PHASER11 to phase the RitRox structure.  Both models were subjected to iterative cycles of manual model building in COOT12 and maximum likelihood-based refinement using the PHENIX package (phenix.refine13). Ordered solvent molecules were added automatically in phenix.refine and culled manually in COOT. Hydrogen atoms were added to the model using phenix.reduce14 and were included in the later stages of refinement to improve the stereochemistry of the model. Positions of H atoms were refined using the riding model 
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with a global B-factor. Regions of the model for translation-libration-screw (TLS) refinement were identified using phenix.find_tls_groups (P.V. Afonine, unpublished work) and the TLS parameters were refined in phenix.refine. Once the refinement converged, the model was validated using the tools implemented in COOT and PHENIX 15, 16. Sections of the backbone with missing or uninterpretable electron density were not included in the final model. Data collection and model refinement statistics are listed in Appendix A. Coordinates and structure factors for both RitR(C128S) and RitRox models have been deposited in the Protein Data Bank (www.rcsb.org) with accession codes 5U8K and 5U8M. 
 
2.2.8 Synthesis of binding site 3 (BS3) dsDNA oligonucleotides 
Early footprinting experiments detected 3 binding sites for RitR(BS1-BS3)1. Since RitR was deemed to have the highest affinity for BS3, this sequence was used to investigate the DNA-binding activity of RitR and its variants. To facilitate co-crystallization of RitR bound to DNA, different lengths of BS3 were designed (Table 2-2), since the length of the oligonucleotide is a key parameter in the crystallization of protein:DNA complexes.  Both strands of BS3-1, BS3-2, BS3-3, BS3-4, and BS3-5 were synthesized by Integrated DNA Technologies (Coralville, IA). Both strands of BS3-6 were synthesized via standard 
automated DNA synthesis techniques in a 1.0 μM scale using commercial 1000 Å CPG-succinyl-nucleoside supports. Deprotection of the nucleobases and phosphate moieties as well as cleavage of the linker were carried out under mild deprotection conditions using a 
mixture of 40% aq. MeNH2 and 28% aq. NH3 (1:1) at room temperature for 2 h. Oligonucleotides were purified by 20% denaturing polyacrylamide gel electrophoresis. 
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Quantification of oligonucleotides was carried out using a Phosphorimager equipped with ImageQuant Version 5.2 software. Double-stranded DNA was obtained by mixing the two single-stranded oligonucleotides in 250 mM TRIS pH 6.5, 150 mM NaCl buffer and heating to 90 oC for 5 min, followed by slow cooling to room temperature. 
 
Table 2-2: Sequences of the BS3 variants used in RitR binding assays. 
Name Sequence Length (bp) 
BS3-1 5'-GGTATGAAACTTTCTCATTATTTAATTGGCTTACTTCT-3' 3’-CCATACTTTGAAAGAGTAATAAATTAACCGAATGAAGA-5’ 38 BS3-2 5'-GGTATGAAACTTTCTCATTATTTAATTGGCTTAC-3' 3’-CCATACTTTGAAAGAGTAATAAATTAACCGAATG-5’ 34 BS3-3 5'-ATGAAACTTTCTCATTATTTAATTGGCTTACTTCT-3' 3’-TACTTTGAAAGAGTAATAAATTAACCGAATGAAGA-5’ 35 BS3-4 5'-AAACTTTCTCATTATTTAATTGGCTTACTTCT-3' 3’-TTTGAAAGAGTAATAAATTAACCGAATGAAGA-5’ 32 BS3-5 5'-CTTTCTCATTATTTAATTGGCTTACTTCT-3' 5’-GAAAGAGTAATAAATTAACCGAATGAAGA-3’ 29 BS3-6 5'-CTTTCTCATTATTTAATTGGCTTA-3' 3’-GAAAGAGTAATAAATTAACCGAAT-5’ 24 
 
 
2.2.9 Size exclusion chromatography (SEC) 
The oligomeric states of wild-type and mutant forms of RitR were assessed by size exclusion chromatography (SEC). All separations were carried out using an Agilent 1220 
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Compact HPLC equipped with a 250 x 4.6 mm BioBasic SEC-300 column equilibrated with pH 6.5, 10 mM TRIS, 150 mM NaCl, and 100 mM malic acid. The column was calibrated with the Gel Filtration Molecular Weight Marker kit from Sigma-Aldrich (Cytochrome C (12.4 kDa), Carbonic Anhydrase (29 kDa), Bovine Serum Albumin (66 kDa), and Sweet Potato Amylase (200 kDa)). The H2O2- or CuCl2- treated RitR proteins were injected (5 μl of 4 mg/mL proteins) onto the column and separated at a flow rate of 0.5 ml/min at ambient temperature. Wild-type and mutant forms of RitR was assayed for DNA-binding activity by 
mixing 260 μM protein (RitR, RitR(L86A/V93A), RitR(L86A/V93A/C128S) and other 
mutants) with 100 μM each of the BS3 variant oligonucleotides (BS3-1, BS3-2, BS3-3, BS3-
4, BS3-5, BS3-6). SEC experiments were carried out under the same conditions used for the RitR proteins in the absence of DNA. 
 
2.2.10 Non-reducing SDS-PAGE and Native SDS-PAGE (NSDS) 
Proteins were incubated with different metals for 2 hours at room temperature. These samples were then mixed with SDS loading dye lacking reducing agent, boiled for 5 min, 
and loaded on 12% SDS polyacrylamide gel. Proteins were revealed by staining with GelCode™ Blue Safe Protein Stain (Thermo SCIENTIFIC, Rockford, IL) for 1 h and destained in MilliQ H2O. The slightly modified protocol for running native SDS-PAGE is followed the protocol from Dr. Petering Lab17.  
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2.3 Results 
2.3.1 Determining the optimal RitR storage buffer for crystallization 
Like many DNA-binding proteins, such as the γδ resolvase18, MarA19, and MarR20, the full-length RitR protein is not stable in low ionic strength buffers. In low ionic strength buffers like 25 mM TRIS pH 8.0, RitR precipitated out as a flocculent white solid, and this precipitate could be redissolved by addition of NaCl. Since it is generally preferred to search for crystallization conditions with the protein in a dilute, low ionic strength buffer, we performed experiments to find the lowest NaCl concentration where RitR would be stable. To begin, purified RitR was desalted into 25 mM TRIS pH 8.0, with concentrations of NaCl ranging from 50 to 200 mM in 50 mM steps. Samples were incubated overnight at 4 °C and the amount precipitate was assessed qualitatively. The lowest NaCl concentration tested that did not give visible precipitate was 150 mM.  With the ionic strength optimized, we set about exploring the effect of buffer identity and pH on RitR stability. This was done using differential scanning fluorimetry together with the Solubility & Stability and Slice pH screens (Hampton research). The Solubility and Stability Screen, which is a collection of 96 small-molecule additives, was run in the 25 mM TRIS pH 8.0, 150 mM NaCl buffer. The top 10 conditions from the Solubility & Stability and the Slice pH screens, as judged by the degree of increase in the Tm above the average Tm, are shown in Table 2-3 and Table 2-4, respectively.  
Since malonate is used as a cryo-protecting agent for protein crystals, 100mM malonate was added to the protein storage buffer.  The agents with similar structures, such as DL- 
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Table 2-3: Compounds from the Solubility & Stability Screen (Hampton Research) giving the highest Tm values in the DSF assay 
Tm - Tm,averaged (oC) Additive 6.2 Spermine tetrahydrochloride 
4.8 GSH, GSSG 
4.7 Choline acetate 
4.7 Ammonium sulfate 
4.6 Succinic acid pH 7.0 
4.4 Sodium malonate pH 7.0 
4.4 Sodium sulfate decahydrate 
4.3 L-Arginine, L-Glutamic acid 
4.1 1-Ethyl-3-methylimidazolium acetate 
4.0 Sodium chloride  
Table 2-4: Buffers from the Slice pH Screen (Hampton Research) giving the highest Tm values in the Thermofluor assay 
Tm - Tm,averaged (oC) Additive 
4.6 DL-malic acid pH 5.6 
4.4 Succinic acid pH 6.0 
4.2 DL-malic acid pH 5.3 
4.0 Succinic acid pH 5.7 3.5 BIS-TRIS propane pH 7.3 
3.4 BIS-TRIS pH 6.6 3.3 ADA pH 7.0 3.3 HEPES sodium pH 6.6 3.2 MES monohydrate pH 6.5 3.1 Sodium cacodylate trihydrate pH 6.1  
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malic acid (ACROS Organics) and citric acid (ACROS Organics), were also used for wild-type RitR protein storage and crystallization. 
According to the Slice pH screen results, the optimal pH is ~6 to 6.5. We chose pH 6.5, 25 mM Tris, 150 mM NaCl, 100 mM malonic acid/DL-malic acid/citric acid buffers to store wild-type RitR.  RitR in these three buffers were crystallized. Crystals were obtained at all these buffers. But better crystals were obtained in DL-malic buffer, so the final RitR storage buffer I used is pH 6.5, 25 mM Tris, 150 mM NaCl, 100 mM DL-malic acid buffer. 
 
2.3.2 Monomeric structure of RitR(C128S) 
Gel filtration chromatography suggests that inactive RitR is predominantly monomeric, but  a second species, consistent in size with a dimer, is also present and accounts for ~10-
20% of the sample. Likely because of this heterogeneity, the full-length, wild-type RitR proved impossible to crystallize. To facilitate crystallization, the only cysteine residue 
(C128) was mutated to serine (RitR(C128S)). This variant proved to be 100% monomeric as judged by gel filtration chromatography and native-PAGE.  
The structure of RitR(C128S) was determined to 1.7 Å resolution by using phases derived from SeMet single-wavelength anomalous diffraction (Se-SAD)(Figure 2-1). It is a monomer, which is in agreement with biochemical data mentioned above. There are two monomers in the asymmetric unit. But these two monomers do not form a dimer, nor with their symmetry mates. RitR(C128S) contains regulatory ALR domain and DNA binding domain (DBD). The only cysteine residue in RitR, C128, is located at the C-terminal end of 
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the long α5 linker helix, which connects the ALR domain with the DNA-binding domain (DBD). The ALR domain structure is same with the earlier solved RitR ALR domain only 
structure (PDB ID: 4LZL3, Figure 1-). DBD has the helix-turn-helix (HTH) motif, which is the simplest and most common motif in prokaryotes and eukaryotes21. This HTH motif contains two fixed angled helices connected by a small loop.  The more C-terminal helix (colored in red in Figure 2-1) is the recognition helix that used for contacting with specific DNA major groove.  
 
 
 
Figure 2-1: Ribbon representation of the structure of full-length RitR(C128S) (A) and a close-up on the inter-domain interface (B).  Important amino acid side chains are shown as sticks. The regulatory domain 
is shown in blue, except for the putative α4-β5-α5 dimer interface, which is colored green. The DNA-binding domain is colored yellow, except for the DNA-contacting helix and trans-activation loop, which are colored red and magenta, respectively. 
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There is an extensive network of salt bridges and hydrogen bonds between the regulatory ALR domain and DBD, with each domain contributing a surface area of approximately ~850 Å2 (Figure 2-1B). E91 makes salt bridges with R202 (3.1 Å). E91 and 
Q94 make hydrogen bonds to Tyr203 with distances of 2.0 Å and 2.2 Å, respectively). R95 interacts with S206 (2.5 Å), residues that are found on the DNA-contacting helix of the DBD, 
helix α4b, and helix α5 of the ALR domain. Both α4 and α5 are contributed to the dimerization interface in other OmpR/PhoB type response regulator proteins. The DNA-contacting helix interacts with helix α4b and is thus not free to interact with DNA. Additionally, the trans-activation loop is involved in the interdomain interface and would thus be unavailable to interact with RNA polymerase. All of these facts demonstrate that this monomeric conformation is not the active, DNA-binding conformation of RitR. 
 
2.3.3 The thiol group of the conserved C128 residue has a perturbed pKa 
We assumed that, like most DNA-binding RR proteins, the active, DNA-binding form of RitR is a homodimer. Comparing the sequences of all RitR homologs in the Streptococci (Figure 2-2A) shows that this Cys residue is strictly conserved. This raises the possibility that RitR could be a redox-responsive response regulator protein. In other cysteine-based redox sensor proteins, the side chain thiol groups of the key cysteine residues have been found to have significantly depressed pKa values 22, 23. In order to ascertain whether or not the C128 thiol group also has a perturbed pKa, and could thus be expected to be redox active under physiological conditions, the pKa of C128 was determined using the DTNB assay. The rate of reaction of DTNB with thiol groups depends directly on the proportion of 
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thiols that are present as the thiolate anion. The reaction (Scheme 2-1) releases TNB-, which readily deprotonates to give TNB2-, a species that absorbs at 412 nm. By monitoring the rate of the DTNB reaction at different pH values, it is possible to derive an estimate of the pKa of the thiol group. Reactions containing 20 µM DTNB in a buffer system consisting of citric acid, HEPES, and bincine (50mM each) were initiated by the addition of 5 µM RitR, 
and the absorbance at 412 nm was monitored (Figure 2-2 B). Nonlinear fitting of these progress curves to Equation 1 gave estimates of the pH-dependent rate constant of the reaction, k(pH). These values were plotted as a function of pH, and then fit to Equation 2  (Figure 2-2C) to gives an estimate of the pKa of C128 of 7.2 ± 0.2. This is slightly decreased from the thiol pKa of cysteine in solution, which is generally quoted above 8.3. Different buffer systems were tested for this assay, giving a pKa range for C128 of 6.9-7.5. The perturbed pKa of C128 suggests that this residue is more reactive than a typical surface-exposed cysteine residue and thus may be part of a redox-sensing switch mechanism in RitR. 
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Figure 2-2: (A) Sequence alignment of RitR homolog in a non Group A/B subset of Streptococcal species demonstrated a conservation of redox sensor C128. (B) The absorbance at 412 nm  (dots) and fitting lines at pH 5.1 (red), 5.5 (blue), 6.0 (green), 6.6 (black), 6.9 (magenta), 7.6 (cyan), 7.9 (purple) and 8.4 (orange). (C) The pH dependence of the rate constants of C128 with DTNB.The plot of rate constants (k(pH)) vs pH gives the C128 pKa of 7.2 ± 0.2. 
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2.3.4 The structure of RitRox 
RitR is a transcriptional regulator with a DNA-binding effector domain, which suggests that RitR probably functions as a homodimer, since oligomerization is an extremely common feature of DNA-binding proteins, and of response-regulators in particular. The depressed pKa of C128 suggested the possibility of a redox-based activation mechanism in RitR. Accordingly, the consequences of H2O2-mediated oxidation of RitR with respect to the oligomeric state and structure were investigated by size exclusion chromatography and X-ray crystallography.  
Initial experiments showed that brief incubations with RitR failed to produce any change in the oligomeric state of the protein (Figure 2-3A). Using different buffers for the oxidation, such as citric acid, malic acid, or malonic acid, all at 50mM and pH 6.5, likewise did not alter the oligomeric state when RitR was treated with 1 mM H2O2 (Figure 2-3B).  Extending the oxidation time to 19h did increase the proportion of dimer present, the 
maximum proportion of dimer (~90%) was only obtained when the SEC running buffer contained 1 mM H2O2. Once the optimal oxidation conditions were established, a preparative scale Sephacryl S-200 10/300 column was used to prepare samples of RitR dimer (i.e. RitRox) for crystallization. The dimer peak from the S-200 column was collected and stored in pH 6.5, 25 mM TRIS, 150 mM NaCl, 100 mM malic acid, and 1 mM H2O2. This material was concentrated to 10 mg/ml and subjected to screening for crystallization conditions. 
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Diffraction-quality crystals of RitRox were obtained from a hanging drop containing 2 μl of protein solution (6 mg/ml RitRox in pH 6.5, 20 mM TRIS, 150 mM NaCl, 100 mM malic acid, 1 mM H2O2) and 1 μl of crystallization solution (10% (w/v) PEG 3350, 0.3 M magnesium sulfate. The structure was determined to 1.7 Å resolution by using RitR(C128S) as the 
 
Figure 2-3: Different amounts of oxidized RitR dimer in different buffer conditions were determined by gel filtration on a Sephacryl S-200 10/300 column. (A) The gel filtration results of RitR in pH8, 25 mM Tris, 150 mM NaCl buffer. Black line represents no H2O2 treatment, while red line represents 1 mM H2O2 treatment. (B) The gel filtration results of RitR in pH 8, 25 mM Tris, 150 mM NaCl, 100 mM malonic acid buffer with different H2O2 treatment conditions. Black line represents no H2O2 treatment. Red line represents RitR was treated with 1 mM H2O2 for 3 h. Blue line represents RitR was treated with 1 mM H2O2 for 19 h. Green represents RitR was treated with 1 mM H2O2 for 3 h and containing 1mM H2O2 in the running buffer. Magenta represents RitR was treated with 10 mM H2O2 for 3 h and containing 1mM H2O2 in the running buffer. The maximum amounts of RitRox were got with 1 mM H2O2 in the running buffer. 
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model. The structure of RitRox shows that the tertiary structures of the individual domains do not change significantly. However, the two chains present in the asymmetric unit form a domain-swapped dimer (Figure 2-4A). Upon oxidation, the DNA-binding domain must be released from the REC domain. The structural change that triggers release of the DNA-binding domain may be a rearrangement of the C-terminal end of the long α5 linker helix, which appears to unwind upon oxidation of C128 (Figure 2-4B) to form an inter-chain disulfide bond. Since there is no DNA to bind, and the restricted conformation imposed by the inter-chain disulfide bond, the DNA-binding domain of one protomer interacts with the REC domain from the other protomer to almost perfectly recapitulate the inactive, monomeric structure (Figure 2-4D). Overlaying the REC domain of chain A together with the DBD of chain B onto the RitR(C128S) monomer gives a root-mean-square deviation for 
aligned Cα atoms of 0.7 Å. This inactive “cross-dimer” conformation may be an intermediate that forms before the oxidized dimer encounters its cognate DNA sequence, or it may indicate that oxidation of C128 is not the entire signal. 
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Figure 2-4: The structure of RitRox. (A) Ribbon representation of the RitRox structure, Rec domain colored in blue (dark blue in chain A and light blue in chain B); α5 helix colored in orange (dark orange in chain A and light yellow in chain B); DNA binding domain colored in green (dark green in chain A and light green in chain B). (B) Close up view of disulfide bond. The 2|Fo|-|Fc| electron density map contoured at 1.0σ is shown as magenta mesh, and the 2|Fo|–|Fc| composite omit map, also contoured at 1.0σ is shown as green mesh. (C) RitRox structure with transparent blue surface in chain B. (D) Superimpose RitRox with inactive monomeric RitR(C128S) (purple). RMSD = 0.7 Å 
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2.3.5 RitR incubated with different metals 
Because RitR is the repressor of iron transport, we hypothesized that iron or another divalent metal might be involved in the activation mechanism of RitR. To study the effect of metals on RitR dimerization, RitR was treated with FeIIICl3, FeIICl2, MgCl2, MnCl2, CaCl2, CuCl2, or ZnCl2, all in pH 6.5, 20 mM TRIS, 150 mM NaCl, 100 mM malic acid buffer. Size exclusion chromatography was used to check the oligomeric state, and the results are shown in Figure 2-5. 
Figure 2-5: Oligomer state of RitR after incubated with different metals. Blue line represents RitR only. Cyan line represents RitR(L86A/V93A) only. This mutant represented an extended dimer, which will be discussed below. Magenta line represents RitR with 1 mM metals. Green represents RitR with 10 mM different metals. Brown and green represent 1 mM and 10 mM different metals, respectively. (A) RitR were incubated with CuCl2. (B) RitR were incubated with FeIIICl3 with DTT. (C) RitR were incubated with FeIIICl3 (D) RitR were incubated with FeIISO4 with 0.1 N HCl. (E) RitR were incubated with MgCl2. (F) RitR were incubated with ZnCl2. (G) RitR were incubated with CaCl2. (H) RitR were incubated with MnCl2. 
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SDS-PAGE, non-reducing-PAGE, and native SDS-PAGE were also used to check the oligomeric state after treatment with the various metals. The results of these experiments are shown in Figure 2-6.  
 
Figure 2-6: (A) Non-reducing-PAGE  results of RitR treated with different metals. 1, wild-type RitR; 2, RitR(L86A/V93A); 3, RitR with 1 mM FeIIICl3; 4, RitR with 10 mM MgCl2; 5, RitR with 10 mM MnCl2; 6, RitR with 1 mM CuCl2; 7, RitR with 10 mM CuCl2; 8, RitR with 1 mM ZnCl2; 9, Marker; 10, RitR with 10 mM ZnCl2. (B) Native SDS-PAGE results of RitR treated with different metals. 1, Marker; 2, wild-type RitR; 3, 
RitR(L86A/V93A); 4, RitR with 1 mM FeIIICl3; 5, RitR with 10 mM MgCl2; 6, RitR with 10 mM MnCl2; 7, RitR with 1 mM CaCl2; 8, RitR with 10 mM ZnCl2; 9, RitR with 10 μM CuCl2; 10, RitR with 100 μM CuCl2;  11, RitR with 1 mM CuCl2; 12, RitR with 10 μM FeIIICl3 with 0.1 mM DTT; 13, RitR with 100 μM FeIIICl3 with 0.1 mM 
DTT; 14, RitR with 1 mM FeIIICl3 with 0.1 mM DTT. Top bands located around the 50 kD marker, corresponding to dimer, while the bottom bands located around the 25 kD marker, corresponding to monomer.  
 
When the metal-treated samples of RitR were run on a non-reducing gel (Figure 2-6A) to preserve any disulfide bonds, wild-type RitR runs mainly as a monomer, while the double mutant RitR(L86A/V93A) runs mainly as a dimer. This constitutively dimeric double mutant will be discussed in detail below. Treatment of the wild-type RitR with Fe3+, Fe2+, 
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Mg2+, Mn2+, Zn2+, did not alter the dimer/monomer ratio. However, treatment with Cu2+ promoted dimerization of RitR as judged from the non-denaturing SDS-PAGE gel. This result was confirmed by native SDS-PAGE (nSDS-PAGE). Increasing the CuCl2 concentration increased the proportion of dimer obtained. These results indicated that Cu2+ induced the dimerization of RitR. 
The structure of RitR dimer by CuCl2 treatment (data not shown) is same with RitRox by H2O2 treatment, because copper also can oxidize the cysteine residue to form disulfide bond 24-26. So the structure of RitRox,CuCl2 is also an inactive conformation. 
 
2.3.6 Structural features important for RitR dimerization 
The active, DNA-binding form of RitR is hypothesized to be a homodimer, which binds to specific sequences in the piu promotor and represses the expression of genes associated with iron uptake and up-regulates the expression of genes involved in the response to oxidative stress. We saw above that the DBD of the RitR dimer obtained by oxidation alone (i.e. in the absence of DNA) is characterized by a conformational change at the C-terminal 
end of α5 and a domain-swapping arrangement that matches almost perfectly with the inactive monomeric structure.  There is virtually no contact between the ALR domains in this so-called “cross dimer.” By analogy to other RR proteins whose active structures are known, we hypothesize that the ALR domains will dimerize in the active, DNA-binding 
state, likely through the same α4-β5-α5 interface that interacts with the DBD in the inactive structure. Again, by analogy to other RRs, there is likely to be a conformational change that 
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makes formation of this ALR dimer more favorable in the activated state. To investigate what residues are involved in the disruption of the ALR-DBD interface, and thus facilitate dimerization of the ALR domains, site-directed mutagenesis was employed. Specific point mutants were chosen based on the RitR(C128S) and RitRox structures and are concentrated in regions of the structure known to be important in other RRs, or in regions that are particularly unusual in RitR. For example, residues in the active site that differentiate RitR from typical REC domains were investigated (K10D, N53D and N53A, D81A). Likewise, 
residues on the unusual α4 helix that were hypothesized to be part of a “hydrophobic gate” that could influence dimerization were also mutated (L86A, L90A, V93A, L86A/V93A, F96G). Residues on β5 that are involved in dimerization in other RRs were targeted (Y100 and Y102), since these residues make extensive interactions with the DBD in both 
structures. Finally, we tested the effects of mutating residues in the α5 linker helix that make key interactions in the ALR-DBD interface (R133A). C128 was targeted due to its central hypothesized role in redox-based sensing (C128A, C128S, C128D) and Y163 was mutated to Phe to break the water-mediated interaction with C128. The locations of the mutagenesis sites are shown in Figure 2-7, and the rationale for each is given in Table 2-5.   
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Table 2-5: Summary of the rationale of each mutation 
Mutation Site Reason for mutation K10 Basic residue in the putative phosphorylation site, usually acidic residue in typical RRs. N53 Phosphorylatable site D81 Switch residue Y100 Switch residue F96 Hydrophobic core and impede the Y100 reorientation for dimerization Y102 Point outward and affect the dimer interface formation R113 Interact with Y100 and impede the Y100 reorientation for dimerization C128 Redox sensing Y163 Interact with S128(C) through a water L86 Hydrophobic core and impede the Y100 reorientation for dimerization L90 Hydrophobic core and impede the Y100 reorientation for dimerization V93 Hydrophobic core and impede the Y100 reorientation for dimerization 
 
Figure 2-7: Cα trace of full-length RitR(C128S) structure with the sites chosen for mutagenesis marked as 
colored spheres. The ALR domain is colored blue, except for the α4-β5-α5 face, which is colored green. The DBD is colored pale yellow, except for the DND-contacting helix (red) and the trans-activation loop (magenta). 
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The oligomeric state of each of the mutants was assessed by size exclusion chromatography in the hope of finding at least one variant that was dimeric even in the fully reduced state. Accordingly, each mutant was analyzed on the BioBasic SEC-300 column in the presence or absence of dithiothreitol (DTT). Wild-type RitR mainly exists as monomer, with a small portion of dimer (green trace in Figure 2-8A), which disappears when DTT is added (red trace). According to the sequence alignment in Figure 1-3, one of the acidic triad residues of typical response regulators is replaced with a basic residue, lysine, in RitR(K10; Figure 2-8B). The side chain of K10 disrupts both the acidic environment and the cleft for Mg2+ binding. The mutant K10D, which partially reconstitutes the Mg2+-binding site, like the wild-type protein, exists mainly as monomer (Figure 2-8C). Interestingly, changing N53, which in typical RRs is the phosphorylatable aspartic acid residue, leads to a shift in the oligomeric state in the N53A variant (Figure 2-8D). This protein has a greater proportion of dimer than the wild-type, but monomer is still the major species. Changing N53 back to Asp (N53D) leads to an unstable and likely mostly unfolded protein (Figure 2-8E).  
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Figure 2-8: Oligomer states of wild-type RitR (A), RitR(K10D) (C), RitR(N53D) (D) and RitR(N53A) (E) without any treatment (green) or with 10 mM DTT treatment (red). (B) The putative active site of RitR. K10 and N53 are shown in stick. 
 
73 
In RitR, the residue that is equivalent to the threonine of the Y/T switch found in typical RRs is D81. This residue is oriented toward N53 and is held there by interactions with a number of active site residues (Figure 2-9). Compared with the corresponding residue in atypical regulator ChxR (L72) and typical regulator PhoP (T79), D81 in RitR represents the active conformer (Figure 2-9). This conformation of D81 is reminiscent of the interaction between T83 and the phospho-Asp side chain in activated PhoB27 (Figure 1-4). In the inactive state, L72 in ChxR and T79 in PhoP forms part of gate residues, but in RitR, D81 points toward the putative active site and leaves L86 replacing the corresponding position. Some other atypical RRs that have been studied, such as ChxR, have a leucine residue at this position. It also shifts away from the active site.  
The hydroxyl group of tyrosine of inactive ChxR and PhoB point outward from the domain, which interrupts the dimer interface formation. In the structure of non-phosphorylated PhoP (Figure 2-9), even it forms a similar “active” dimer with the switch residue Y98 pointing outward, but this dimer was obtain at high crystallization 
concentration and the helix α4 exhibits very high flexibility, which suggests this high concentration induced dimer is not a stable dimer. The phosphorylation-induced dimerization of PhoP (PDB ID: 2PL15) is stable with Y98 side chain pointing inward. So in RitR structure, Y/T switch is effectively “uncoupled”, where Asp81 is in the active form but Tyr100 is in the inactive form.  
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Figure 2-9: Comparison of gate regions of two ALR REC domains, RitR (PDB ID 4LZL3) and ChxR (PDB ID 3Q7T4), and the canonical REC domain of PhoB (PDB ID 1B00) and PhoP (PDB ID 2PKX5). These structures are all in an inactive state according to the positions of their Y/T switch residues. Even PhoP forms a dimer (Chain A colored in grey, chain B colored in yellow), but the dimer is a high protein concentration induced, unstable dimer. The activated dimer of PhoP is a more stable dimer with the switch residues shift inward. Gate residues are represented in green spheres, Y/T switch residues are shown as sticks with orange carbon atoms, and important catalytic residues are shown as sticks with cyan carbon atoms. Note that the Y/T switch residues L72 in ChxR, T83 in PhoB and T79 in PhoP form part of the gate, whereas D81 in RitR does not and is turned toward N53, resembling the active conformation of PhoB. In RitR, the switch residue side chain position is substituted by gate residue L86, which is strategically placed in front of tyrosine 100, allowed by the unusual formation of the kinked α4 helix in RitR. 
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In order to determine whether or not D81 and Y100 act similarly to the switch residues in other RR proteins, both residues were mutated (singly) to alanine and the effects on the oligomeric state assessed by SEC. Substitution of Y100 with Ala does not significantly increase the proportion of RitR in the dimeric conformation (Figure 2-10A). After treatment with DTT, there was no evidence of the dimer form of the Y100A variant. In 
contrast, the D81A variant exists as 65% dimer and 35% monomer (Figure 2-10B). After 
treatment with DTT, the proportion of dimer is less (~50%), but still represents a significant portion of the sample.  
As shown in Figure 2-11, F96, which is located at the C-terminal end of helix α4b, is involved in the hydrophobic interactions within the hydrophobic core (β3, α3, β4). Substituting Gly for Phe at position 96 does increase the proportion of dimer compared to the wild type, but after DTT treatment, there was no dimer detectable. Also, the F96G 
 
Figure 2-10: Results of SEC experiments on the Y100A (A) and D81A (B) variants. The green traces show the results in the absence of DTT treatment, and the red traces show the data after treatment with 10 mM DTT. 
76 
variant was not stable in solution.  
 
 
Figure 2-11: (A) F96 residue is involved in the hydrophobic interactions within hydrophobic core. (B) Oligomer states of RitR(F96G) (B), RitR(Y102A) (D), RitR(R113A) (E), RitR(C128A) (G) and RitR(Y163F) (H) with or without DTT treatment. Green represents no DTT treatment; brown red represents proteins were treated with 10 mM DTT. (C) Y102 and R113 both interact with the switch residue Y100 through water molecules. (F) Y163 interacts with serine in redox sensor C128 position through a water molecule.  
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Like Y100 discussed above, Y102 also points outward, away from the core of the ALR 
domain and projects out from the α4-β5-α5 face of the protein (Figure 2-11C), which may interfere with formation of the dimer interface. In addition, Y102 forms hydrogen bonds with Q87 and Y100 (through a water molecule), which likely impedes the reorientation of the Y100 side chain. When Y102 is mutated to Ala, there is little effect on the monomer-dimer equilibrium. The slight increase in the proportion of dimer becomes undetectable after treatment with 10 mM DTT by analytical SEC (Figure 2-11D). R113, which is located 
on the α5 linker helix, is also involved in interactions with Y100 and also makes a key interaction with the DBD in the inactive structures. Substitution of R113 with Ala results in a protein that is purely monomeric, whether or not it is treated with DTT (Figure 2-11E). 
As expected, the C128 mutants (C128A) are purely monomeric (Figure 2-11G). The hydroxyl group of Y163 forms a water-mediated hydrogen bonding interaction with the hydroxyl group of S128 in the C128S variant (Figure 2-11F). This interaction could potentially be involved in the pKa perturbation of C128. To test this idea, Y163 was mutated to Phe to remove the hydroxyl group. This change has very little effect on the monomer-dimer equilibrium. There is a slight increase in the proportion of dimer compared to the wild-type (Figure 2-11H), and treatment with DTT pushes the protein fully toward the monomeric form. 
One feature of the RitR ALR domain that distinguishes it from typical OmpR/PhoB-type 
RRs is the kinked α4 helix. Helix α4 is broken in two, with an approximately 100o angle 
between the helical axes of the two pieces (α4a and α4b). No REC domain has been shown to have a similar conformation of helix α4. Three hydrophobic residues located in α4a 
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(L86), the short stretch of helix between α4a and α4b (L90), and in α4b (V93), pack against 
the central β sheet and make van der Waals interactions with V54 (Lβ3α3), I79 (β4), A97 
(Lα4β5), Y100 (β5) and Y102 (β5) to form the hydrophobic core of this part of the protein (Figure 2-12A). This solidly packed core would seem to be a mechanical barrier impeding the reorientation of Tyr100 as seen in the structures of activated REC domains: a sort of “hydrophobic gate.” If reorientation of Y100 is required for RitR dimerization as seen in other RRs, and if the hydrophobic gate residues do influence the conformation of Y100, then mutating these residues should have an impact on dimerization.  
To test this idea, a series of mutants was constructed, including L86A, L90A, and V93A. The oligomeric state of each mutant was analyzed by size exclusion chromatography. The mutant L90A exists as a roughly equal mixture of monomer and dimer, and treatment with DTT shifts the equilibrium toward the monomeric form (~30% dimer; Figure 2-12B). Interestingly, RitR(L86A) and RitR(V93A) both exist as predominantly dimer in solution, and the response of each of these mutants to DTT is quite different (Figure 2-121C, D). The RitR(L86A) variant is nearly insensitive to DTT, with only slightly more monomer present after treatment with 10mM of the reductant. On the other hand, the V93A variant shifted dramatically, becoming predominantly monomeric after DTT treatment. Since they had the greatest abount of dimer of any mutants tested, the RitR(L86A) and RitR(V93A) mutants were combined (RitR(L86A/V93A); Figure 2-12E). The double mutant was slightly more stable to DTT treatment than the RitR(L86A) variant. In all, Ala substitution on any of the three hydrophobic gate residues dramatically increases the proportion of RitR dimers. The RitR(L86A/V93A) double mutant was purified in large quantities for crystallographic structure determination.  
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Figure 2-12: The effects of gate residues on RitR dimerization. (A) Schematic view of RitR gate residues van der Waals interactions (yellow dotted lines) and hydrogen-bonding network (green dotted lines) in the 
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dimer/gate region. Oligomer states of wild-type RitR(L90A) (B), RitR(L86A) (C), RitR(V93A) (D) and RitR(L86A/V93A) (E) without any treatment (green) or with 10 mM DTT treatment (red).  
 
2.3.7 Mutations to the gate residues L86 and V93 result in an “extended” dimer 
We were surprised to learn that the retention time of the RitR(L86A/V93A) dimer was significantly earlier (5.4 min) than that of the “cross dimer” conformation (5.6 min) observed for the wild-type protein oxidized with H2O2 (Figure 2-13). In addition, the tiny monomer peak of the RitR(L86A/V93A) variant eluted earlier than that of the wild-type RitR monomer. Both of these observations suggest that the conformation of RitR(L86A/V93A) is more extended, making it behave like a larger protein on the SEC column. This led us to believe that the inter-domain interactions between the RitR(L86A/V93A) ALR domain and the DNA-binding domain are disrupted. This is supported by the small difference in thermal stability between the double mutant and the wild-type protein measured by differential scanning fluorimetry. The average Tm value 
(46.6oC) measured for RitR(L86A/V93A) is lower than that of wild-type RitR (52.2 oC), which suggests that RitR(L86A/V93A) is less stable than RitR. The D,L-malic acid buffer used for storage of the wild-type protein is still a good buffer to store RitR(L86A/V93A) (Table 2-6 and Table 2-7).  
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Table 2-6: Buffers from the Solubility & Stability Screen (Hampton Research) giving the highest Tm values in the Thermofluor assay.  
N.O. Tm - Tm,averaged (oC) Buffer 1 4.3 Sodium phosphate monobasic, Potassium phosphate dibasic 2 3.5 Methyl α-D-glucopyranoside 3 3.3 Lithium citrate tribasic tetrahydrate 
4 3.2 Sodium sulfate decahydrate 5 3.1 Sucrose 6 2.9 Succinic acid pH 7.0 7 2.7 Spermine tetrahydrochloride 8 2.6 Sodium malonate pH 7.0 9 2.5 DL-Malic acid pH 7.0 
              
Figure 2-13: SEC retention times of wild-type RitR (as purified, colored in blue), wild-type treated with H2O2 (colored in brown), and the RitR(L86A/V93A) variant (colored in cyan). 
 
82 
 
Table 2-7: Buffers from the lice pH Screen (Hampton Research) giving the highest Tm values in the Thermofluor assay.  
N.O. Tm (oC) Buffer 1 3.0 DL-malic acid pH 5.3 2 2.7 DL-malic acid pH 5.9 3 2.7 Succinic acid pH 6.0 
4 2.5 Succinic acid pH 5.7 
 
 
2.3.8 Size exclusion chromatography of RitR : BS3 and RitR(L86A/V93A) : BS3 
Since the two domains in the double mutant appeared to be dissociated from one another, while still allowing the protein to dimerize, it is possible that the RitR(L86A/V93A) mutant dimer conformation is the active conformation. To ascertain whether or not this variant is active, the DNA-binding ability of RitR(L86A/V93A) to bind to DNA was assessed by SEC. RitR is known to directly bind and repress piu transcription, and three binding sites (BS1-3) were identified by electrophoretic mobility shift assay (EMSA)1. Due to the much higher affinity of RitR for BS3, we concentrated on this target sequence. In this thesis, I tested the affinity of six lengths of BS3 for crystallization (Table 2-1). And BS3-1 is BS3.  
As shown above, and in Figure 2-14A below, RitR exists mainly as a monomer in the absence of any oxidant. Incubating the wild-type protein with the BS3-1 olignucleotide did 
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not result in formation of a stable RitR:BS3-1 complex. Oxidation of RitR with 1 mM H2O2 for several hours prior to the addition of BS3-1 DNA, resulted in about 60% RitR forming the “cross dimer” RitRox conformation. There is no peak corresponding to the RitRox:BS3-1 complex. The RitR(L86A/V93A) variant, on the other hand, is present almost exclusively as the extended dimer, and when DNA was added, the majority of the protein elutes as a complex with the BS3-1 oligonucletide (retention time ~5.1 min). Oxidation of RitR(L86A/V93A) with H2O2 did not significantly alter the oligomeric state of the double mutant or its ability to bind to the BS3-1 DNA. To verify the binding of RitR(L86A/V93A) to BS3-3 while the wildtype RitR protein does not, differential scanning fluorimetry was used. When the protein bound to BS3-3, the protein would get stabilized and would not be easier to be denatured (higher Tm).  But if the protein cannot bind to the DNA, Tm value would not be affected. In all three buffers, RitR Tm value does not change significantly, while the Tm value of mutant RitR(L86A/V93A) significantly increases (Figure 2-15). These results show that wild-type RitR in both its reduced and oxidized forms is not able to bind to the dsDNA oligonucleotide BS3-1. However, there is a complex peak formed for the sample RitR(L86A/V93A) with dsDNA BS3-1, while RitR(L86A/V93A) with its presumed altered conformation, is able to do so, whether or not it is treated with H2O2. This suggests that the L86A/V93A substitutions bypass the C128-mediated redox-sensing trigger, resulting in a constitutively active form of RitR. 
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Figure 2-14: Size exclusion chromatography results for RitR with and without the BS3-1 dsDNA oligonucleotide (A) and RitR(L86A/V93A) with and without BS3-1 (B). In both panels, the traces for the wild-type RitR protein alone are blue, the RitR(L86A/V93A) protein alone cyan, BS3-1 alone black, RitR or RitR(L86A/V93A) with BS3-1 without H2O2 green, and with 1 mM H2O2 red. For the mixture of RitR or RitRox with BS3-1, dsDNA BS3-1 and proteins were eluted separately. For the mixture of RitR(L86A/V93A) with BS3-1, the RitR(L86A/V93A):BS3-1 complex was eluted, as indicated by the earlier elution time when compared to the BS3-1-only and protein-only peaks.  
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2.3.9 Single mutants in helix α4 also bind to BS3-1 
The studies above verified that mutagenesis on both L86 and V93 that located in the kinked 
α4 helix bind to the target DNA BS3-1. To investigate the binding ability of three single 
mutants (L86A, L90A, V93A) in α4 helix, the oligomer states of them with BS3-1 were determined by SEC. The results were shown in Figure 2-16. These three single mutants on 
α4 helix all bind to BS3-1, because a complex peak eluted earlier than BS3-1 only peak.  
 
Figure 2-15: Tm value change of (A) RitR, RitRox and (B) RitR(L86A/V93A) after incubated with BS3-3 dsDNA. 1: pH 6.5, 25 mM TRIS, 150 mM NaCl, 100 mM DL-malic acid; 2: 20 mM HEPES pH 7.2, 5 mM MgCl2, 1 mM CaCl2, 0.1 mM EDTA; 3: 20 mM HEPES pH 7.2, 5 mM MgCl2, 1 mM CaCl2, 0.1 mM EDTA, 150 mM NaCl. After incubated with BS3-3, RitR Tm did not change significantly in three different buffers. Similar results were obtained for RitRox. But the mutant RitR(L86A/V93A)  Tm value increased significantly in all three buffers. 
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2.3.10 Crystallization of RitR(L86A/V93A) 
RitR(L86A/V93A) is almost entirely dimeric as observed by SEC, but there are detectable amounts of monomer. Since this heterogeneity would make the protein difficult to crystallize, the dimer form was purified by preparative SEC with the same protocol used to purify the RitRox dimer (with the exception of the H2O2 treatment). The fractions 
containing the RitR(L86A/V93A) dimer were concentrated to 7,2, 10.1, or 34.0 mg/ml and 
         
Figure 2-16: Gate residue variants bind to the dsDNA BS3-1 due to a complex peak eluted. In the panel, the traces for the wild-type RitR protein alone are green, the RitR(L86A/V93A) protein alone cyan, BS3-1 alone brown, RitR(L86A) with BS3-1 magenta, RitR(L90A) with BS3-1 blue and RitR(V93A) with BS3-1 red. 
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used to set up sparse matrix screens for the identification of crystallization conditions (Index, PEG/Ion, SaltRx, and PEGRx from Hampton Research). These screens resulted in only clear drops, phase separation, or amorphous precipitate; no conditions resulted in crystalline protein. Examination of the conditions that gave phase separation (super-concentrated protein) showed that the protein favors neutral pH (HEPES or BIS-TRIS at pH 6.5-7.5), PEG3350, and a variety of salts having monovalent cations (ammonium sulfate, lithium sulfate, sodium formate, sodium malonate). These conditions were optimized with different RitR(L86A/V93A) concentrations on both sitting drop and hanging drop methods at different temperatures (room temperature, 16oC, 22oC). Considering the protein crystallization diagram, increase the protein concentration (supersaturation) is necessary for nucleation. So the highest protein concentration I tried is 88 mg/mL. But only stronger phase separation was obtained. There is no crystal formed. For those phase separation conditions, additive screen (Hampton) was also tried. But still no crystal formed. I also tried to use some other proteins crystals as microseeds (sbADC, RitRox, RitR(C128D)) to crystallize the RitR(L86A/V93A) protein, but none succeeded.  
Some proteins only crystallize with the cognate DNA, for example, AmrZ in Pseudomonas 
aeruginosa28. Based on the shorter retention time on size exclusion column, RitR(L86A/V93A) is assumed to be an extended dimer. Because it’s so hard to crystallize RitR(L86A/V93A) protein, RitR(L86A/V93A) probably is the protein that only crystallizes with cognate DNA. Then I tried to co-crystallize RitR(L86A/V93A) with dsDNA. 
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2.3.11 Shorten BS3-1 length for crystallization 
One variable of protein-DNA complex crystallization is the length of DNA. The general principle is “smallest functional”. So different lengths of oligonucleotides were designed to provide blunt-ended dsDNA fragments. In addition, the ratio of protein to DNA is also important for successful crystallization. This ratio relates directly to the shape of the protein component, rather than the oligonucleotide, because the overall shape of the B-DNA is regular and cylindrical.  
         
Figure 2-17: Complex peak area comparison of 216 μM RitR(L86A/V93A) with 100 μM of BS3-1 (red), BS3-2 (orange), BS3-3 (green), BS3-4 (blue) and BS3-5 (purple).  
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To find out which blunt-ended dsDNA at what ratio to RitR(L86A/V93A) protein gives the most quantity of protein-DNA complex for crystallization, the complex peak area of different ratios of RitR(L86A/V93A) to dsDNA (BS3-1 to BS3-5) was determined by SEC. 
RitR(L86A/V93A) protein (216 μM ) was mixed with 100 μM of dsDNA (BS3-1 to BS3-5). The results were shown in Figure 2-17. Comparing the complex absorbance at 280 nm of RitR(L86A/V93A) with different lengths of DNA, BS3-3 with 35 bp nucleotides gives the most quantity of protein-DNA complex. 
 
2.3.12 The ratio of RitR(L86A/V93A) : BS3-3 and RitR(L86A/V93A) : BS3-6 
Based on the above results, BS3-3 gives the most quantity of protein-DNA complex, so BS3-3 was chosen to cocrystallize with RitR(L86A/V93A). Another shorter dsDNA (BS3-6) was also used in cocrystallization with RitR(L86A/V93A) protein. Because the dsDNA is limiting, to get the maximum protein-DNA complex, the “best” ratio of RitR(L86A/V93A) over BS3-3/BS3-6 was determined by comparing the absorbance of complex peak at different protein : DNA conditions. According to the gel filtration results shown in Figure 2-18, the absorbance of protein-DNA complex increases as the protein to DNA ratio increases. For RitR(L86A/V93A) with BS3-3 (Figure 2-18A), the maximum complex was obtained at 
the ratio of 4 : 1 with the excess protein. Increasing the ratio to 10:1 does not increase the protein-DNA complex peak absorbance. For RitR(L86A/V93A) with BS3-6 (Figure 2-18B), the BS3-6 DNA peak overlaps with the RitR(L86A/V93A) protein only peak. The binding affinity is lower than that of BS3-3, because even treated with 10 fold more protein, the complex absorbance still not get maximum. So the maximum ratio of 10 : 1 with the excess 
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protein was used. The two conditions were used for incubating protein with DNA, and then the complex was separated on a HiPrepTM 26/60 Sephacryl® S100 HR column. Before 
making the crystallization tray, extra BS3-3/BS3-6 DNA was added into the complex solution. But there is no crystal was obtained but salt crystals.  
 
2.3.13 Structure of the RitR(L86A/V93A) REC domain  
Likely owing to the higher degree of flexibility in the “extended dimer” of the RitR(L86A/V93A), we were not successful in obtaining diffraction-quality crystals of the 
 
Figure 2-18: Gel filtration results of different ratios of RitR(L86A/V93A) : BS3-3 (A) and RitR(L86A/V93A) : BS3-6 (B). In both panels, the traces for the RitR(L86A/V93A) protein alone are dark green, the RitR(L86A/V93A) protein alone cyan, BS3-3 or BS3-6 alone brown, 100 μM BS3-3 or BS3-6 were incubated with 25 μM (green), 50 μM(purple), 100 μM (dark yellow), 200 μM (orange) and 500 μM (blue) of RitR(L86A/V93A).  
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full-length protein. Attempts to “lock down” the DNA-binding domains by co-crystallizing a number of BS3 variants with the double mutant. This was also unsuccessful. In order to determine whether or not the ALR domains of RitR(L86A/V93A) formed a stable dimer, an expression construct was prepared that included only residues 1-124  (RDLV; the same residues used in the original wild-type ALR domain structure). Diffraction-quality crystals were obtained from hanging drops containing 1 μl protein solution (4.4 mg/ml RDLV in 10 
mM TRIS pH 8.5, 50 mM Succinic acid) and 1 μl crystallization solution (20% (w/v) PEG 3350, 0.2 M magnesium sulfate, 0.1 M TRIS pH 8.5), which diffracted to 1.8 Å resolution. The crystals belonged to space group P2221 (a = 50.1 Å, b = 62.9 Å, and c = 80.3 Å) and contained 2 chains per asymmetric unit. We expected that the structure would be solved easily by molecular replacement, since the structure of the wild-type ALR domain was known. However, the molecular replacement calculation consistently failed, no matter which REC domain structure was used as the search model. SeMet-substituted RDLV was prepared, and it crystallized in the same condition used for the native protein, except 1 mM DTT was added to prevent heterogeneity due to oxidation of the SeMet residues. The data 
extended to 1.9 Å resolution and the anomalous signal from the 14 Se atoms provided excellent initial phase estimates that allowed Autobuild 29 to build an approximately 74% complete model. The two chains in the asymmetric unit form a dimer, which is consistent with the size exclusion chromatography results (data not shown). There are numerous hydrogen bonds between two chains, with an interface area of approximately 2,261 Å2.  
Shockingly, the topology of the RitR(L86A/V93A) ALR dimer is drastically altered from 
the (β/α)5 topology seen in all previous REC domain structures (Figure 2-19, Figure 2-10). There are two primary differences between the RDLV and all other REC domain structures. 
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First, the kinked α4 helix rearranges to form an extension of strand β4 and a long loop 
leading into β5. Owing to the loss of α4, β5 is no longer parallel to β4. Thus the central sheet in the RDLV ALR domain is mixed rather than parallel as it is in the wild-type ALR. 
Second, “α5,” which is technically the 4th α-helix in the structure, is no longer docked with 
β5 and the rest of the domain, but rather participates in a domain-swapping interaction with the other protomer of the dimer. The two protomers literally swap their “α5” helices, and other than coming from the opposite dimer, there is little difference in the positions of 
“α5” of the RDLV and α5 of the monomeric ALR with respect to the rest of the tertiary structure.  
Figure 2-19: Ribbon representation of the RDLV structure (A) showing the arrangement of the secondary structure elements. Chain A of the RDLV dimer is colored dark blue and dark orange (the rearranged β4, 
β5 and α5);  chain B is colored light blue.and yellow (the rearranged β4, β5 and α5). The Y100 residues of each chain (shown as sticks) stack with each other in the dimer interface. Note the loss of the α4 helix, 
which becomes part of β4 and a long loop leading into β5. This reverses the direction of strand β5 and results in a mixed β sheet structure, rather than the parallel sheet typical of REC domains. The “α5” helices are swapped between the two chains, but occupy a position in the structure very similar to that of α5 in the monomeric RitR REC domain. (B) The overlay of the RDLV structure (chain A, colored in dark blue) onto the wild-type RitR REC domain structure (colored in grey) highlights the extent of the structural rearrangements leading to this dimeric form of the ALR domain. 
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Of course, the pronounced changes in the topology of the RDLV REC domain lead to serious changes in the active site and switch residues (D81 and Y100; Figure 2-20). With 
the rearrangement of the hydrophobic core in the β4-α4 region of the protein, the side chains of N53 and N55, which point away from each other in the wild-type structure, both rotate ~180° to participate in a hydrogen bonding network that includes the amide 
nitrogen of V54. The side chain of the switch residue D81, which makes a hydrogen bonding interaction with the V54 amide nitrogen atom in the wild-type REC domain moves 
slightly in the RDLV REC domain so that it no longer interacts with V54. The other switch residue, Y100, also has an ~180° change in the orientation of its side chain, though in this 
case it is due to the “flipping” of the β5 strand rather than a simple rotation about the Cα-Cβ bond. In this orientation, the rings of Y100 from each protomer stack against one another at the heart of the dimer interface. 
Figure 2-20: Comparison of the active site and switch residues in the wild-type RitR REC domain (A) and the RDLV variant (B). The wild-type REC domain is colored grey; RDLV dimer is colored in dark blue (chain A) and light blue (chain B).  Because the kinked α4 helix forms the loop between β4 and β5 and 
changes the orientation of β5, the loop between β3 and α3 then moves due to the changed interactions. The N55 side chain flips and occupies the space occupied by K10 in the wild-type RitR REC domain. 
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2.3.14 Structure of the RD2LV REC domain construct 
Because of the radical nature of the structural changes observed in the RDLV variant, we thought it important to confirm that the structure is biologically relevant. To this end, we constructed a slightly longer form of the RDLV REC domain that includes the putative redox-sensing C128. This longer construct was dubbed RD2LV. SeMet-substituted protein was produced and diffraction-quality crystals were obtained from Hanging drops containing 1 μl of protein solution (19 mg/ml RD2LV in 10 mM glycine pH 8.8, 25 mM L-
Arg) and 1 μl of crystallization solution (22.5% (w/v) polyethylene glycol (PEG) 3350, 12% Tacsimate pH 8.2).. These crystals diffracted to 2.6 Å resolution. They belonged to space group P21212 with a = 115.3 Å, b = 125.4 Å, and c = 40.2 Å. The asymmetric unit contained four molecules arranged as two homodimers (Figure 2-21B). 
 
97 
Figure 2-21: Ribbon representations of the RD2LV REC domain structure (A) and the RD2LV asymmetric unit (two dimers). The presence of C128 does not alter the domain swapped dimer, which is nearly identical in both structures. There are inter-dimer disulfide bonds that technically turn this into a tetramer. This appears to be an artifact of crystallization, as no tetramer is detectable in SEC traces of RD2LV (data not shown).  
 
The structure of RD2LV is nearly identical to that of the shorter RDLV protein, both in terms of the tertiary structure of the protomer as well as the quaternary structure of the dimer (Figure 2-21A). The largest difference between the two structures is the fact that the 
“α5” helix is longer in RD2LV, which is not unexpected. This leads both to a modest increase in the number of hydrogen bonds and salt bridges between two chains, while the buried surface area of the interface is nearly unchanged (2,272 Å2 vs 2,261 Å2). More importantly, there are two disulfide bonds between the C128 residues of the two dimers (Figure 2-21B). The inter-dimer disulfide bonds are likely an artifact of the high concentrations required for crystallization, since there is not clear evidence of tetramerization in the analytical SEC data for the RD2LV variant (data not shown). 
Presumably, the α5 helices of the two protomers in a single dimer could also become disulfide linked, and this would hold the two DBDs in the proper orientation for DNA 
binding. The arrangement of the α5 helices in the RD2LV dimer suggests that the highly unusual REC domain structure observed here may be biologically relevant.  
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2.3.15 RitR with GADDY motif (RitRGADDY) 
A comprehensive investigation of OmpR family proteins30 shows that RitR homologs have lost not only the phosphorylatable Asp residue, but also several highly conserved acidic residues that comprise the REC “GADDY motif” (see residues highlighted with red in Fig. 2-22), which is begins in the loop between α4 and β5 (Lα4β5) and ends near the 
middle of strand β5. The GADDY motif contributes to hydrogen bonding in the dimer interface of canonical REC domains 3, 31. The terminal Tyr residue of the GADDY motif is the Y/T couple residue. We hypothesized that the loss of the GADDY motif in RitR (the motif becomes (F/Y)AVSY in RitR homologs) may explain why it only forms dimers in response to Cys128 oxidation.  
 
Figure 2-22: Sequence alignment of RitR homologs with other DNA binding proteins in the OmpR family. The major differences in the Streptococcal RitR homologs and the typical REC domain proteins are labeled in red. Asn/Ser substitutes for the phosphorylatable Asp residue, and the conserved GADDY motif is replaced with (F/Y)AVSY in RitR proteins. 
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To explore the hypothesis, we constructed a triple mutant of RitR where the equivalent “FAVSY” sequence is changed to GADDY (RitRGADDY). The oligomeric state of RitRGADDY was investigated by SEC and the results are shown in Figure 2-23. The RitRGADDY variant has significantly more dimer than wild-type RitR protein in the absence of added oxidant. The retention time of the RitRGADDY dimer is the same as that of RDLV, but earlier than the RitRox cross dimer. The retention time of the RitRGADDY monomer is also earlier than that of the wild-type RitR monomer. These observations suggest that both the dimeric and monomeric forms of RitRGADDY are more “extended” than the wild-type, likely due to dissociation of the ALR and DBD domains. The dimer/monomer ratio in RitRGADDY is still dependent on the redox state of C128. After treatment with 1 mM H2O2, RitRGADDY forms pure extended dimer, while it forms pure extended monomer after treatment with DTT  (Figure 2-23).  
                  
Figure 2-23: Size exclusion chromatography results of the RitRGADDY mutant with or without H2O2 or DTT treatments. The mutant RitRGADDY protein (magenta) exists as a mixture of extended dimer and extended 
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monomer. After treatment with H2O2 (red), it forms almost pure dimer. And after DTT treatment (dark blue), it forms almost pure monomer. The RitRox “cross dimer” is dark red, the RitR(L86A/V93A) (“extended dimer”) is cyan, wild-type RitR is green. 
 
2.3.16 The role of C128 in the RitR(L86A/V93A) variant 
C128 in RitR is highly conserved among a non-Group A/B subset of streptococcal species. To check if C128 has a role in the DNA-binding activity of RitR, we mutated C128 to Ser in the RitR(L86A/V93A) variant. The RitR(L86A/V93A)  variant was used for these experiments, since it is the only form of RitR that we are reliably able to bind to DNA. The affinity of this RitR(L86A/V93A/C128S) triple mutant (LVC) for the BS3 target sequence was qualitatively assessed by SEC and differential scanning fluorimetry. As is evident in figure 2-24, the LVC mutant binds to the BS3 forming protein-DNA complex. There is a peak corresponding to the complex with a retention time of 5.1 min, and stability of the protein significantly increased in the presence of DNA. As expected from the results above, it seems that oxidation of C128 is only the beginning of the signal, and some other factor is required to trigger the structural rearrangement of the α4-β5-α5 face of the REC domain that leads to dimerization, and it would seem, to DNA binding. 
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Our collaborators in the Ulijasz laboratory at Loyola University Chicago constructed three C128 mutants in the natural chromosomal position in Streptococcus pneumoniae strain R800 and D39: C128A (sensory dead), C128S (reduced mimetic) and C128D (oxidized mimetic). They found that the C128A mutant strain exhibited significantly impaired growth under aerobic conditions, whereas the C128S exhibited an intermediate growth defect. Conversely, the C128D mutant grew faster than the wild type. The results of the streptonigrin killing assay, which is an indirect indicator of cellular iron concentrations, 
 
Figure 2-24: The LVC triple mutant still binds to the BS3-3 target dsDNA. Size exclusion chromatography results of LVC in the presence of BS3-3 (A) show that a peak eluted at 5.1 min that is not present in traces of either the protein or DNA alone and likely corresponds to the complex between the two. The presence of BS3-3 also significantly increased the stability of LVC as judged by differential scanning fluorimetry (B).  
1: pH 6.5, 25 mM TRIS, 150 mM NaCl, 100 mM DL-malic acid; 2: 20 mM HEPES pH 7.2, 5 mM MgCl2, 1 mM CaCl2, 0.1 mM EDTA; 3: 20 mM HEPES pH 7.2, 5 mM MgCl2, 1 mM CaCl2, 0.1 mM EDTA, 150 mM NaCl. 
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suggest that these effects are due to RitR-mediated repression of iron transport (to be published). 
To investigate the structure and function relationship of the RitR(C128D) mutant, the oligomeric state and the protein structure were determined. The results are shown in Figure 2-25. The RitR(C128D) mutant exists as monomer, even after treatment with 1 mM H2O2 for several days. The structure of RitR(C128D) is very similar to that of the RitR(C128S) structure. Superposition of the RitR(C128S) and RitR(C128D) structures using secondary structure matching (SSM)32 gives a root-mean-square deviation (rmsd) of 0.3 Å 
 
Figure 2-25: (A) Size exclusion chromatography results of RitR(C128D) with 1 mM H2O2 or 1mM DTT. The traces of RitR(C128D) only colored in blue, H2O2 treatment colored in red and DTT treatment colored in green. (B) Overlay of RitR(C128D) and RitR(C128S) structures. RitR(C128D) is colored green, while the RitR(C128S) structure is colored cyan. The rmsd for the matched Cα atoms in the two structures is 0.30 Å. 
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for 220 of the 229 Cα atoms in the RitR(C128S) chain A. This indicates that the two structures are essentially identical. The long α5 linker helix still connects the REC and DBD domains of the protein and runs almost the entire length of the protein. However, the C-terminal end of this helix is disordered in the RitR(C128D) variant. This suggests that the Cys > Asp substitution mimics the oxidized form of RitR at least enough to trigger the disordering of the C-terminal end of α5 that was observed in the RitRox structure, even though it was apparently not enough to trigger dissociation of the domains. 
 
2.4 Conclusions 
To propagate a signaling response, the typical TCST system employs a sensory histidine kinase that phosphorylates a receiver domain on a conserved aspartate residue. However, RitR is an orphan TCST response regulator in Streptococcus pneumonia R6 that lacks a cognate histidine kinase. In addition, there are some other characteristics suggesting that RitR has a different activation mechanism: the phosphorylatable aspartate is replaced by asparagine in RitR; D10 in the acidic triad is substituted by basic lysine; one switch residue T83 is substituted with D81; and there is a conserved cysteine residue near the DBD, C128, that is not present in other response regulators. This cysteine residue appears to be redox active and to influence the quaternary structure of RitR.  
Analogy to other DNA-binding response regulators suggests that the active form of RitR binds to DNA as a dimer. As purified, RitR exists as a monomer in equilibrium with a very small amount of homodimer. To get homogenous protein for crystallization, C128 was 
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mutated to serine; the resulting C128S variant is purely monomeric. The structure of RitR(C128S) showed that the ALR domain and the DNA-binding domain are linked by an 
unusually long α-helix that runs the length of the entire protein, with C128 near the C-terminal end. Bioinformatic analysis of all streptococcal RitR homologs showed that C128 is strictly conserved, suggesting that RitR may be a novel redox sensor. The environment of 
the cysteine thiol group, as inferred from the position of S128 Oγ is quite polar (Figure 2-11F). Thus there is no clear indication why the C128 thiol group has a pKa of 7.2 (Figure 2-2), which is significantly lower than the pKa of free cysteine in aqueous solution. It is possible that other hydrogen bonding interactions, e.g. the water-mediated hydrogen bond to Y163, as well as the concentration of basic amino acids toward the C-terminus of α5 
(H127, H147, and R160, as well as R135, which is located on the loop after α5) might mitigate the unfavorable interaction between a cysteine thiolate and the helix dipole. However, what is evident is that the C-terminus of helix α5, despite an extensive hydrogen bonding network around C128 that includes H147, D115, R160 and D164, is one of the 
more dynamic regions of the structure. The last few turns of helix α5 become disordered in the H2O2-oxidized protein, as well as the oxidized (sulfenate/sulfinate)-mimetic mutant RitR(C128D) (Figure 2-4 and Figure 2-25). Cysteine sulfenic acid (Cys-SOH) is a not-uncommon feature in redox-active proteins. For example, sulfenic acid was found to be an intermediate for disulfide bond formation in vitro33. The dramatically faster growth phenotype of the C128D mutant strain of S. pneumoniae verifies that the disordering of the C-terminal end of α5 is one step of RitR activation. 
Iron is an important micronutrient in bacteria, which influences cell growth, virulence and metabolism. To stop the repressor signal, the gnd gene that co-transcribed with RitR, 
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may be involved in the shutdown of oxidization-induced RitR activation. The gnd encodes a 6-phosphogluconate dehydrogenase that catalyzes NADPH formation. NADPH is, in turn, the cosubstrate of glutathione reductase, which may be involved in repressing RitR activation by reducing the sulfenic acid or disulfide bond into the reduced thiol group (Figure 2-26). 
 
Figure 2-26: Proposed thiol group oxidation and reduction metabolism of RitR.  
The structure of an oxidized, dimeric form of RitR was determined by X-ray crystallography. Oxidation of C128 to the disulfide caused a conformational change that 
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caused the DBD to release from the ALR domain. Surprisingly, the freed DBD was observed bound to the ALR domain of the other, disulfide-linked molecule of RitR, recapitulating almost exactly the structure of the inactive, monomeric protein.  
A second dimeric conformation was found in the RitR(L86A/V93A) variant. L86 and V93 were both mutated to Ala. These residues are found in the kinked α4 helix that interacts with the DBD and form part of the hydrophobic core of this region of the protein.  RitR(L86A/V93A) elutes significantly earlier than the “cross-dimer” conformation of the oxidized, inactive wild-type RitR, suggesting that it has a different, likely more extended, overall shape. This “extended-dimer” binds to the target DNA according to gel filtration and differential scanning fluorimetry.  
Attempts to crystallize the full-length RitR(L86A/V93A) protein alone, or in complex with oligonucleotides of various lengths were unsuccessful. Only blunt-ended dsDNA was tested in these experiments; it is possible that sticky-end dsDNA might promote crystallization of the protein:DNA complex by forming long, repeating assemblies of oligonucleotides34. Because the protein component is usually globular, packing of the bound protein within the lattice formed by neighboring DNA oligonucleotide assemblies can be important for growth of a three-dimensional crystal.  
Since the full-length protein did not crystallize readily, we targeted the isolated RitR(L86A/V93A) REC domain for crystallization. The crystal structures of two constructs were determined: a 1-124 version that matches the original wild-type REC domain construct (RDLV) and a longer 1-132 version that includes the putative redox-active C128 (RD2LV). Both RDLV and RD2LV exhibited the same unprecedented conformational change 
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for a response regulator protein, where helix α4 is disordered and the two protomers swap 
their “α5” helices to form the dimer. The α5 helices point in opposite directions, which would place the DNA-binding domains far apart and give the extended shape suggested by gel filtration. 
The fact that strains harboring a reduced mimetic RitR mutants (e.g. C128S) have a growth defect phenotype, it seems that oxidation of C128 is part of the activation mechanism. The RitRox structure demonstrates that the dissociation of the REC domain from the DBD upon oxidation, but the dissociated DBD re-binds to the REC domain of the other protomer. So there must be an additional factor that leads to dimerization of the ALR domains, the active form of which likely has a similar structure to the RitR(L86A/V93A) REC domain.  
Based on these studies, we propose a model for RitR activation, as shown in Figure 2-27. Under reducing conditions, RitR mainly exists as inactive monomer. Upon oxidation, as might happen during the oxidative burst phase of the pneumococcus growth where millimolar amounts of H2O2 are produced 35, RitR favors the dissociated and extended conformation. In the absence of target DNA, RitR would eventually form the inactive cross-dimer. In the presence of DNA, it may bind to DNA at low affinity. Under the influence of some still-unknown factor, the ALR domain of RitR would undergo a conformational 
rearrangement of the α4-β5-α5 region to promote dimerization and place the two DBDs far from the ALR domains. In that way, RitR can keep the extended, active conformation to bind to DNA with high affinity. Alternatively, the ALR domains might be triggered to 
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dimerize before binding to DNA, and only bind to target DNA when the active conformation has been obtained.  
 
Comparative transcriptome analysis demonstrated that, in addition to repressing expression of the piu iron transport genes, RitR also activates expression of bacterial ferritin, several genes involved in sugar uptake and other genes involved in DNA repair 1. To check whether up-regulated sugars might contribute to RitR activation (dimerization), 
 
Figure 2-27: The proposed RitR activation mechanism. 
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co-incubation of RitR with several carbohydrates (sucrose, sorbitol, mannitol, glucose, isoleucine) was conducted at room temperature for several hours. Size exclusion chromatography results showed that no oligomer state change was observed. So future studies on finding the trigger for RitR ALR domain dimerization are still needed to explore. 
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Chapter 3  
Uncharacterized Protein Q15Z91 from Pseudoalteromonas atlantica is 
an ALR-Regulated Diguanylate Cyclase 
 
3.1 Introduction 
Aspartate-less receiver (ALR) proteins are a subclass of response regulator proteins in bacterial signal transduction systems. In typical two-component signaling systems, the receiver domain of the regulator would be phosphorylated in the conserved aspartate residue by the cognate histidine kinase. In TCSTs with ALR-containing response regulators, there is no conserved Asp residue for phosphorylation, which means that ALRs must necessarily respond to different regulatory stimuli. Chapter 2 described my work aimed at elucidating the activation mechanism of an ALR protein, RitR. I showed that it functions as an “extended dimer” there the DNA-binding domains are released from the ALR domain, partly in response to oxidation of C128. Owing to its activity as a DNA-binding protein, it was difficult to make quantitative studies of RitR activation. The assays used to detect DNA binding often gave contradictory results and could be highly dependent on the experimental system (e.g. choice of buffer, salt concentration, and temperature). For this reason, we chose to study an ALR-containing response regulator whose effector domain has an enzymatic activity, which would allow a much more nuanced and quantitative assessment of activation. We identified just such a protein through BLAST 2, 3 searches 
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using residues 1-132 of RitR, which comprise the ALR domain and the extended α5 helix that contains the redox-active cysteine (C128). By manually filtering the results of the BLAST search for sequences that contained the same “HCS” motif found in RitR, we found an uncharacterized protein from Pseudoalteromonas atlantica TC6, which is known only by its UNIPROT accession code, Q15Z91, which catalyzes the formation of the bacterial second messenger molecule bis-(3’-5’)-cyclic dimeric guanosine monophosphate (c-di-GMP) from two molecules of GTP. In this chapter I describe my structural and enzyme kinetics studies of Q15Z91. 
 
3.2 Methods 
3.2.1 Expression and purification of Q15Z91  
The coding sequence of Q15Z91 (Genbank locus ID Patl_0265) was optimized for expression in E. coli and synthesized by GenScript Inc (Piscataway, NJ). The synthetic gene was sub-cloned into the pE-SUMO kan expression vector (LifeSensors Inc, Malvern, PA) using primers containing BsaI and XbaI restriction sites (Q15Z91 forward: 5’-GGTCTCAAGGTATGCAAAATCCGGAAAGTGC-3’, Q15Z91 reverse: GCTCTAGATCATTATGACACCAGACGGTTACGA-3’). The His6-tagged SUMO-Q15Z91 fusion protein was expressed from Origami2 E. coli cells (Invitrogen Inc, Carlsbad, CA) carrying the pE-SUMO-Q15Z91 plasmid. Cultures were grown in Luria-Bertani medium with 50 µg/mL kanamycin at 37 °C. When the cultures reached an OD600nm of ~0.7, protein 
expression was induced with 0.4 mM IPTG. The temperature was reduced to 16 °C and the 
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cultures were grown overnight with shaking at 250 rpm. Cells were harvested by centrifugation, resuspended in 5 mL of buffer A (25 mM TRIS pH 8.0, 300 mM NaCl, 10 mM imidazole) supplemented with 1 mg/mL hen egg lysozyme (Hampton Research) and 0.1 mg/mL DNAse I (Worthington Biochemical Corp., Lakewood, NJ) per gram wet weight of cells. Cells were lysed using a Branson Sonifier S-450 cell disruptor (Branson Ultrasonics 
Corp., Danbury, CT) for a total of 10 min of sonication at 60 % amplitude with 30 s pulses separated by 50 s rest periods. The temperature was maintained at or below 4 °C by suspending the steel beaker in an ice bath directly over a spinning stir bar. The lysate was 
clarified by centrifugation at 39,000 x g for 45 minutes and then applied to a 5 mL HisTrap column (GE Lifesciences, Piscataway, NJ) at a flow rate of 5 mL/min to isolate the His6-SUMO-Q15Z91 fusion protein. The protein was eluted by a 4-step gradient of buffer B (25 
mM TRIS pH 8.0, 300 mM NaCl, and 250 mM imidazole; 5, 15, 50, and 100%). The His6-SUMO-Q15Z91 fusion protein eluted in the third step and was ~90 % pure, as judged on coomassie-stained SDS-PAGE gels.  Fractions corresponding to A280nm peaks on the chromatogram were pooled ~3 µM SUMO protease (LifeSensors Inc) were added. The sample was loaded into SnakeSkin dialysis tubing and dialyzed overnight against 4 L of SUMO protease digestion buffer (25 mM TRIS pH 8.0, 150 mM NaCl). The dialysate was passed through the HisTrap column a second time to remove the cleaved His6-SUMO tag as well as the protease. The resulting Q15Z91 preparation was > 95% pure. The protein was desalted using a 2x5 mL HiTrap Desalting column (GE Lifesciences) equilibrated with 25 mM TRIS pH 7.5, 150 mM NaCl and stored at -80 °C. The mutants described below were purified using the same protocol as the wild type protein. 
115 
Q15Z91 co-purified with c-di-GMP. To get c-di-GMP-free Q15Z91 protein, SadR, a phosphodiesterase from Pseudomonas aeruginosa, was used to linearize the c-di-GMP. The SadR expression construct was a kind gift of professor Holger Sondermann in the Department of Molecular Medicine, College of Veterinary Medicine, Cornell University. The His6-tagged SadR protein was purified as described by De, et al4, omitting the precision protease cleavage step. SadR treatment results in the degradation of c-di-GMP to free pGpG, which is easily removed by gel filtration. The His6-tagged SadR protein was added to the 
purified Q15Z91 and dialyzed in 4 L of 50 mM TRIS pH 8.0, 150 mM NaCl, 2 mM MgCl2 
buffer at 4 oC overnight. The dialysate was passed through the HisTrap column a third time to separate c-di-GMP free Q15Z91 (Q15Z91free) from the His6-tagged SadR. The resulting Q15Z91 protein was desalted using a HiTrap Desalting column equilibrated with 25 mM TRIS pH 7.5, 150 mM NaCl and stored at -80 °C. In the desalt step, the free pGpG would be separated from protein. The c-di-GMP free mutants described below were purified using the same protocol as Q15Z91free. 
 
3.2.2 Mutagenesis of Q15Z91 
The full-length mutants were obtained using the Q5 site-directed mutagenesis kit (New England Biolabs, Ipswich, MA) as described for RitR in Chapter 2. The sequences of the mutagenic PCR primers are listed in Table 3-1. 
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Table 3-1: Primers used for mutagenesis 
Name Primer sequence sumo-Q15Z91_C142S_Fwd CCTGATTTCTTCCACCGATGGCC sumo-Q15Z91_C142S_Rev GCCAGGGTGCGCAGTTTC sumo-Q15Z91_R212N/D215A_Fwd TCTGCTGCGATGGGCCGCTACGGC sumo-Q15Z91_R212N/D215A _Rev TTCATTCTGCAGGCTAGCTTCAATCGTGGTTG sumo-Q15Z91_I99A _Fwd GAAATCACTGGCTCTGTCGGGCC sumo-Q15Z91_I99A _Rev GGGGTGTCTTTGCCATAC sumo-Q15Z91_G102A _Fwd GATTCTGTCGGCCCTGGAAGCGG sumo-Q15Z91_G102A _Rev AGTGATTTCGGGGTGTCTTTG  
3.2.3 Crystallization, structure determination, and model refinement 
Crystals of Q15Z91 alone were grown by the vapor diffusion method with sitting-drop geometry. Crystals formed in many different conditions. The highest quality crystals formed in drops comprised of equal parts protein solution (8 mg/ml Q15Z91 in 10 mM 
TRIS/100mM citric acid pH 4.5, 150 mM NaCl, and crystallization solution (20% (w/v) PEG 3350, and 0.2 M sodium citrate tribasic dehydrate). Cube-shaped crystals appeared after 
several months at 4oC and were prepared for flash-cooling by soaks in solutions containing 
2 μl of well solution and 0.7 μl of glycerol (~26%). Crystals of Q15Z91 without GTP bound 
were grown by mixing 1 μl of  8 mg/mL Q15Z91 that pre-incubated with 5mM MgCl2, 200 
μM ZnCl2, 3 mM GTP with crystallization solution (8% v/v Tacsimate pH 7.0, 20% w/v Polyethylene glycol (PEG) 3,350). Cube-shaped crystals appeared after several months at 4 
oC. Crystals were prepared for flash-cooling in the same way as Q15Z91 alone crystals.  
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X-ray diffraction data were collected from crystals of Q15Z91 at beamline 21-ID-D of the Life Science Collaborative Access Team (LS-CAT) at the Advanced Photon Source (APS). Data were collected from crystals of the protein with GTP at LS-CAT beamline 21-ID-G. Data were processed with HKL2000 5. The structure of Q15Z91 was determined by molecular replacement using 3BRE REC domain and effector domain as two ensembles in Phaser5.  The initial model comprising 88% of the asymmetric unit contents was built by Autobuild6. Chain A of this model was used as the search model for molecular replacement in PHASER7 to phase the Q15Z91 with GTP bound structure. Both models were subjected to iterative cycles of manual model building in COOT8 and maximum likelihood-based refinement using the PHENIX package (phenix.refine9). Ordered solvent molecules were added automatically in phenix.refine and culled manually in COOT. Hydrogen atoms were added to the model using phenix.reduce10 and were included in the later stages of refinement to improve the stereochemistry of the model. Positions of H atoms were refined using the riding model with a global B-factor. Regions of the model for translation-libration-screw (TLS) refinement were identified using phenix.find_tls_groups (P.V. Afonine, unpublished work) and the TLS parameters were refined in phenix.refine. Once the refinement converged, the model was validated using the tools implemented in COOT and PHENIX 9, 11. Sections of the backbone with missing or uninterpretable electron density were not included in the final model. Data collection and model refinement statistics are listed in Table 3-2. Coordinates and structure factors for both Q15Z91 and Q15Z91 with GTP models will be deposited in the Protein Data Bank (www.rcsb.org). 
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3.2.4 Quaternary structure characterization by size exclusion chromatography  
SEC experiments were carried out using an Agilent 1220 Compact HPLC equipped with 
a 250 x 4.6 mm BioBasic SEC-300A column equilibrated with 25 mM TRIS pH 7.5, 150 mM NaCl. The column was calibrated with the Gel Filtration Molecular Weight Marker kit from Sigma-Aldrich (Cytochrome C (12.4 kDa), Carbonic Anhydrase (29 kDa), Bovine Serum Albumin (66 kDa), and Sweet Potato Amylase (200 kDa)). Q15Z91 was pre-incubated with 1 mM H2O2 or 1mM DTT and 5 µl of the treated proteins were injected onto the column and separated at a flow rate of 0.5 ml/min at ambient temperature. The separation was monitored using a variable wavelength UV-visible detector set to 280 nm. 
 
3.2.5 Size exclusion chromatography with multi-angle light scattering (SEC-MALS) 
To confirm the molecular weights estimated from the calibrated SEC runs of Q15Z91 on the BioBasic SEC-300A column, the separations were repeated on the SEC-MALS system in the laboratory of Dr. Blake Hill at the Medical college of Wisconsin. The multiple-angle light scattering detector provides a direct estimate of the molecular weights of particles eluting 
from the column that is independent of the retention time.  The same 250 x 4.6 mm BioBasic SEC-300A column was used with 24 hour equilibration in 25 mM TRIS pH 7.5, 150 mM NaCl at 0.5 ml/min. The running buffer is same as used above, except that it was 
filtered through a 0.022 μm filter, rather than a 0.22 µm filter. Due to the relatively low sensitivity of the MALS detector the separation was done with 100-200µg of Q15Z91, rather than the ~15 µg used for the UV/vis-monitored separations. The concentrated 
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proteins were centrifuged at 16,900 x g for 20 min at 4oC before loading.  
 
3.2.6 Biofilm assay on borosilicate tubes 
Assays to quantify the degree of biofilm formation in E. coli expressing wild-type or mutant forms of Q15Z91 were performed as a way to assess the in vivo activity of the proteins. Overnight cultures of Origami2 E. coli carrying the pSUMO-Q15Z91 (or mutant) plasmids were adjusted to the same inoculum amounts in 3 ml of fresh LB broth with 50 
µg/ml kanamycin in 14 ml borosilicate glass tubes. After growth with rotating at 37 °C for ~5 hours, the cultures were equalized by adding extra fresh LBkan medium and then protein 
expression was induced by the addition of 0.4 mM IPTG. The cultures were allowed to grow overnight at 25oC. The next day, the cultures were removed from their respective test tubes, which were washed three times with tap water. After washing, crystal violet was used to stain any biofilm that had been deposited on the walls of the tubes. After staining, the culture tubes were washed with tap water five times. The culture tubes were then dried and the residual stain – that bound in the biofilm – was dissolved in 2 mL of 80% (v/v) 
ethanol/20% (v/v) acetone. The absorbance at 540 nm was measured on a spectrometer and taken to be a qualitative indicator of the degree of biofilm formation induced by wild-type Q15Z91 or the various mutants tested. 
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3.2.7 Enzymatic assay 
3.2.7.1 RP-HPLC based end-point assay 
As a convenient check for catalytic activity of the various forms of Q15Z91 studied here, protein was incubated for a set period of time with GTP and MgCl2 and the reaction mixtures were characterized by reverse phase high performance liquid chromatography (RP-HPLC). Each 200 µl reaction contained 20 μM enzyme, 25 mM TRIS pH 7.5, 150 mM NaCl, 2mM MgCl2, and 0.5 mM GTP. The GTP was prepared fresh as a 100 mM stock in mqH2O. Reactions were incubated at room temperature for 30 min, and then quenched by boiling for 5 min. After centrifugation at 30,000 g for 10 min, the supernatants were analyzed on a 150 x 3 mm Aquasil C18 column (Thermo Scientific). Buffer A was 10 mM NaH2PO4/K2HPO4 pH 6.3, and buffer B was 30% (v/v) methanol, 70% (v/v) buffer A. The 
gradient from 5% to 100% B over 28 min, then held at 100% B for 5 min, 5% buffer B for 5 
min.  All separations were run at 50 °C and were monitored at 254 nm. 
 
3.2.7.2 Biomol Green microplate assay 
Reactions were prepared in a volume of 500 μl and contained 10 μM enzyme, 25 mM TRIS pH 7.5, 150 mM NaCl, 2 mM MgCl2, and 0.5 mM GTP. Reactions were initiated with the addition of GTP. Aliquots were taken at set intervals and quenched by boiling for 5 min. 
After centrifugation at 30,000 g for 10 min, the supernatants were kept at 4 oC. The negative control was the reaction buffer containing GTP. The amount of pyrophosphate released was quantified by adding 0.005 U pyrophosphatase (Thermo Scientific) to each 
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reaction, followed by a 1.5 h incubation room temperature. Then 50 μl of the pyrophosphatase-treated reaction mixture were mixed with 100 μl Biomol Green reagent and incubated at room temperature for 20 min. The absorbance of the mixtures at 620 nm was recorded and converted to concentration of phosphate via a standard curve prepared with 0.03125 nM-2 nM inorganic phosphate. 
 
3.2.7.3 EnzCheck® Pyrophosphate Assay Kit (Sigma) 
This assay were conducted by following the optimized procedure published by Webb12, 13. Pyrophosphatase can catalyze pyrophosphate into 2 molecules of inorganic phosphate. In the presence of inorganic phosphate, purine nucleoside phosphorylase (PNP) catalyzes 2-amino-6-mercapto-7-methylpurine ribonucleoside (MESG) into ribose 1-phosphate and 2-amino-6-mercapto-7-methylpurine that absorbs maximally at 360 nm. Each 1 mL reaction 
contained 1 μM enzyme with 2-amino-6-mercapto-7-methylpurine ribonucleoside (MESG), purine nucleoside phosphorylase in the reaction buffer was incubated at 22 oC for 10 min. The reactions were initiated with the addition of GTP and the absorbance at 360 nm was monitored. The concentrations of GTP tested range from 50 μM to 1000 μM.   
3.3 Results 
3.3.1 Q15Z91 is an ALR-regulated diguanylate cyclase 
Q15Z91 is 310 amino acids long (34.6 kDa) and consists of an N-terminal ALR domain 
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fused to a diguanylate cyclase domain. Alignment of the RitR and Q15Z91 sequences shows that the phosphorylatable aspartate residue is replaced by arginine in Q15Z91 (Figure 3-1). The conserved C128 that has been shown to play an important role in RitR activation is retained in Q15Z91, though the residues flanking it are different between the two proteins. The effector domain contains the GGEEF motif characteristic of diguanylate cyclase enzymes. 
 
 
Figure 3-1: Sequence alignment of Q15Z91 with the RitR REC domain. Arginine (colored in red) substitutes the conserved aspartate residue of the typical response regulator proteins (N53 in RitR). The conserved Cys128 of RitR is colored in orange; the GGEEF motif of Q15Z91 is colored blue. 
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3.3.2 Purification of Q15Z91  
The pSUMO-Q15Z91 plasmid was transformed into BL21 Star(DE3) cells, T7 LysY/Iq cells (New England Biolabs, Ipswich, MA), and Origami2 cells (Novagen) Single colonies were used to inoculate large-scale expression cultures, which were grown at 37 °C to an OD600nm of ~0.7, at which point protein expression was induced by the addition of 0.4 mM IPTG. Three strains were attempted to express Q15Z91, but only the Origami2 cells expressed soluble proteins and exhibited an obvious biofilm phenotype. Induction at higher or lower OD600nm resulted in lower yields of soluble protein.  
Q15Z91 was not stable in the purification buffers. To find the optimal storage buffer and pH, the Solubility & Stability Screen (Hampton research) and Slice pH (Hampton research) were used in differential scanning fluorimetry assays. The results showed that Q15Z91 is not stable, its average Tm being 33oC; this is not surprising given that P. atlantica 
Table 3-2: Buffers from the Solubility & Stability Screen giving the highest Tm values in the DSF assay. 
Tm - Tm,averaged (oC) Additive 
8.4 Adipic acid 6.7 Ethylenediaminetetra acetic acid disodium  5.9 TCEP hydrochloride 5.9 Sodium phosphate monobasic, potassium phosphate dibasic 5.6 Ammonium sulfate 5.5 L-Argininamide dihydrochloride 5.1 Ethylenediamine dihydrochloride 5.1 Magnesium sulfate hydrate  
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is a psychrophilic bacterium. The top 10 conditions as judged by their increase in the Tm above the average, are shown in Table 3-2 and Table 3-3. Based on these data, 25mM 
TRIS/100mM citric acid pH 4.5, 150 mM NaCl was chosen as the storage buffer for Q15Z91.  
 
3.3.3 The structure of Q15Z91 with c-di-GMP and citrate bound 
The structure of Q15Z91 was determined by molecular replacement using 2.0 Å resolution data. The model contains residues 11-310, as well as two citrate molecules and two c-di-GMP dimers. As shown in Figure 3-2A, Q15Z91 is a dimer, with citrate bound at the active sites (A site) of the diguanylate cyclase (DGC) domains, and c-di-GMP dimers at 
Table 3-3: Buffers from the Slice pH Screen giving the highest Tm values in the DSF assay. 
Tm - Tm,averaged (oC) Additive 5.5 Sodium citrate tribasic dihydrate pH 4.5 
4.9 Citric acid pH 4.4 
4.7 DL-malic acid pH 4.7 
4.6 Sodium citrate tribasic dihydrate pH 4.2 
4.6 DL-malic acid pH 5.0 
4.3 DL-malic acid pH 5.3 
4.3 Succinic acid pH 5.1 
4.1 Citric acid pH 4.1 
4.1 Succinic acid pH 4.8 
4.1 Succinic acid pH 5.4  
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the inhibitory sites (I site). Chain A (light green) has no inter-domain interface, while chain B (light blue) has a weak interface. And there is a S-S bond between two chains. We can see clear electron density for the disulfide bond (Figure 3-2B). This Q15Z91 dimer structure is an inactive conformation, because the c-di-GMP bound in the I sites immobilizes the two DGC domains in an unproductive back-to-back orientation. 
 
 
Figure 3-2: The structure of Q15Z91 dimer with c-di-GMP and citrate bound (A).  The two protomers are colored light green and light blue. The ALR domain of Q15Z91 is at the top of the image, and the DGC catalytic effector domain is at the bottom. Citrate and c-di-GMP are shown as sticks with yellow carbon atoms. Mg2+ ions are shown as small green spheres associated with the tri-phosphate moieties of the citrate molecules. The citrate molecules from crystallization buffer are bound in the active sites (A site) and the c-di-GMP dimers are bound in the inhibitory sites (I site) of the DGC domain. The two 
polypeptides comprising the dimer are linked by a disulfide bond formed between C142 on both chains (B). The 2|Fo|-|Fc| electron density map contoured at 1.0σ is shown as a magenta mesh, and the 2|Fo|-|Fc| composite omit map, also contoured at 1.0σ, is shown as a green mesh. 
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The ALR domain of Q15Z91 has the same (β/α)5 topology and α4-β5-α5 dimer interface (Figure 3-3) characteristic of typical OmpR/PhoB RRs. As shown in Figure 3-3B, the switch residue F110 (equivalent to Y100 of RitR) is oriented inward, which is the conformation associated with the activated forms of typical OmpR/PhoB RRs and is thought to facilitate dimer formation. However, the other Ser/Thr switch residue is replaced by G91 in Q15Z91. In the phosphorylation-dependent RRs, phosphorylation induces a conformational change of the Ser/Thr switch residue that results in the reorientation of the Tyr/Phe switch residue to facilitate dimerization. In Q15Z91, the residue that is equivalent to the Ser/Thr switch residue in typical RRs is G91, so obviously side chain reorientation cannot be an integral part of the activation mechanism in Q15Z91. This is similar to what was seen in RitR, where the Ser/Thr switch equivalent, D81, had a minimal impact on dimerization. In addition, R61 in Q15Z91 replaces the phosphorylatable aspartate residue of the typical RRs. Comparison of the Q15Z91 and RitR ALR domains shows that the side chain of R61 
takes the place of the “lid residue” K10 of RitR and that the loop between β1 and α1 shifts away from the “phosphorylation site” comparison with that in RitR. It seems that the ALR domain of Q15Z91 has evolved to be an obligate dimer, and that activation may be more subtle than a change from monomer to dimer as has been seen for the DNA-binding RR proteins. 
Figure 3-3: ALR domains of the Q15Z91 dimer (A) and the overlay of the Q15Z91 and RitR ALR 
domains (PDB ID 4LZL1) (B). Chain A of Q15Z91 ALR domain colored in light green, chain B colored in blue. RitR ALR domain is colored cyan. The active site residues and switch residues equivalent are shown in stick. The Cα atom of G91 (Ser/Thr switch residue equivalent) in Q15Z91 is shown in sphere. 
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The active site of each DGC domain has one molecule of citrate and a Mg2+ ion bound (Figure 3-4).  Due to the asymmetric arrangement of the domains—the lack of any inter-domain interface in chain A, and the weak interface between the ALR and DGC domains in chain B—there some differences in the way GTP binds to the two DGC domains. In chain A, there are no contacts between the ALR domain and the citrate. Without GTP addition in the crystallization condition, the structure of purified Q15Z91 alone has c-di-GMP bound, which must have co-purified during the protein expression in cells. In the I site, c-di-GMP forms a dimer through stacking their guanosine rings, interactions between phosphate group with N11 and N21 on the Hoogsteen-edge of the guanine base of the other chain and hydrogen bond between O61 with N7 of the other c-di-GMP (Figure 3-4). 
The DGC domains found in other response regulator proteins also have a Rxx(D/E) motif that is associated with the inhibitory site. In Q15Z91, the residues of this Rxx(D/E) motif are R212 and D215. A shown in Figure 3-4, R212 interacts with the O6 and N7 atoms on the Hoogsteen-edge of the guanine base of one c-di-GMP molecule with 2.9 Å and 3.0 Å, respectively. The gunidinium group of R212 also interacts with the phosphate group of the second c-di-GMP within the c-di-GMP dimer at a distance of 2.8 Å. The carboxyl group of D215 forms hydrogen bonds with the N1 and N2 atoms on the Watson-Crick-edge of the guanine base of the second c-di-GMP molecule. There are also many other residues contributing to interacting with c-di-GMP dimer, including T232-N2 of the second c-di-GMP (2.7 Å), R168-posphate group of the c-di-GMP (2.8 Å), E213-posphate group of the c-di-GMP (2.9 Å).  
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In addition to the I site with Rxx(D/E) motif, DGC has two active sites (A site) with GGEEF motif. In the structure of Q15Z91, two citrate molecules form the protein storage 
 
Figure 3-4: Two molecules of c-di-GMP dimerize through stacking of their bases and bind to the inhibitory sites on chain A (A) and chain B (B). The c-di-GMP dimers are shown as sticks with yellow carbon atoms. R212 and D215 are the most conserved residues in the I site. The 2|Fo|-|Fc| electron density map, contoured at 1.0σ, is shown as magenta mesh, and the 2|Fo|-|Fc| composite omit map, also contoured 
at 1.0σ, is shown as green mesh. 
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buffer binds in the two A site respectively (Figure 3-5). E223, D179, carbonyl group of I180 and the citrate coordinate the Mg2+ ion. The basic residues K301 and R305, as well as the 
amide N atoms of F182, F183 and K184 interact with two carboxyl groups of citrate. In chain B, where there is a small interface between the ALR and DGC domains, Q78 from the ALR domain interacts with H192, which takes on multiple conformations. Due to the small interaction interface, this interdomain construction is probably caused by the whole geometry of this c-di-GMP inhibited dimer. 
 
Figure 3-5: Citrate binds in slightly different orientations in the active sites of chain A (A) and chain B (B). Citrate is shown as sticks with yellow carbon atoms. The residues in the A site are also shown as sticks, with carbons colored according to the chain color. The labels of the conserved GGEEF residues are colored in blue. The 2|Fo|-|Fc| electron density map, contoured at 1.0σ, is shown as magenta mesh, and the 2|Fo|-|Fc| composite omit map, also contoured at 1.0σ, is shown as green mesh. 
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The structure of Q15Z91 with the substrate GTP was also determined with 1.8 Å data (Figure 3-6). The structure of Q15Z91 with GTP and c-di-GMP is same with the structure of Q15Z91 with citrate and c-di-GMP, except the GTP molecules bound in the A sites. The imidazole of H192 packs on top of the 6-membered ring of the nucleotide. The carboxyl group of D196 interacts with N2 of the guanosine. The guanidine group of R219 interacts 
with O6 of GTP. K184 forms a hydrogen bonding interaction to the 3’ hydroxyl of GTP in chain B, while it interacts with 2’-OH of GTP in chain A. E223, D179, and the phosphate groups of GTP coordinate the Mg2+ ion; the metal, therefore, serves to anchor the tri-phosphate moiety of GTP to the enzyme. The basic residues K301 and R305 interact with the terminal phosphate group. In chain B, where there is an interface between the ALR and DGC domains, Q78 from the ALR domain interacts with H192, which takes on multiple conformations and appears to have less of an interaction with the GTP. The relative 
interactions between D196, K184, and the GTP are different from those observed in chain 
A: K184 makes a hydrogen bonding interaction with the 3’ hydroxyl of GTP rather than the 2’ hydroxyl, and D196 loses the interactions with H192 due to the inter-domain interaction between Q78 and H192. 
Comparison with the structure of diguanylate cyclase PleD (PDB ID 2V0N14), the structure of Q15Z91 with GTP and c-di-GMP is more likely an activated but product-inhibited form of Q15Z91. 
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Figure 3-6: The structure of Q15Z91 with c-di-GMP and GTP bound (A). Chain A is colored in light green, while chain B is colored in light blue. Citrate and c-di-GMP are shown as sticks with yellow carbon atoms. GTP binds in slightly different orientations in the active sites of chain A (B) and chain B (C). GTP is shown as sticks with yellow carbon atoms. The residues involved in GTP interactions are also shown as sticks, with carbons colored according to the chain color. The labels of the conserved GGEEF residues are colored in blue. The 
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2|Fo|-|Fc| electron density map, contoured at 1.0σ, is shown as magenta mesh, and the 2|Fo|-|Fc| composite 
omit map, also contoured at 1.0σ, is shown as green mesh. 
 It was not possible to obtain crystals of the un-inhibited (c-di-GMP-free) Q15Z91 and the 
Q15Z91(C142S) variant discussed below. The flexible conformation of the two catalytic domains without the product binding and disulfide bond may be one reason for the failures in crystallization of both c-di-GMP-free Q15Z91 and Q15Z91(C142S). 
  
3.3.4 Probing the roles of conserved residues by site-directed mutagenesis 
As mentioned in Chapter 2, the RitR double mutant RitR(L86A/V93A) exhibited activated characteristics (extended conformation and the ability to bind DNA). So the equivalent residues of Q15Z91, I99 and G102, were targeted for mutagenesis. C128 of RitR plays an important role in redox control. To determine whether or not the equivalent 
residue of Q15Z91, C142, has a similar role, this residue was changed to serine (C142S). Finally, R212 and D215 in the Rxx(D/E) I-site motif were mutated to Asn and Ala to determine the effect of disrupting the I-sites required for product inhibition. As described above, Q15Z91 and its variants only fold correctly in Origami2 E. coli cells, which have been engineered to have a less reducing environment in the cytoplasm and thus promote formation of disulfide bonds. After IPTG induction, biofilm formation was observed for in cultures expressing all forms of Q15Z91 we tested (Table 3-4). The fact that all of the Q15Z91 variants promoted biofilm formation indicates that none of them has been inactivated or catastrophically destabilized by the mutations. 
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The c-di-GMP produced during expression binds so well to the I-site that it co-purifies with Q15Z91, even persisting through dialysis and desalting steps. To remove the product inhibition, we used the phosphodiesterase SadR from Pseudomonas aeruginosa to linearize c-di-GMP into pGpG, which is easily removed by gel filtration. This c-di-GMP-free protein is called Q15Z91free. To determine whether or not the mutants had c-di-GMP bound, the absorbance at 260 nm (due to the nucleotide) was measured for Q15Z91 and each of the 
mutants. The results demonstrate that only the C142S and R212N/D215A variants do not have c-di-GMP bound. This was expected for the double mutant, since both of those residues are involved in key interactions with the c-di-GMP dimer in the I-site. The fact the 
loss of C142S impacts product binding to the I-site as drastically it does was surprising and 
likely indicates that reduction of the C142-mediated disulfide bond increases Q15Z91-catalyzed DGC activity by relieving the product inhibition.  
 
Table 3-4: Characteristics of wild-type and mutant forms of Q15Z91. 
Proteins Biofilm formation c-di-GMP Q15Z91 + + I99A + + G102A + + 
C142S + - R212N/D215A + -  
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3.3.5 The oligomeric state of Q15Z91 
As shown in Figure 3-7, Q15Z91 mainly exists as a dimer with c-di-GMP bound (retention time 5.2 min). The peak with a retention time of ~6.2 min is due to c-di-GMP, which is verified by the higher absorption at 260 nm than at 280 nm. After treatment with SadR and gel filtration, Q15Z91free still mainly exists as a dimer; the absence of the peak at ~6.2 min 
is further evidence that that peak is due to c-di-GMP. The Q15Z91free protein is considerably less stable than Q15Z91 (with c-di-GMP bound), as evidenced by the greater proportion of aggregated protein seen in the chromatogram. The retention time of the Q15Z91 dimer was 
 
Figure 3-7: The affects of H2O2 or DTT treatment on the oligomeric states of Q15Z91 (A) and Q15Z91free (B) were analyzed by SEC. The traces of protein only colored in green, protein with 1 mM H2O2 treatment colored in brown red and protein with 1 mM DTT treatment is colored in cyan. 
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longer than expected based on the molecular weight standards. This may be due to shape effects or direct interactions between the protein and column matrix.  
 
In order to get a more accurate mass estimate for the molecule responsible for the peak at 5.2 min, Q15Z91free was analyzed by size exclusion chromatography with multi-angle static light scattering (SEC-MALS). The chromatograms were analyzed using the ASTRA software package (Figure 3-8). The major peak in the UV trace (retention time range 5.1-6.3 min) has a mass of 65-79 kDa, which is close to the mass of the Q15Z91 dimer. The peaks that elute earlier than 5 min were verified to be high molecular weight aggregates. To check the effects of reducing or oxidizing agents on the oligomeric state, DTT and H2O2 were added to Q15Z91 and Q15Z91free samples (1 mM each). SEC analysis (Figure 3-7) 
 
Figure 3-8: SEC-MALS results for Q15Z91free. 
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shows that oxidizing and reducing C142 have no effect on the oligomeric state of either form of the protein (free or product-inhibited).  
The oligomeric state of each of the Q15Z91 point mutants was also checked by size exclusion chromatography (Figure 3-9). The mutants I99A and G102A both existed as dimers with c-di-GMP bound. Like the wild-type protein, both mutants existed as dimers after treatment with SadR to remove the c-di-GMP. Interestingly, in spite of being treated in exactly the same way, SadR was apparently not able to remove all of the c-di-GMP from the 
I99A mutant. Consistent with the UV/vis data, the other two mutants C142S and R212N/D215A, existed as dimers without c-di-GMP bound. Neither of these mutants is affected by treatment with DTT or H2O2.  
Figure 3-9: The oligomeric states of Q15Z91(I99A) (A), c-di-GMP free  Q15Z91(I99A) (B), Q15Z91(G102A) (C), c-di-GMP free  Q15Z91(G102) (D), Q15Z91(C142S) (E), Q15Z91(R212N/D215A) (F) with or without H2O2 or DTT treatment were analyzed by SEC. The traces of protein only colored in green, protein with 1 mM H2O2 treatment colored in brown red and protein with 1 mM DTT treatment is colored in cyan. 
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3.3.6 Preliminary quantitation of biofilm phenotype 
In order to quantify the observed biofilm formation phenotype of Origami2 cells expressing Q15Z91 or its mutants, the amount of biofilm material deposited on the walls of 
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culture tubes was measured by the degree of staining with crystal violet as described in the methods section. All proteins were expressed as His6-SUMO fusion proteins; the fact that biofilm formation was observed in response to Q15Z91 expression is evidence that the SUMO tag does not affect the catalytic activity of the protein. After dissolving the crystal violet-stained biofilm in a mixture of ethanol and acetone, the absorbance at 540 nm was measured. The amount of dye, and thus the absorbance, is proportional to the amount of biofilm present. Cultures were induced at an OD600nm of ~0.7, except for the 
Q15Z91(C142S) culture in LB with kanamycin. After growing for 7 hours at 37 °C, the OD600nm of C142S mutant in kanamycin-containing culture was still about 0.3, so 0.4 mM IPTG was added to induce SUMO-Q15Z91(C142S) expression. It is circumstantial, but this 
result may suggest that the C142S variant is constitutively active, and therefore, that the reduced form of the protein is the activated form. Not surprisingly, uncontrolled DGC activity is apparently toxic to E. coli cells.  
In Figure 3-10A, it is clear that all of the other mutants formed biofilm and that the cells are evenly distributed in the medium. The cells carrying the pSUMO-C142S plasmid aggregated at the bottom of the culture tube. The A540 of the biofilm extract from the 
Q15Z91(C142S) culture is the highest one. The double mutant R212N/D215A only formed a small amount of biofilm, which suggests that the I-site is also important for the cyclase activity. 
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Figure 3-10: Biofilm formation after IPTG induction in Origami2 cells with Q15Z91 related plasmids. (A) 
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cultures photo (B) After crystal violet stain. (C) Biofilm amounts are quantified by absorbance at 540 nm. The 
biofilm formed in Q15Z91(C142S) is significantly higher than others. 
 
3.3.7 Preliminary enzymatic activity 
Three different assays were attempted in order to characterize the diguanylate cyclase activities of Q15Z91 and Q15Z91free, in the presence and absence of DTT and H2O2. The first was an end-point assay where the proteins were incubated for 30 min in the presence of GTP and MgCl2. The reaction products were then characterized by reverse-phase HPLC. Extensive method development work failed to identify combinations of stationary and mobile phases whereby GTP could be separated from the product c-di-GMP. In all of the methods tested, the analytes were not retained on the columns.  
The second assay used the Biomol Green reagent to quantify the inorganic pyrophosphate released by the DGC.  Since Biomol Green can only detect Pi, pyrophosphotase was used to digest the PPi into two equivalents of Pi. The reactions contained 10 µM Q15Z91 or Q15Z91free, 0.2 mM GTP, and 2 mM MgCl2, and were incubated at RT for a total of 180 min. Aliquots were quenched at specific time points and the Pi content was measured to build a time course of the reaction. The preliminary results for Q15Z91 and Q15Z91free with GTP are shown in Figure 3-11. Both Q15Z91 and Q15Z91free exhibit a very low rate of PPi release. This is not unexpected, since both proteins purify as their product-inhibited forms. Consistent with the SEC results above, the addition of 1 mM DTT results in a much more rapid reaction. The reaction is so rapid, in fact, that it was complete by the time the first aliquot was taken (10 min). The effect of DTT is especially 
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pronounced with the Q15Z91free enzyme, likely because this reaction is not contaminated with c-di-GMP. 
Due to the speed of the reaction with the DTT-treated protein, we sought a direct assay that would allow us to monitor earlier time points. The EnzCheck assay kit (Sigma) allows the real-time monitoring of phosphate release by coupling it to purine nucleoside phosphorylase-catalyzed phosphorylation of the synthetic nucleotide MESG, which absorbs light at 360 nm. The first experiments with this assay were inconclusive, since the 10 min pre-incubation with MESG, purine nucleoside phosphorylase appeared to destabilize the enzyme, resulting in extremely small rates. 
 
 
Figure 3-11: Time courses for the reaction of Q15Z91 (A) and Q15Z91free (B) with 0.2 mM GTP in the absence or presence of H2O2 or DTT. Blue line represents only. Red line represents 1 mM H2O2 treatment. 
Green line represents 1 mM DTT treatment. Purple line represents the reaction conducted at 4 oC. 
 
143 
3.4 Discussion 
Q15Z91 is a diguanylate cyclase that is regulated by an ALR domain. Key residues for the phosphorylation-dependent activation of typical response regulator receiver domains, particularly the acidic triad residues, have been lost in Q15Z91. The phosphorylatable aspartate is replaced by arginine, and the other two acidic triad residues are replaced with Met and Glu. These changes exclude the possibility of phosphorylation-dependent activation of Q15Z91. In spite of this, the positions of the switch residues positions and the dimer interface of Q15Z91 are similar to those of the typical, phosphorylation-dependent OmpR/PhoB RRs. Q15Z91, like RitR, the other ALR domain-containing protein discussed here, also has a conserved cysteine residue in the linker between the ALR and effector domains. 
Q15Z91 purifies as a product-inhibited form with c-di-GMP bound. The Q15Z91 structure, as well as the SEC results, demonstrates that Q15Z91 exsits as a dimer. After removal of c-di-GMP, it maintains this dimer conformation. Neither H2O2 nor DTT have any effect on the oligomeric state of Q15Z91. Preliminary activity tests show that the activities of Q15Z91 and Q15Z91free are dramatically increased in the presence of DTT. To check the 
role of the conserved cysteine residue, Cys142 was mutated into serine. The variant 
Q15Z91(C142S) is also dimeric, providing ample evidence that Q15Z91 is not regulated by 
a switch between dimer and monomer as RitR is. Interestingly, the C142S mutant is no longer able to bind c-di-GMP, or at least only with much reduced affinity compared with the wild-type protein. Cyclic di-GMP, as an important second messenger, regulates biofilm formation, which is an important phenotype to check the cyclase activity in heterogeneous 
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cell systems. According to the results of our biofilm assays, there is a significantly increment of biofilm formation for Q15Z91(C142S) mutant. In other words, the variant 
C142S seems to greatly reduce product inhibition by c-di-GMP, which means the disulfide bond formation is likely essential for c-di-GMP binding. In summary, C142 of Q15Z91 is not essential for dimerization, but involved in facilitating c-di-GMP binding and product feedback inhibition.  
In RitR, the C128 functions as redox sensor to control the inter-domain interactions for later dimerization and activation. Considering the dimer structure of Q15Z91, Q15Z91 appears to be constitutively active and this activity is modulated by product inhibition. 
Under oxidizing conditions, where the C142 disulfide bond is formed, product inhibition is potent and the DGC activity of Q15Z91 is low. Under reducing conditions, the C142 disulfide bond is broken, decreasing the affinity for c-di-GMP and largely removing the product inhibition. Taken together, the cysteine located at the C-terminal end of the α5 linker helix is important for the activation mechanism of Q15Z91. This is a departure from the well-studied phosphorylation-dependent diguanylate cyclases PleD14-16 and WspR4, where product inhibition is modulated by changes in the oligomeric state (dimer-tetramer equilibrium) that are influenced by additional domains. In short, Q15Z91 replaces the extra domain of PleD and WspR with a redox-active cysteine that directly influences product inhibition.  
There are about fifty DGCs in P. atlantica T6c. These DGCs tend to be fused to PAS or GAF sensor domains, to additional regulatory domains, or to phosphodiesterase domains.  These apparent redundancy but with different activation mechanisms DGCs/PDEs raises a 
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question that how the small molecule c-di-GMP to regulate the activities of these different proteins. By studying Q15Z91, we find that c-di-GMP inhibition regulation is dependent on  
the C142 disulfide bond formation. So we can assume that there are definitely other mechanisms combining with product binding to regulate specific DGC/PDE activity upon different environmental stimulation. 
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Chapter 4 
An Unusual PLP-Dependent Enzyme in Enduracididine Biosynthesis 
 
4.1 Introduction 
The emergence of antibiotic-resistant pathogens is a serious and growing threat to global health. There is an urgent need for new antibiotics to combat this threat. Unfortunately, the pace of antibiotic development has slowed almost to a standstill (Figure 
4-1).  
 
Figure 4-1: The numbers of new antibiotic compounds approved have been declining steadily since 1980. Data from the FDA Center for Drug Evaluation and Research. 
In response to the dismal rate of antibiotic development, among other problems, Congress passed the Food and Drug Administration Safety and Innovation Act (FDASIA). 
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Title VIII of this law, Generating Antibiotic Incentives Now (GAIN), created a fast track for new antibiotic approvals that seems to be paying off. While there have been no new classes of antibiotics, a number of new drugs based on old scaffolds have been introduced since the 
passage of the FDASIA; in 2014-15 six new antibiotics were approved by the FDA. Happily, it seems that interest in antibiotic development is on the rise. Consequently, any information regarding the biosynthesis or activity of antibiotics or key building blocks of these compounds, is potentially useful in these renewed efforts to discover new antibiotics.  
In this context, the non-proteinogenic amino acid L-enduracididine (L-End, 1, Scheme 
4-1) is particularly interesting. This conformationally restricted form of arginine is present in a number of antibiotics, including some with potent activity against antibiotic-resistant strains like methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Some prominent examples are the cyclic depsipeptide antibiotics enduracidin 3, mannopeptimycin 4 and the recently discovered teixobactin 5. 
Enduracidin was first isolated from Streptomyces fungicidicus No. B 54773. It is a seventeen amino acid lipodepsipeptide containing one residue of L-End and one of D-End 
(Scheme 4-2). In spite of having different amino acids and acyl chain, the overall structure enduracidin is similar to the cyclodepsipeptide antibiotic ramoplanin 6. Both enduracidin and ramoplanin are active against resistant bacteria  
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by binding to the external membrane surface of the lipid II intermediate, inhibiting the transglycosylation reaction of cell wall biosynthesis 7. Ramoplanin has entered phase III 
 
Scheme 4-1: Compounds mentioned in this chapter.  1, L-enduracididine; 2, L-β-hydroxyenduracididine; 
3, D-β-hydroxyenduracididine; 4, capreomycidine; 5, L-arginine; 6, 2-oxo-4-hydroxy-5-guanidinovaleric acid (i.e. 4-hydroxy-ketoarginine, 4HKA); 7, 2-ketoenduracididine (2KE); 8, L-3,4-dihydroxyphenylalanine (L-DOPA); 9, dopamine. 
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clinical trials for VRE suppression in gastrointestinal tract infections and prevention of bloodstream infections, but enduracidin is hampered by its low aqueous solubility 8.  
Another cyclic End-containing nonribosomal antibiotic, mannopeptimycin, is a glycosylated hexapeptide that also has activity against resistant Gram-positive bacteria, including MRSA and VRE 4, 9. Mannopeptimycin also inhibits peptidoglycan synthesis by binding to lipid II 9. Studies of the mechanism of action suggested that mannopeptimycin may first binds to the lipoteichoic acids of the Gram-positive cell wall, and then accumulates to interact with lipid II9. The structure of mannopeptimycins α, β, γ, δ, and ε from Streptomyces hygroscopicus LL-AC98 were characterized in 2002 4.  They contain the non-proteinogenic amino acids L-β-hydroxyenduracididine (2, L-βhEnd) and D-β-hydroxyenduracididine (3, D-βhEnd). Methods for the total synthesis of mannopeptimycins 
α and β were published recently 10, but these two mannopeptimycins have relatively poor anti-bacterial activities.  Much work (a Sci-Finder search returns more than 2000 analogs) has gone into making derivatives in the hope of finding one that has better therapeautic properties than the mannopeptimycins 11-17. However, almost all of these involve changes to the attached glycans; very few of them alter the peptide core itself.  
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Mannopeptimycin and enduracidin are both antibiotics with potent activity against antibiotic-resistant strains. To improve the physico-chemical properties and/or biological activities for therapeutic applications, they probably require further chemical modifications. However, the total syntheses of enduracidin and mannopeptimycin are limited by the complexity of the structures and lmited commercial availability of some non-proteinogenic amino acid building blocks like  enduracididine and its derivatives. Hence, a supply of L-End in quantities suitable to support drug development would greatly facilitate efforts to make derivatives of L-End-containing natural products.  
Several synthetic routes to L-End or its β-hydroxy analogs have been published. Shiba et al. began with the methyl ester of L-histidine, which underwent cleavage of the imidazole ring to give a protected amide that was subsequently deprotected, guanidinylated, and treated with HF to give L-End as a diasteriomeric mixture 18. The whole procedure involves 
only 4 steps, but it requires HF, which is hazardous, and the yield of the proper diasteriomer is low (22%). Dodd et al. used an aziridine-based method to synthesize 9-phenylfluorenyl-protected L-End with 4 steps, but the yield is still low (33%) 19. No improvement in the yield was obtained after many attempts.  The azide derivatives of β-hydroxy-End were first synthesized by Oberthür et al 20. It takes 21 steps to synthesize 2 with ~16% overall yield, and 24 steps to synthesize compound 3 with ~10% yield. After optimization, shorter routes were developed (e.g. 8 steps from Garner’s aldehyde), but with no improvement in the yields (16% for 2 and 8% for 3) 21. Recently, the most efficient route to N-mannosyl-D-β-hydroxy-End was published by Cheng et al., which gave 43% yield 22. Given the difficulties of synthesizing the nitrogen-rich iminoimidazolidine ring of 
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the L-End, and the presence of two chiral centers, an enzymatic or chemo-enzymatic route to L-End may prove to be the most efficient means of producing large quantities of L-End. 
 
4.2 Biosynthesis of enduracididine 
The enduracididine biosynthetic genes were first identified by comparing the enduracidin biosynthetic cluster in S. fungicidicus to that of the mannopeptimycins from S. 
hygroscopicus 23, 24. The enduracidin and mannopeptimycin scaffolds are very different. In fact, aside from the presence of L-End in both products, and the fact that both are non-ribosomally produced depsipeptides, there are no similarities between them. Thus, the presence of 3 pairs of genes in the two biosynthetic clusters with high pairwise sequence identity suggested that these genes are likely responsible for L-End biosynthesis. The products encoded by these gene pairs are MppP/EndP (85%), MppQ/EndQ (66%), and MppR/EndR (73%) (Mpp = mannopeptimycin; End = enduracidin; Figure 4-2). Primary sequence analysis suggested that products P and Q were pyridoxal-5’-phosphate (PLP)-dependent aminotransferases, and that R was likely an acetoacetate decarboxylase. 
Experiments by K. Hatano et al. 25 used radio-labeled amino acids to investigate the biosynthetic origin of L-End and found that the most radioactivity was incorporated into the L-End fraction of the enduracidin that was produced when cultures were fed with labeled L-Arg. Thus, it was concluded that the biosynthesis of L-End, now presumed to be carried out by Mpp/EndP, Mpp/EndQ, and Mpp/EndR, likely begins from L-Arg 25. This, in turn, suggests that the iminoimidazolidine ring of End is probably formed by cyclization 
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 between the γ-carbon and one of the guanidine N atoms of arginine 25. There is precedent 
 
Figure 4-2: Comparison of the mannopeptimycin biosynthetic cluster (A) with that of enduracidin (B) suggested that the three genes mppP/endP, mppQ/endQ and mppR/endR are involved in enduracididine biosynthesis. These genes are enlarged and colored in blue. Comparing the sequences of MppP with EndP, MppQ with EndQ, and MppR with EndR (C) shows a high degree of pairwise sequence identity. On the basis of their sequences, Mpp/EndP and Mpp/EndQ are predicted to be PLP-dependent aminotransferases and Mpp/EndR is predicted to be an acetoacetate decarboxylase. 
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for this sort of transformation in the biosynthesis of another arginine-derived non-proteinogenic amino acid, L-capreomycidine (L-Cap, 4; Scheme 4-3). Capreomycidine is found in the antibiotic viomycin, and its biosynthesis was initially thought to provide a possible chemical logic for L-End biosynthesis. In the viomycin biosynthetic cluster from S. 
vinaceus, L-Cap (compound 4) is produced from L-Arg (compound 5) by two enzymes: VioC 
and VioD. VioC is an Fe(II)/α-ketoglutarate-dependent oxygenase that hydroxylates L-Arg 
at the β-carbon to give 3S-hydroxy-L-Arg 26. This product is then cyclized by VioD, a PLP-dependent aminotransferase that catalyzes an intra-molecular transamination to give the 
 
Scheme 4-3: L-capreomycidine biosynthesis mechanism by VioD. 
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6-membered capreomycidine ring 27, 28. 
According to their amino acid sequences, MppP and MppQ were both predicted to be class I/II aminotransferases, while MppR was predicted to be an acetoacetate decarboxylase. Assuming that L-End biosynthesis likely occurs in a similar way to L-Cap biosynthesis, that is by activation of L-Arg by hydroxylation followed by transamination, it was not clear exactly how two aminotransferases and a decarboxylase would accomplish this transformation. Clearly, there had to be a difference in the biosynthetic schemes of L-Cap and L-End. 
The first clues came from studies of MppR 29. In spite of its low (~20%) sequence identity with acetoacetate decarboxylase, MppR was shown to have a nearly identical tertiary structure.  Differences in the active site of MppR, such as the loss of key residues for the decarboxylation reaction, suggested that MppR was not a decarboxylase. This was subsequently confirmed experimentally. The real breakthrough came when it was demonstrated that MppR is able to cyclize the ketone derived from γ-hydroxy-L-arginine, to give the ketone form of enduracididine (i.e. 2-keto-End, compound 7, Scheme 4-1). This product is actually observed bound to the catalytic lysine residue of MppR in crystals soaked with 2-oxo-4-hydroxy-5-guanidinovaleric acid (4HKA, compound 6). In addition, experiments with MppQ showed that it was a true aminotransferase, capable of transaminating L-Arg and pyruvate or glyolxylate, or the reverse, 2-ketoarginine and alanine or glycine (unpublished results). These observations suggest that MppR generates 
7 from the highly oxidized arginine derivative 6, which is then transaminated by MppQ to give the amino acid, L-End. The L-β-hydroxy-End found in mannopeptimycin is produced 
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from L-End by the Fe(II)-dependent oxygenase MppO, which hydroxylates the β-carbon of L-End to give L-βhEnd (compound 2) 30. D-βhEnd is presumably generated from L-βhEnd by epimerization 31. All of this was plausible based on the data available at the time, but raised the question of where the highly oxidized arginine derivative 6 comes from. 
Extensive work by predecessors on the enduracididine project failed to produce any of the S. hygroscopicus MppP in soluble form. Multiple strategies beyond the typical optimization of expression conditions were employed, including for example, truncation of the N- and C-termini, codon optimization, and site-directed mutagenesis. Switching to the S. 
fungicidicus homolog EndP from the enduracidin pathway gave no better results. A final BLAST search preparatory to throwing the MppP project away altogether returned a homolog from Streptomyces wadayamensis that was significantly longer than either MppP or EndP. Both of these are listed in GenBank at 293 amino acids, which is considerably 
shorter than the ~415 residues typical of aminotransferases. The S. wadayamensis homolog is 376 amino acids, so it would seem that a non-standard initiation codon fooled the annotation software into thinking the MppP and EndP coding sequences began about 100 codons into the gene. This at least made it clear why the protein would not express—all of 
the expression constructs tried to date contained at most ~3/4 of the gene! The S. 
wadayamensis enzyme expressed well in E. coli.  
With soluble protein in hand, we were finally able to begin the work of identifying the catalytic activity of MppP. S. wadayamensis is an endophytic strain isolated from mandarin organge trees (Citrus reticulata), which produces, among other natural products, mannopeptimycin 32. Since it was expected from the work with MppR and MppQ that MppP 
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must catalyze the first step of the pathway, the S. wadayamensis MppP (SwMppP) was incubated with L-Arg and monitored by UV-Vis spectroscopy. The results of these first crude experiments, which will be discussed in detail in Chapter 5, indicated that MppP reacted with L-Arg, finally accumulating a colored (pale pink) intermediate when the cuvette had been exhausted of dioxygen. Before delving into the experimental results we ultimately obtained, however, it will be instructive to investigate the chemistry of PLP and some properties of well-characterized PLP-dependent enzymes. 
 
4.3 Pyridoxial 5’-phosphate is a versatile cofactor 
PLP is a versatile cofactor catalyzing manifold reactions, including transamination, racemization, C-C bond formation or cleavage, β- and γ-elimination/substitution, and oxidative decarboxylation 33. Some general reaction mechanisms are shown in Scheme 4-4. Due to its electron sink properties, PLP is inherently reactive and readily catalyzes reactions with amino acids, for example, without the aid of any enzyme. In fact, it has been said that, in general, PLP-dependent enzymes do not so much accelerate the PLP-catalyzed reaction, but rather direct the catalytic power of PLP in a single direction 34. In other words, PLP-dependent enzymes provide modest rate accelerations and strictly control the reaciton specificity. Toney 35 reviewed and summarized the three major factors that determine the reaction specificity in PLP-dependent enzymes: stereoelectronic control, the electrophilic strength of the Schiff base-pyridine ring π-electron system, and the placement of the substrate’s side chain. Certain factors are common to most PLP-dependent enzymes, such as the covalent complex between a catalytic lysine residue on the enzyme and the PLP 
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cofactor; this is the internal aldimine. When substrates bind, they react, normally by attack 
on the C4’ of PLP to displace the enzyme lysine side chain and form the external aldimine. 
As shown in Scheme 4-4, the external aldimine is the branch-point for many of the reaction types, such as decaboxylation or Cα-H abstraction. Which bond is going to be broken depends on the orientation relative to the pyridine ring. Thus, the bond aligned 
parallel to the π-orbitals (perpendicular to the PLP plane) promotes π–σ-orbital overlap, is weakened and is more easily cleaved 35. Hence, decarboxylases bind their substrates so that the bond to the carboxyl group is located perpendicular to the PLP plane. Conversely, 
enzymes that begin with Cα-H proton abstraction, such as transaminases and racemases, orient the Cα-H bond perpendicular to the PLP ring.  
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The protonation state of the pyridine nitrogen atom is another key factor influencing the reaction specificity. In aspartate aminotransferase, for example, this nitrogen is kept in the protonated, pyridinium form by the juxtaposition of the negatively charged carboxyl group of a conserved aspartic acid residue 36. In enzymes like alanine racemase, where the 
carbanion at Cα must be stabilized, the pyridine nitrogen is kept deprotonated via interaction with the guanidinium group of a conserved arginine 37. 
Percudani and Peracchi have created a B6 database utilizing hidden Markov models to compare the sequences of PLP-dependent enzymes. Their analysis distributes PLP-dependent enzymes into seven separate clusters based on their functions 38.  The representatives of these seven clusters are shown in Figure 4-3. Five of these clusters are essentially identical to the traditional classification system for PLP-dependent enzymes, which is based on 5 distinct topologies or “Fold Types” 39. The Type I PLP-dependent enzymes are also called the aspartate aminotransferase (ATase) superfamily. Enzymes in this superfamily are typically dimeric (sometimes higher order oligomers) and have three discontinuous domains: the N-terminal extension, the large domain, and the small domain. The active site is located at the interface between the large and small domains, and is composed of residues from two protomers of the oligomer. Fold Type I is the largest and most diverse in terms of function and structure of N terminal domain, including class I, II, III, and V aminotransferases as well as enzymes catalyzing other PLP-dependent reactions like cystathionine γ-lyase, serine hydroxymethyltransferase 39, 40.  Class I ATase mainly contains aspartate aminotransferase, tyrosine ATase, aromatic ATase, alanine ATase and l-aminocyclopropane-1-carboxylate synthase. Class II ATase mainly comprises glycine acetyltransferase, 5-aminolevulinic acid synthase, histidinol-phosphate aminotransferase. 
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Class III mainly contains ornithine ATase, 4-aminobutyrate ATase, ω-amino acid-pyruvate ATase. Class V ATase mainly contains phosphoserine ATase, serine-pyruvate ATase. 
The Type II PLP-depedent enzymes are evolutionarily distinct from the Type I enzymes, despite having similar tertiary structures33, 41. Fold type II includes the tryptophan synthase family of enzymes that mainly catalyze replacement and elimination reactions at Cβ, while 
most aspartate ATase family proteins promote reactions on the Cα atom of the substrate41.  Fold Type II also contains acetyltransferases, ammonia lyases, and some racemases. In contrast to the Type I enzymes, the active sites of Type II enzymes are consist entirely of residues from a single protomer (such as tryptophan synthase42). Another distinguishing characteristic of these two enzyme families is the existence of a regulatory domain in the Type II enzymes43, 44, whereas this is lacking in the Type I proteins. 
 The other fold types have fewer members than either of those discussed above. Fold Type III, also called the alanine racemase family, contains primarily amino acid racemases and decarboxylases. The structures of these proteins consist of an N-terminal β/α barrel and a C-terminal mostly β sheets domain 39. Fold Type IV contains the class IV aminotransferases, which take mainly branched-chain amino acids and D-amino acids as substrates. The structures of the Type IV enzymes are very similar to the Type I ATases, but the PLP is bound in the opposite orientation  
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Figure 4-3: Ribbon diagrams of representative structures of the seven Fold Types of PLP-dependent enzymes. Each depicts the functional oligomeric state. The PLP and catalytic lysine, as well as substrates when available, are shown as sticks. PDB ID 7AAT45 is the structure of mitochondrial aspartate aminotransferase from Gallus gallus, which is the representative of fold type I and functions as a dimer (chain 
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A colored in green, chain B colored in cyan). PDB ID 1BKS46 is the structure of tryptophan synthase from 
Salmonella typhimurium, which functions as an α2β2 complex (α subunit colored in green, β subunit colored in cyan). The α and β subunits catalyze different reactions and indole is the channeled intermediate connecting 
the two reactions (α and β)47-49. The β subunit belongs to PLP Fold Type II. PDB ID 1SFT37 is the structure of alanine racemase from Bacillus stearothermophilus, which is the representative of fold type III and functions as dimer (chain A colored in green, chain B colored in cyan). Each monomer contains two domains: and N-terminal eight-stranded α/β barrel and a C-terminal mostly β-strand domain. PDB ID 1DAA50 is the structure of D-amino acid aminotransferase from Baccilus sp. YM-1, which is the representative of fold type IV and functions as a dimer (chain A colored in green, chain B colored in cyan). Each monomer contains two domains that are very different from the structures of the L-amino acid aminotransferases. PDB ID 1GPA51 is the structure of glycogen phosphorylase from Oryctolagus cuniculus, which belongs to Fold Type V and functions as dimer (chain A colored in green, chain B colored in cyan). PDB ID 1XRS52 is the structure of lysine 5,6-aminomutase from Clostridium sticklandii, which is the representative of fold type VI and functions as an α2β2 tetramer (α subunits colored in green, β subunits colored in cyan). The larger α subunit consists of a PLP 
binding α/β barrel surrounded with additional α helices and β strands. The smaller β subunit contains two domains: the dimerization domain and the adenosylcobalamin (B12)-binding Rossmann domain. PDB ID 2A5H53 is the structure of lysine-2,3-aminomutase from Clostridium subterminale, which belongs to Fold Type VII and functions as a tetramer (chain A colored in green, chain B colored in cyan, chain C colored in magenta, and chain D colored in yellow). This enzyme is S-adenosylmethionine-, [4Fe-4S]2+-, and PLP-dependent. S-
adenosylmethionine and PLP are shown as sticks; [4Fe-4S]2+ is shown in sphere. 
 
compared to the Type I ATases. Fold Type V contains just one enzyme: glycogen 
phosphorylase (EC 2.4.1.1), which uses the phosphate group of PLP for catalysis54. The two new classifications obtained from the hidden markov model analysis by Percudani and Peracchi are designated Type VI and Type VII. Type VI includes the L- and D-lysine 5,6-
aminomutases (EC 5.4.3.3 and 5.4.3.4; e.g. PDB ID: 1XRS55) and D-ornithine 4,5-
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aminomutase (EC 5.4.3.5). Type VII contains the lysine 2,3-aminomutase family enzymes (e.g. PDB ID: 2A5H 56). 
 
4.4 Aminotransferases (ATase) 
The PLP-dependent aminotransferases catalyze transamination reactions in which the 
α amino group of an amino acid is transferred onto the α-carbon of a 2-oxo acid, forming the 2-oxo acid form of the amino acid and the amino acid form of the 2-oxo-acid. The example of the thoroughly studied asparate aminotransferase-catalyzed reaction is shown 
in Figure 4-4A. Aspartate aminotransferase (AATase) has a large domain, a small domain and an N-terminal extension (Figure 4-4B). It functions as a dimer with the active site residues contributed by both domains and by both chains of the dimer, as discussed above. In L-amino acid aminotransferases, the catalytic lysine residue is located on the si face of 
C4’ of the cofactor and the re face is accessible by solvent or substrate. 
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Figure 4-4: The reaction catalyzed by aspartate aminotransferase (A). Ribbon representation of the aspartate aminotransferase dimer (PDB ID: 1ARS57). Chain A is colored grey, chain B is colored light green. The active site of AATase shows the binding mode of PLP in this and similar enzymes (C). The catalytic K258 and PLP are shown as sticks with yellow carbon atoms. The asterisk on atom labels denotes that the residue is contributed by the other chain of the dimer. 
 
4.4.1 The AATase active site 
As shown in Figure 4-4C, the catalytic K258 of the E. coli AATase is covalently bound to the PLP as the internal aldimine. The negatively charged D222 stabilizes the pyridine N atom of PLP as the pyridinium, which allows the ring to accept electrons from the substrate stabilizing the carbanion that forms during catalysis. The C3’ hydroxyl group of PLP makes 
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a hydrogen bonding interaction with N194 and Y225, both highly conserved among the Type I AATases. The phosphate group of the cofactor interacts with R266, T109, S257, Y70* (from the other protomer of the dimer); S296* interacts with the phosphate group through an intervening water molecule. The pyridine ring of PLP is clamped between W140 above 
and A224 below. W140 is important for retaining PLP in the active site. Mutating W140 to His in the E. coli AATase resulted in a 50-fold increase in the dissociation rate constant for PLP58. Also, the angled, unstacked imidazole ring of this W140H variant facilitated water access to the re face of the substrate Cα, resulting in a faster rate of racemization and decreased aminotransferase activity58.  
 
4.4.2 Conformational changes associated with catalysis 
Because the substrates of AATase are aspartate and α-ketoglutarate, the elimination and replacement reactions cannot happen. In the structure of the E. coli AATase with the inhibitor 2-methyl-L-aspartate (PDB ID: 1ART59), R386 coordinates the α-carboxylate group of the inhibitor and holds in in the plane of the PLP ring, which discourages decarboxylation. After the deprotonation of Cα, the resulting quinonoid intermediate is capable of undergoing either transamination or racemization. Kochhar and Christen found that human mitochondrial AATase that had been truncated by limited proteolysis with trypsin (residues 27/32-410) had the same racemization activity as the intact protein, but much lower transamination activity60. In addition, increasing organic solvent (methanol) proportion in the reaction resulted in decreased racemization but the same transamination activity of AATase60. Thus, it appears that AATases have evolved a strategy to discourage 
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the racemization reaction by limiting the access of water to the catalytic center. This strategy involves closing the active site with N-terminal extension. This excludes water from the active site, preventing water molecules from pronating the re side of the quinonoid intermediate.  
The small domains of many Type I aminotransferases also shifts towards the large domain upon substrate binding, forming a “closed” conformation57, 61, 62. In E. coli AATase, this movement of the small domain creates a repulsive interaction between G38 and Y225, which may reduce the pKa of the aldimine and, thus, enhance catalysis61. The lower imine pKa of the internal aldimine is mainly due to the 90 ° torsion angle of the C4-C4’ bond (C3-
C4-C4’-Nζ) and the repulsive interaction between G38 and Y225 that destabilizes the unprotonated aldimine in the Michaelis complex 61, 63. 
 
4.4.3 Dual substrate recognition 
As mentioned above, the aminotransferase reaction involves two different substrates being transformed, in succession, into two products. In many cases, these two substrates have very different side chains, such as different charges (e.g. alanine vs α-ketoglutarate), inverse absosolute configuration (e.g. D-p-hydroxyphenylglycine and L-glutamate), and/or different size side chains (e.g. aspartate and α-ketoglutarate). Aminotransferases have evolved several ways to solve the problem of having such different substrates binding in the same active site in the same orientation relative to the same PLP cofactor. These 
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include the “glutamate switch,” the “arginine switch,” and remodeling of hydrogen bonding networks33, 64.   
The “glutamine switch” works as shown in Figure 4-5. When the substrate, lysine, forms the external aldimine with PLP (PDB ID: 2CJD65) in the lysine ε-aminotransferase from 
Mycobacterium tuberculosis, the carboxylate group of E243 neutralizes the guanidinium 
group of R422. This prevents repulsion due to the juxtaposition of like charges. However, in the structure of the lysine ε-aminotransferase with α-ketoglutarate bound (PDB ID: 2CJH65), E243 rotates out of the active site, which allows the interaction between R422 and 
the α-carboxylate group of α-ketoglutarate. The “arginine switch” works in a similar way, as it is also based on the flexibility of active site residues as demonstrated in the active site of GABA aminotransferase. Comparing the structures of GABA aminotransferase in complexes with either an inactivator CPP-115 with one carboxylate group (similar to 
GABA) (PDB ID: 4ZSY 66) or the metabolite of CPP-115 with two carboxylate groups that is 
similar to glutamate (PDB ID: 4ZSW 66), R445 that interacts with the one carboxylate group of the CCP-115 metabolite, switches out and interacts with E270 in the CPP-115 bound structure 66, 67. 
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Figure 4-5: Dual substrate recognition in lysine ε-aminotransferase from Mycobacterium tuberculosis. When lysine is bound in the active site of lysine ε-aminotransferase as the external aldimine (A), E243 forms a salt 
bridge with R422. When α-ketoglutarate is bound in the active site (B), E243 rotates away from R422, which 
allows R422 to interact with the α-carboxylate group of α-ketoglutarate. 
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4.5 L-3,4-dihydroxyphenylalanine (L-DOPA) decarboxylase 
4.5.1 Mechanisms of decarboxylation and oxidative deamination 
Some PLP dependent enzymes were found to react with O2, such as 3,4-dihydroxyphenylalanine (DOPA) decarboxylase/L-aromatic amino acid decarboxylase 68, and so-called “paracatalytic” reactions 69 with O2 have been described. DOPA decarboxylase catalyzes the conversion of L-DOPA (compound 8) and L-5-hydroxy tryptophan into two important neurotransmitters, dopamine (compound 9) and serotonin. The mechanism is 
shown in Scheme 4-5A. Upon substrate binding, the internal aldimine is converted into external aldimine. Due to the orientation of the substrate carboxyl group perpendicular to the PLP ring, decarboxylation happens. The subsequent quinonoid intermediate is protonated at Cα position, giving the corresponding amine product (9). Mutagenesis studies of Y332 demonstrated that this residue is probably the proton donor in the step of quinonoid protonation70. Notably, the mutant Y332F has a decarboxylation-dependent oxidative deaminase activity, rather than decarboxylase70. In other words, Y332F reacts with L-amino acids and dioxygen to generate the corresponding aromatic aldehydes, CO2 and ammonia. 
DOPA decarboxylase also catalyzes the oxidative deamination of serotonin and dopamine71, 72. The proposed oxidative mechanism of 9 is shown in Scheme 4-5B. The internal aldimine is converted into the external aldimine with dopamine, and after deprotonating on Cα, the quinonoid intermediate forms. Based on its close proximity to the substrate Cα and mutagenesis studies, T246 is thought to function as a nucleophile to 
abstract the α-proton 73. In the presence of O2, the quinonoid intermediate reacts with O2 
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and forms a superoxide anion and semiquinone, followed by a hydroperoxy-PLP intermediate. After several steps, the final aldehyde product, H2O2, and ammonia form. In the absence of O2, the quinonoid intermediate would equilibrate with a ketimine73.
 
 
Scheme 4-5: Decarboxylation (A) and oxidation deamination (B) by DOPA decarboxylase. 
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4.5.2 Structure of human DOPA decarboxylase 
DOPA decarboxylase belongs to group II of Fold Type I, which contains the L-amino acid decarboxylases. The group II of L-amino acid decarboxylases include aromatic amino acid decarboxylase, histidine decarboxylase, and glutamate decarboxylase 74. They share a similar active site conformation and many conserved features. Binding of PLP into the apoenzyme is thought to be the essential regulator of activity 75. Upon PLP binding, DOPA decarboxylase undergoes a large conformational change into a more compact and less solvent accessible conformation 1.  
As shown in Figure 4-7, human DOPA decarboxylase is a homodimer with three domains: an N-terminal domain composed of three α-helices that contact with the other protomer, a large domain with a central seven-stranded β-sheet surrounded by α helices, and a C-terminal domain with a 4-stranded β-sheet covered by α helices on one side. The apoenzyme adopts an open conformation (PDB ID: 3RBL 1); while after PLP binds in the two active sites, it forms a closed conformation (PDB ID: 1JS62). In the apoenzyme 
structure, Y274 interacts with H302. After PLP binding, this movement (from open to 
closed conformation) makes the aromatic stacking interactions among W304, F80 and 
Y274 (Figure 4-7B). In the active site, the catalytic K303 covalently binds to PLP as the internal aldimine. H192 and A273 are stacked above and below the PLP ring. H192 is also involved in the catalysis of oxidative deamination. In the substrate analog-bound structure (PDB ID: 1JS32), the 
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Figure 4-7: (A) The structure of DOPA decarboxylase in an open  (PDB ID: 3RBL 1) and closed (PDB ID: 1JS62) conformation. The domain organization of chain A is highlighted with different colors (N-terminal domain colored in purple, large domain colored in blue, and C-terminal domain colored in orange). Chain B colored in grey. (B) Conserved residues in human DOPA decarboxylase are shown in stick. 
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iminic nitrogen of H192 is 4.8 Å away from the OH group of T246, which facilitates the 
deprotonation of T24676. As mentioned above, deprotonated T246 would abstract the Cα hydrogen and trigger the formation of the quinonoid intermediate (Scheme 4-5B). D271 makes a salt bridge interaction with the protonated pyridine nitrogen of PLP. Several 
residues, including S194, S149, H302, F309, are involved in interacting with phosphate group of PLP. I101* and F103* (from the other chain), Y79, F80, T82 are involved in substrate binding. 
The sequence of SwMppP suggests that it belongs to the class I/II ATase group of the Fold Type I PLP-dependent enzymes. The sequence identity between SwMppP and a Fold Type I ATase (PDB ID 1ARS57) or DOPA decarboxylase (PDB ID 3RBL1) is quite low (20% 
and 17%, respectively). In addition, many of the key active site residues of both the ATases and DOPA decarboxylase are different in SwMppP, suggesting that SwMppP probably has a different function. Two other genes in the L-End biosynthesis gene cluster, MppR and MppQ, are involved in the cyclization of 6 into 7 and the transamination of 7 into L-End (1), 
respectively (Figure 4-2). Hence, we speculate that SwMppP can only be a novel PLP-dependent hydroxylase/deaminase to catalyze the oxidation of L-Arg (5) into its γ-hydroxy, 2-oxo derivative 6. To find out the relationship between the function and structure, we used biophysical methods, as well as enzyme kinetics, to characterize SwMppP. Our findings are detailed in Chapter 5. 
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Chapter 5 
Streptomyces wadayamensis MppP is a PLP–Dependent L-Arginine Oxidase in the L-
Enduracididine Biosynthetic Pathway 
 
5.1 Background 
A UV-visible spectrum of SwMppP with L-Arg (Figure 5-1A) has the peak at 415-420 nm associated with the internal aldimine form of Fold Type I PLP-dependent aminotransferases. In buffers with pH < 7.0, like MES pH 6.7, the spectrum of SwMppP was unchanged over a full hour at room temperature. Thus, 10 mM MES pH 6.7 was chosen as the storage buffer for the enzyme. In high pH buffers, like NaPO4 pH 8.4 or BIS-TRIS propane pH 9.0, the enzyme exhibits much higher activity, even though the enzyme loses 
both its color and the peak at 415 nm (t1/2 ≈ 30 min). So we use high pH buffers for later kinetics study. 
Since enduracididine biosynthesis is thought to begin from L-Arg, and the other two enzymes in the pathway, MppR and MppQ, are thought, based on our own results, to be involved in later steps, we tested SwMppP for activity with L-Arg. Upon addition of 1 mM L-Arg to a solution of 30.0 μM SwMppP in 50 mM Bis-TRIS propane, pH 9.0, the peak at 415-
420 nm shifted ~10 nm to the right (425-430 nm), indicative of formation of the external aldimine 1, 2 (Figure 5-1A). After approximately 70 seconds, two new species absorbing at 510 and 560 nm began to accumulate. The former reached a maximum and plateaued, while the latter only accumulated for a short time and then quickly decayed (Figure 5-1A, 
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inset). Agitating the cuvette resulted in the disappearance of the 510 nm peak. After a short time, the 510 nm peak would accumulate again. This observation suggested that SwMppP reacts with molecular oxygen as well as L-Arg. To confirm this putative reaction with O2, we 
performed the same experiments in a Clark electrode to monitor the consumption of dioxygen 
directly. As is evident in Figure 5-1B, dioxygen is consumed upon addition of the enzyme, and 
the rate of O2 consumption increases with the concentration of L-Arg.  
Figure 5-1: SwMppP reacts with L-Arg. Absorbance spectra recorded on a Hewlett-Packard 8453 
diode array spectrophotometer for the reaction of 30 μM SwMppP with 2 mM L-Arg and ambient (∼250 μM) O2 (A). Spectra were recorded every 0.5 s, but only the traces every 10 s are shown here for clarity. The purple line represents the enzyme alone in 50 mM BIS-TRIS propane pH 9.0. The blue gradient traces represent the absorbance changes over 300 s (10 s interval data from lighter to darker blue as time goes). The inset shows the absorbance changes at 510 (green), and 560 nm (orange). The consumption of dioxygen was confirmed by monitoring the reaction in a Hansatech Oxygraph Clark electrode (B). Reactions were initiated by adding SwMppP into solutions containing different concentrations of L-Arg (black arrow).  
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Having established that SwMppP reacts specifically with L-Arg and molecular oxygen, we set about identifying the product(s) of the reaction. Proton NMR analysis of SwMppP reaction mixtures and an L-Arg standard (Figure 5-2), showed that SwMppP converted L-Arg into at least one new product. Preliminary data from 1H COSY, 1H-13C HSQC, and 1H-13C HMBC spectra (Appendix 5-1) showed that the SwMppP-catalyzed reaction between L-Arg and molecular oxygen yields two products: 2-oxo-4(R)-hydroxy-5-guanidinovaleric acid (i.e. 4-hydroxy-2-ketoarginine, compound 2 in Figure 5-3) and 2-oxo-5-guanidinovaleric acid (i.e. 2-ketoarginine, compound 3 in Figure 5-3). 
 
Figure 5-2: Proton NMR results of L-Arg (2.0 mM, bottom) and the reaction of 10 μM SwMppP with 2.0 mM L-
Arg (top), both in 20 mM sodium phosphate pH 8.4 buffer. 
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Figure 5-3: Compounds encountered in our studies of SwMppP. 1 is L-arginine. 2 and 3 are the two products of the reaction of SwMppP with L-Arg, 2-oxo-4(R)-hydroxy-5-guanidinovaleric acid (2) and 2-oxo-5-guanidinovaleric acid (3), respectively. 4 and 5 are the H2O2-catalyzed decarboxylation products of 2 and 3 that were observed by mass spectrometry in the absence of catalase, 4-guanidino-(S)-3-hydroxybutyric acid 
and 4-guanidinobutyric acid, respectively. Compounds 6 -10 are analogs of L-Arg used to explore the substrate specificity of SwMppP: 6 is L-ornithine; 7 is L-citrulline; 8 is L-canavanine; 9 is NG-methyl-L-arginine; 10 is D-arginine. 
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5.2 Methods 
5.2.1 Cloning, expression, and purification of S. wadayamensis and Streptomyces 
globisporus MppP 
The coding sequences of SwMppP (GenBank accession code KDR62041) and 
Streptomyces globisporus MppP (SgMppP; GenBank accession code IH67_RS0105915) were optimized for expression in E. coli and synthesized by GenScript Inc. (Piscataway, NJ). The synthetic genes were subcloned into the pE-SUMOkan expression vector (LifeSensors Inc., Malvern, PA) using primers containing BsaI and XbaI restriction sites (Table 5-1). The integrity of the SwMppP coding sequence was confirmed by Sanger sequencing (GeneWiz, Inc).  The H29S and F191Y mutants of SwMppP were constructed by the QuickChange mutagenesis method with primers pSUMO-SwPH29A_F/R or pSUMO-SwPF191Y_F/R, respectively, and the pSUMO-SwMppP plasmid as the template. The H29A, F115Y, S190A, D218S, E15A and E15Q mutants of SwMppP were generated with the Q5 site-directed mutagenesis kit (New England Biolabs). 
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Table 5-1: Primers used for mutagenesis 
Names Primers sequences pSUMO-SwMppP_F 5′-GGTCTCAAGGTATGACGACGCAACCGC-3 pSUMO-SwMppP_R 5′-GCTCTAGATCATTAGCGGGTTTCCAGGAC-3′ pSUMO-SgMppP_F 5′-GCGGTCTCAAGGTATGAACCGCATTCTGCCGAAAGTC-3′ pSUMO-SgMppP_R 5′-GCTCTAGATTAGCCTTGACGTTCAGCGGTATC-3′ pSUMO-SwP(H29A)_F 5’-CGCAGACGGCGCCGCCCGTCAGG-3’ pSUMO-SwP(H29A)_R 5’-ATGTTCAGTTCGGAGTTCAGTGC-3’ pSUMO-SwP(H29S)_F 5’-GAACATCGCAGACGGCAGCGCCCGTCAGGCAC-3’ pSUMO-SwP(H29S)_R 5’-GTGCCTGACGGGCGCTGCCGTCTGCGATGTTC-3’ pSUMO-SwP(F115Y)_F 5’-TCATCCGACGTATGATAACATCGCTG-3’ pSUMO-SwP(F115Y)_R 5’-ACCAGTGCCACGCGATCG-3’ pSUMO-SwP(F191Y)_F 5’-CACTGGATACGAGTTATCGTGGTTTCGATG-3’ pSUMO-SwP(F191Y)_R 5’-CATCGAAACCACGATAACTCGTATCCAGTG-3’ pSUMO-SwP(S190A)_F 5’-ACTGGATACGGCTTTTCGTGGTTTCGATGCG-3’ pSUMO-SwP(S190A)_R 5’-GCCAGAACGGTGCCATGT-3’ pSUMO-SwP(D218S)_F 5’-GGTTATTGAATCTACCGGTAAACTGTGGCCGACGC-3’ pSUMO-SwP(D218S)_R 5’-ACCCAGCGACAGCCAGCT-3’ pSUMO-SwP(T12A)_F 5’-CTGAAAGAAAACCTGGCGCAATGGG-3’ pSUMO-SwP(T12A)_R 5’-CCCATTGCGCCAGGTTTTCTTTCAG-3’ pSUMO-SwP(E15A)_F 5’-GACGCAATGGGCATACCTGGCAC-3’ pSUMO-SwP(E15A)_R 5’-AGGTTTTCTTTCAGTTGCGGTTG-3’ pSUMO-SwP(E15Q)_F 5’-GACGCAATGGCAATACCTGGCAC-3’ pSUMO-SwPΔ1-22_F 5’- TAGGTCTCTAGGTCTGAACATCGCAGACGGC-3’  
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The His6-SUMO-SwMppP fusion proteins were expressed from E. coli BL21 Star (DE3) cells (Invitrogen Inc., Carlsbad, CA) carrying the pE-SUMO-SwMppP plasmid. Cultures were grown in Luria-Bertani medium with 50 μg/mL kanamycin at 37 °C. When the cultures reached an OD600nm of ∼1.0, protein expression was induced with 0.4 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). The temperature was reduced to 25°C, and the cultures were grown overnight while being shaken at 250 rpm. Cells were harvested by centrifugation, resuspended in 5 mL/g of buffer A (25 mM TRIS pH 8.0, 300 mM NaCl, 10 mM imidazole, and 100 μM PLP) supplemented with 0.1 mg/mL DNase I (Worthington Biochemical Corp., Lakewood, NJ). The cells were lysed using a Branson Sonifier S-450 cell disruptor (Branson Ultrasonics Corp., Danbury, CT) for a total of 10 min at 60% amplitude with 30 s pulses 
separated by 50 s rest periods. The temperature was maintained at or below 4 °C by suspending the steel beaker in an ice bath directly over a spinning stir bar. The lysate was clarified by centrifugation at 39000 x g for 45 min and then applied to a 5 mL HisTrap column (GE Lifesciences, Piscataway, NJ) at a flow rate of 5 mL/min to isolate the His6-SUMO-SwMppP fusion protein. The protein was eluted by a four-step gradient of buffer B (25 mM TRIS (pH 8.0), 300 mM NaCl, and 250 mM imidazole; 5, 15, 50, and 100%). The His6-SUMO-SwMppP fusion protein eluted in the third and fourth steps and was ∼90% pure, as judged by Coomassie-stained sodium dodecyl sulfate−polyacrylamide gel electrophoresis (SDS-PAGE). Peak fractions were pooled and dialyzed overnight against 4 L 
of 25 mM TRIS pH 8.0, 150 mM NaCl, 100 μM PLP, and ∼3 μM SUMO protease (LifeSensors Inc.). The dialysate was passed through the HisTrap column a second time to remove the cleaved His6-SUMO tag as well as the protease. The resulting SwMppP preparation was 
>95% pure. The protein was desalted using a HiTrap desalting column (GE Lifesciences) 
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into 10.0 mM MES pH 6.7 and 20 μM PLP and stored at −80°C. All SwMppP mutants were purified by the same protocol as the wild type enzyme. Selenomethionine-labeled SgMppP was expressed from T7 Express Crystal cells (New England Biolabs, Ipswich, MA) carrying the pE-SUMO-SgMppP plasmid. Cells were grown in Selenomethionine Medium Complete (Molecular Dimensions, Newmarket, Suffolk, U.K.) with 50 μg/mL kanamycin. SgMppP was expressed and purified using the same protocols described for SwMppP, except that SgMppP was desalted into three different buffers based on the results of differential scanning fluorimetry experiments with the Slice pH screen (10 mM ADA pH 7.0, 20 μM PLP; 10 mM DL-Malic acid pH 6.0, 20 μM PLP; 10 mM Succinic acid pH 6.0, 20 μM PLP).  
 
5.2.2 UV/Vis spectroscopy of SwMppP and its mutants reacting with L-Arginine and 
dioxygen 
A Hewlett-Packard 8453 diode array spectrophotometer was used for scanning the 700 
μL reaction of ~30 μM enzyme (SwMppP or its mutants) with 2 mM L-Arg and ambient (∼250 μM) O2 in 50 mM BisTris propane pH 9.0 buffer. The scan was taken every 0.5 s from 200 nm and 700 nm. 
 
5.2.3 Characterization of MppP reaction products by NMR 
Reactions (4.8 mL) were conducted in 50 mL conical tubes with gentle agitation to prevent depletion of dioxygen.  All enzymes were stored in 10 mM MES pH 6.7, 20 μM PLP 
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buffer. To avoid side reactions due to free PLP, the concentration of free PLP was limited by concentrating the proteins to ~600 μM, thus limiting the volume of enzyme (with free PLP) required for the reaction. For wild type SwMppP,  ~10 μM SwMppP was added to a solution of 2 mM L-Arg in 20mM sodium phosphate pH 8.4. Due to the reduced catalytic efficiency of the mutants, more enzyme (~65 μM) was used in these reactions. The SwMppP(F115Y) variant was desalted into 20 mM sodium phosphate pH 8.4, 10 μM PLP buffer, since it was not stable in the absence of free PLP. Control reactions contained 2 mM L-Arg in 20 mM 
sodium phosphate pH 8.4, with the same volume of enzyme storage buffer (i.e. no enzyme). All reactions were shaken at 25oC, 200 rpm for 2.5 h and protected from light. At the end of the reaction time, samples were evaporated to dryness using a Centrifan PE Rotary Evaporator (KD Scientific, Holliston, MA) at 40oC for 6 h. The resulting residue was taken up in 600 μL D2O and centrifuged at 13,000 x g for 10 min to remove any remaining particulates. The supernatants (500 μL) were loaded into NMR tubes for 1H NMR, 13C NMR, and 2D NMR (1H-1H COSY, HSQC, and HMBC) to determine the structures of the reaction products. 
 
5.2.4 Characterization of MppP reaction products by mass spectrometry 
Reactions (1.0 mL) contained 2 mM L-Arg in MilliQ H2O, 10 μM SwMppP in MilliQ H2O, with or without 53 U of catalase from bovine liver (Sigma-Aldrich, St. Louis, MO).  The two negative controls were 2 mM L-Arg in MilliQ H2O and 2mM L-Arg in water with 53 U catalase. Reactions were run in the dark at 25 °C for 2.5 h with shaking at 200 rpm. All samples were boiled for 10 min and centrifuged at 30,000 x g for 10 min. The supernatants 
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were diluted 10-fold with MilliQ H2O and then directly injected into a Shimadzu LCMS-2020.  
 
5.2.5 Ammonium detection by NADH based GDH assay3 
To detect ammonium formation in the reaction of SwMppP with L-Arg and O2, I referred to the well-known method summarized in Scheme 5-1. L-glutamate dehydrogenase (GDH) is an NAD(P)H-dependent enzyme that catalyzes the conversion of α-ketoglutarate, NH4+ and NADH into glutamate, NAD+, and H2O. NADH absorbs UV light at 340 nm, but NAD+ does not. So upon addition of GDH, the absorbance at 340 nm decreases in the presence of NH4+. 
 
Scheme 5-1: Ammonia assay reaction. The assay detects the absorbance decrease at 340 nm, due to the NADH oxidation. 
The 1000 μl reactions were conducted in 50 mM HEPES pH 7.5 buffer and included 20 
μM SwMppP, 20 μM or 50 μM L-Arg, 140 μM NADH and 3.5 mM α-ketoglutarate. The reaction components were mixed and incubated for 10 min at room temperature. This was 
used to blank the spectrophotometer and the absorbance at 340 nm was monitored to ensure a flat baseline. The reaction was initiated by the addition of 10-2 units of GDH (Sigma) and the absorbance at 340 nm was recorded for ~15 min, until the absorbance reached a plateau.  
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5.2.6 Defining the relationship between O2 usage and H2O2 formation 
To determine how many O2 were used to generate H2O2, the regeneration of O2 by catalase was measured in a Hansatech dioxygen electrode. The reaction mixtures contained 
25 μM, 50 μM, or 100 μM L-Arg in 50 mM BIS-TRIS propane pH 9.0. When the O2 
concentration was stable, 10 μM SwMppP was added into the solution and O2 consumption was monitored. When the reaction reached equilibrium (plateau in the dioxygen concentration), 10 μl of 0.5 mg/mL catalase was added to the 1 mL reaction to disproportionate two equivalents of H2O2 into one equivalent of O2 and two equivalents of water. 
 
5.2.7 Reactions with 18O2, H218O 
Reactions in the presence of 18O2 were conducted in a tonometer, a closed, airtight reaction vessel. The body of the tonometer contained 10 μM SwMppP in 100 mM ammonium bicarbonate pH 9.0 with 50 ng/mL catalase. One short arm of the tonometer contained 20 μL of 500 mM L-Arg, and the other was connected to a 500 mL bottle of 18O2 with an air-tight valve. The tonometer was connected to a Schlenk line, which was used to purge the tonometer of oxygen by 45 cycles of vacuum (~5 s) and flushing with argon (45 s). Prior to removing the tonometer from the Schlenk line, the atmosphere was removed with the vacuum pump to enable the labelled dioxygen to fill the tonometer. The tonometer was closed and removed from the Schlenk line. The reaction was started by mixing the 
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enzyme solution in the tonometer body with the L-Arg in the side arm. Without O2, the quinonoid I intermediate accumulated, which has a pale pink to orange color. Then the 18O2 was allowed to fill the tonometer. The reaction was carried out at room temperature for 2 h. After the reaction, the tonometer was opened and samples were analyzed by ESI-MS. 
The 200 μl reaction of SwMppP and L-Arg in H218O was conducted in 1.7 mL eppendorf tubes at room temperature overnight. The reaction contained 10 μM SwMppP, 2 mM L-Arg and ~95.4% H218O. The products of the reaction were identified by ESI-MS. 
 
5.2.8 Crystallization of wild-type and mutant forms of SwMppP, as well as SgMppP 
Initial crystallization conditions were identified by screening 15 mg/mL SwMppP and its mutants against the Index HT screen (Hampton Research). After optimization, diffraction-quality SwMppP crystals were obtained by the hanging drop vapor diffusion 
method from 30% polyethylene glycol monomethyl ether 550 (PEG MME 550), 50 mM MgCl2, and 0.1 M HEPES pH 8.0. Drops contained 2 μL of protein solution at 15 mg/mL and 
1 μL of crystallization solution. Crystals formed as plates or rods after 3−4 days and grew to maximum dimensions of ∼200 μm × ~50 μm × ~5 μm. Initial crystallization conditions for the homologous enzyme SgMppP (S. globisporus) were identified in the same way by screening 15 mg/mL SgMppP against the Index HT screen. Crystals of SeMet-substituted 
SgMppP in 10 mM ADA pH 7.0, 20 μM PLP were grown from 10% PEG MME 5000, 5% Tacsimate pH 7.0, and 0.1 M HEPES pH 7.5. SgMppP crystallized as small rods (∼100 μm × 
~10 μm × ~10 μm). Both types of crystals were cryo-protected by sequential soaks in 
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holding solutions containing 5, 10, or 20% glycerol and flash cooled by plunging into liquid nitrogen.  
The structure of SwMppP with D-Arg bound was obtained by transferring crystals into 
30 μL drops of the crystallization solution supplemented with 35 mM D-Arg. After being soaked for 5 min at RT, crystals were treated with paratone N and flash-cooled.  The structure of SwMppP with L-Arg bound was obtained by transferring crystals into 30 μL drops of the crystallization solution supplemented with 10 mM L-Arg and 20% glycerol. After being soaked for 5 h at RT, crystals were plunged into liquid N2. The structure of SwMppP with 2 bound was obtained by transferring crystals into 30 μL drops of the crystallization solution supplemented with 10 mM 2-keto-Arg (contaminated with ~10% L-Arg) with 20% glycerol. After being soaked for 2 h at RT, crystals were plunged into liquid N2. 
SwMppP(H29A) and SwMppP(H29S) crystalized under the same conditions as the wild-type protein. SwMppP(H29A) and SwMppP(H29S) at 12 mg/ml in 10 mM MES pH 6.7, 20 
μM PLP were mixed 2:1 with 30% (w/v) PEG MME 550, 0.1 M HEPES pH 7.5, 0.1 M MgCl2. The volume of the resulting drops was 3 µl. Crystals of SwMppP(F115Y) were grown by 
mixing 1 µl of enzyme at 12 mg/ml in 10 mM MES pH 6.7, 20 µM PLP with 1 µl of 17.5% 
PEG 3350, 0.04 M citric acid, 0.06 M BIS-TRIS propane, pH 6.4. Crystals of SwMppP(D218S) were grown by mixing 2 µl of enzyme at 12 mg/ml in 10 mM MES pH 6.7, 20 μM PLP with 1 µl of  20% (w/v) PEG 3350, 0.1 M magnesium formate. The well solution contained microseeds derived from poor crystals grown during screening. The structures of Ala and Ser mutants of H29 (SwMppP(H29A/S)) with L-Arg bound were obtained by transferring 
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crystals into 30 μL drops of the crystallization solution supplemented with 10 mM L-Arg 
and 20% glycerol. After being soaked for 5 h at RT, crystals were plunged into liquid N2.  
X-ray diffraction data for SeMet SgMppP and native SwMppP were collected at beamline 21-ID-D of the Life Science Collaborative Access Team (LS-CAT) at the Advanced Photon Source (APS). The SwMppP·D-Arg data set was collected at LS-CAT beamline 21-ID-G. All data were processed with HKL20004. 
 The structure of SgMppP was determined by the single wavelength anomalous diffraction (SAD) method using 3.5 Å resolution data collected from a crystal of SeMet-substituted SgMppP at 0.97889 Å, 61.0 eV below the tabulated K-edge wavelength for Se (0.97950 Å). AutoSHARP5 was used to determine the Se substructure, which contained 14 of the 16 Se atoms in the asymmetric unit, and calculate density-modified electron density 
maps. An initial model comprising ∼90% of the asymmetric unit content was built using BUCCANEER6. 
Chain A of this partially refined model (with B factors set to 20.0 Å2) was used as the search model for molecular replacement in PHASER7  to phase the unliganded SwMppP data set. The molecular replacement solution was subjected to iterative cycles of manual model building in COOT8 and maximum likelihood-based refinement using the PHENIX package (phenix.refine9). Ordered solvent molecules were added automatically in phenix.refine and culled manually in COOT. Hydrogen atoms were added to the model using phenix.reduce10 and were included in the later stages of refinement to improve the stereochemistry of the model. Positions of H atoms were refined using the riding model with a global B factor. Regions of the model for translation-libration-screw (TLS) 
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refinement were identified using phenix.find_tls_groups (P. V. Afonine, unpublished work), and the TLS parameters were refined in phenix.refine. Once the refinement converged (R = 0.136, and Rfree  = 0.162), the model was validated using the tools implemented in COOT and PHENIX9, 11. Sections of the backbone with missing or uninterpretable electron density were not included in the final model. Side chains with poor or missing electron density were modeled in favored rotameric conformations, and the B factors were allowed to refine without additional restraints. This was done to alert end users, who are more likely to display a model colored by B factors than to pay attention to atom occupancy values or download electron density maps, that these residues are not well defined in the electron density.  
The final, refined model of SwMppP, stripped of water molecules and H atoms, and with all B factors set to 20.0 Å2, was used to determine the structure of the enzyme with L–Arg bound, 2, 3 and D-Arg bound by difference Fourier. The model was also used to determine the mutants’ structures. Restraints for the L-Arg-PLP, 2, 3 and D-Arg-PLP external aldimine were generated with phenix.elbow12. Data collection and model refinement statistics are listed in Appendix C. Coordinates and structure factors for both SwMppP and SwMppP·D-Arg models have been deposited in the Protein Data Bank (www.rcsb.org) with accession codes 5DJ1 and 5DJ3. 
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5.2.9 Preparation of 2-keto-arginine (3) 
The 2-oxo acids used in this study were prepared by a modification of the procedure first described by Meister13. For example, compound 3 was prepared by dissolving 2 g of L-Arg in 50 mL of water and the pH was adjusted to 7.2 with concentrated HCl. Next, 100 mg of Crotalus atrox L -amino acid oxidase (LAAO) and 1.5 mg of catalase were dissolved in 10 mL of water and added to the amino acid solution. The volume was adjusted to 100 mL with water, and the reaction mixture was incubated in the dark at room temperature while being vigorously stirred. After 18 h, the 100 mL reaction mixture was concentrated to 7 mL at 50 °C under vacuum. The 2-oxo acid crystallized from the concentrated reaction mixture 
at 4 °C after approximately 1 week. The crystalline material was harvested, dried, and 
stored at − 20 °C. The compound was characterized by nuclear magnetic resonance (NMR) and ESI-MS and found to be predominantly the desired product. 
 
5.2.10 Steady State Enzyme Kinetics 
All 1.0 mL kinetic assays were conducted in triplicate at 25 °C in 50 mM BIS-TRIS propane, pH 9.0. The initial velocity of SwMppP-catalyzed hydroxylation of L-Arg was measured directly by monitoring the decrease in the dioxygen concentration using a dioxygen electrode (Hansatech Instruments, Norfolk, U.K.). The concentration of L-Arg was varied from 10 to 10,000 μM. The kcat and KM values were determined from the initial velocity data using the equation v0 = Vm[A]/(KM + [A]), where [A] is the concentration of L-Arg, v0 is the initial velocity, Vm is the maximal velocity, and KM is the Michaelis constant. 
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5.2.11 The stoichiometry of L-Arg and O2 in the reaction 
The stoichiometry of the reaction was determined by measuring the quantity of O2 consumed in reactions with a constant enzyme concentration (10 μM SwMppP or its mutants) and different L-Arg concentrations. Reactions were monitored using the Hansatech dioxygen electrode. The concentration of dioxygen remaining when the reaction reached equilibrium was subtracted from the starting concentration to obtain the concentration of dioxygen consumed. The stoichiometry was computed using the following formula: 
 
𝐸𝐸𝐸𝐸.  𝑜𝑜𝑜𝑜 𝑂𝑂2 𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑒𝑒𝑐𝑐 𝑝𝑝𝑒𝑒𝑝𝑝 𝑒𝑒𝐸𝐸. 𝑜𝑜𝑜𝑜 𝐴𝐴𝑝𝑝𝐴𝐴 𝑎𝑎𝑐𝑐𝑐𝑐𝑒𝑒𝑐𝑐 =  [𝑂𝑂2]𝑖𝑖𝑐𝑐𝑖𝑖𝑡𝑡𝑖𝑖𝑎𝑎𝑖𝑖 − [𝑂𝑂2]𝑝𝑝𝑒𝑒𝑐𝑐𝑎𝑎𝑖𝑖𝑐𝑐𝑖𝑖𝑐𝑐𝐴𝐴[𝐿𝐿 − 𝐴𝐴𝑝𝑝𝐴𝐴]  
 
5.2.12 SwMppP substrate specificity  
Reactions containing 686 μl of 30 µM SwMppP in 50 mM BIS-TRIS propane pH 9.0 were initiated by adding different L-Arg analogs (compounds 6, 7, 8, 9 and 10) to a final concentration of 2 mM. The reactions were monitored by recording spectra from 200-700 nm (0.5 s between scans) for 300 s in a Hewlett-Packard 8453 diode array spectrophotometer. The products of these reactions were identified by NMR and ESI-MS as discussed previously.   
The inhibition constant of D-Arg was determined using the O2 consumption assay 
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described above for the steady state kinetics. D-Arg concentrations ranging of 0, 250, 500, 1,000, 2,500, 5,000, and 10,000 µM were added to different L-Arg solutions (5, 10, 25, 50, 100, 250, 500, 1000, 2500 and 5000 µM) in 50 mM BIS-TRIS propane pH 9.0. Reactions were initiated by the addition of SwMppP to a final concentration of 10 µM and initial velocities were recorded. The inhibition constant was determined using the following equation: 
                                                     𝑣𝑣𝑜𝑜 =  ∆[𝑂𝑂2]
𝑡𝑡
                                                          Equation 1 
Each data set of rate vs L-Arg concentrations was fitted with Michaelis-Menten equation (Equation 2).  
𝑣𝑣 =  (𝑣𝑣max ∗  [L-Arg])/(𝐾𝐾M +  [L-Arg])    Equation 2 
Reciprocal plot of resulting vmax and L-Arg concentration gives a series of linear plot at different D-Arg concentrations. The slope is KM/vmax(1+[D-Arg]/Ki), and the intercept is 1/Vmax. Reploting the slope vs [D-Arg], and the data were fitted linearly, which gives Ki (-x intercept).  
Fluorescence titration experiments were conducted to measure the binding constant of D-Arg. SwMppP (10 µM after mixing) was mixed with different concentrations of D-Arg (40 
μM, 80 μM, 160 μM, 320 μM, 640 μM and 1280 μM) and the total fluorescence was 
measured with excitation at 415 nm. The results are shown in Figure 5-25. By fitting the fluorescence data into the following single exponential equation:  
                                   y = A1^exp(−kobs ∗ x) +  C                                               Equation 3 
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In this equation, A1 is the amplitudes associates with the phase rate constants kobs. The C is the constant of fluorescence intensity at the end of the reaction. The dependence of the observed rate constants kobs was fitted into the following hyperbola equation to give the Kd,app: 
                                   kobs= kmax*[D-Arg]/(Kd,app+[D-Arg])                                Equation 4 
 
5.2.13 Testing for communication between the two binding sites of SwMppP(D188A) 
5.2.13.1 Isothermal Titration Calorimetry (ITC) 
The D188A mutant was used for the determination of binding constants, since this mutant is catalytically dead. About 3 mL of ~300 µM SwMppP(D188A) was prepared for ITC analysis by dialysis against 2 L of 15 mM MES pH 6.7 overnight at 4 oC. The dialysis buffer was used to dilute the protein to 90 μM, and was also used to prepare a solution of 80 mM L-Arg. All solutions were degassed at 4oC for 30 min before loading into the Nano ITC instrument (TA Instruments, New Castle, DE). The protein solution was placed in the reaction chamber, and the 80 mM L-Arg solution in the syringe. Injections of 2.5 μl were made every 300 s for a total of 20 injections. The titration experiments were done in 
triplicate at 4, 10, 12, 18 and 20 °C in order to find the optimal temperature (maximal signal-to-noise and best baseline). 
 
5.2.13.2 Determination of binding constants by fluorescence titration 
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Binding constants for the D188A mutant of SwMppP were also determined by fluorescence titration. Reactions were prepared by mixing 1.5 mL of 14 μM SwMppP(D188A) in 100 mM BIS-TRIS propane pH 9.0 with 1.5 mL of solutions with  concentrations of L-Arg ranging from 5 to 2560 µM in the same buffer. The reactions were mixed by pipetting and incubated at room temperature for 8 min. Fluorescence data were collected on a XXX fluorimeter (Shimadzu, XXX, Japan). Samples were excited at 415 nm (5 
nm bandwidth) and the emission was measured from 436-700 nm (15 nm bandwidth).  
The delta fluorescence data at 480 nm on each L-Arg concentration was obtained by subtract the fluorescence intensity with 0 µM L-Arg in 100 mM BIS-TRIS propane pH 9.0 buffer. Then the fraction of sites occupied and the concentration of D188AL-Arg complex were calculated. The plot of calculated [D188AL-Arg] complex versus [L-Arg] at 480 nm was fitted to hyperbolic equation:  
                    [EL] 480=([EL]480, max * [L-Arg])/(Kd,app + [L-Arg])                       Equation 5 
 
5.2.14 Pre-steady state enzyme kinetics 
Pre-steady state kinetics data were collected on a Model SF-xxDX double-mixing stopped flow spectrophotometer. Since the reaction of SwMppP with L-Arg consumes oxygen, the substrate binding and related changes at the PLP center could be monitored by 
watching the total fluorescence signal when exciting the internal aldimine at 415 nm in samples of anaerobic enzyme and L-Arg. Likewise, the rate of formation of the first quinonoid intermediate (Q1) could be measured by monitoring the absorbance at 510 nm 
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under anaerobic conditions. The instrument was prepared for anaerobic work by overnight incubation with a solution of 1 mM dextrose, 10 U/mL glucose oxidase, which had been flushed through the entire system. Solutions for anaerobic stopped flow experiments were prepared in a tonometer. Briefly, 7 ml of 20 μM SwMppP in 10 mM MES pH 6.7, 20 μM PLP 
and 100 μM glucose (with or without 5 ng/mL catalase) were placed in the main body of the tonometer and 25 μl (1 U/µl) glucose oxidase were placed in the side arm. The tonometer was attached to a Schlenk line and dioxygen was removed from the solution 
using 45 cycles of vacuum (~5 s) and flushing with argon (~30 s). Because the SwMppP protein is light-sensitive and somewhat unstable at room temperature, this procedure was conducted on ice and the tonometer was covered with foil to protect it from light. Different concentrations of L-Arg in 100 mM BIS-TRIS propane pH 9.0 with 200 μM glucose were placed in glass syringes and sparged with argon gas for 5 min to remove dioxygen. Before removing the argon nozzle and mounting the syringe on the stopped flow instrument, 10 μl of glucose oxidase were injected through the luer tip. Single mixing experiments were conducted at 25 °C with 10 µM SwMppP and 10 to 1280 µM L-Arg (all concentrations are after mixing 1:1) 
To measure the rates of the O2-dependent steps, double mixing experiments were performed where anaerobic enzyme was mixed 1:1 with a saturating amount of anaerobic L-Arg. This was then mixed 1:1 with buffer containing various concentrations of dioxygen. As above, the instrument was made anaerobic overnight with the glucose/glucose oxidase treatment described above. The first tonometer contained 40 μM enzyme, 10 ng/mL catalase in 10 mM MES pH 6.7, 20 μM PLP under anaerobic conditions. The second 
tonometer, made anaerobic as described above, contained 2,560 μM L-Arg in 100 mM BIS-
204 
TRIS propane pH 9.0. The third tonometer contained 100 mM BIS-TRIS propane pH 9.0 
with different concentrations of dioxygen (20, 40, 78, 158, 296, 465 μM). Defined dioxygen concentrations were obtained using a Maxtec Maxblend gas blender to mix XX% pure O2 gas with gaseous N2. The concentrations of dioxygen produced at different settings of the mixing valve were determined using the Clark-type electrode. Samples of oxygenated buffer were prepared by sparging the 100 mM BIS-TRIS propane pH 9.0 buffer with set concentrations of dioxygen for 5 min. After the first mixing step, the reactions were aged for 20 s prior to the second mixing step in order to convert all of the enzyme to the Q1 intermediate. The second step mixed the anaerobic reaction mixture with buffer containing different concentrations of dissolved O2. The reactions were monitored at 510 nm and 560 nm for 100 s for each data set. 
Data were analyzed by Origin (OriginLab) or Kinetic Studio (TgK Ltd.). For the two 
phases fluorescence data excited at 415 nm under anaerobic condition, it was fitted into the following equation: 
                                   y=A1^exp(-k1*x)+A2^exp(-k2*x)+C                                  Equation 6 
In this equation, A1 and A2 are the amplitudes associates with the first and second phase rate constants k1 and k2, respectively. The C is the constant of fluorescence intensity at the end of the reaction. The dependence of the observed rate constants k1 for the first phase (based on the amplitude) was fitted linearly. The dependence of the observed rate constants k2 for the second phase was fitted to the following hyperbolic equation:  
                                    k2= kmax*[L-Arg]/(Kapp+[L-Arg])                                            Equation 7 
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In the equation, Kapp is the apparent equilibrium constant for the conversion of the external aldimine into Quinonoid I intermediate. The rate constant kmax is the maximum rate constant.  
The Quinonoid I intermediate accumulation was also monitored by recording the absorbance at 510 nm under anaerobic condition. This data has two phases and was fitted into Equation 6. The dependence of the observed rate constants k1 and k2 were both fitted into Equation 7.  
With different concentrations of O2, the kinetics of Quinonoid I intermediate decay, Quinonoid II formation and decay were studied. The first 15 s of Quinonoid I decay step corresponding to one turnover was fitted to Equation 6. The dependence of the observed rate constants k1 for the largest amplitude phase was fitted linearly. The second phase rate constants cannot be fitted meaningfully. The absorbance at 560 nm corresponding to Quinonoid II formation was fitted to the following three exponential equation: 
                             y=A1^exp(-k1*x)+A2^exp(-k2*x)+A3^exp(-k3*x)+C                       Equation 8 
In this equation, A1, A2 and A3 are the amplitudes associates with the first, second and third phase rate constants k1, k2 and k3, respectively. The C is the constant of absorbance intensity at the end of the reaction. The dependence of the observed rate constants k1 was fitted linearly. The dependence of second phase rate constants was fitted linearly. The dependence of third phase rate constants was fitted to Equation 6. 
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5.3 Results 
5.3.1 Side product H2O2 catalyzed the decarboxylation of two products (3, 4) 
The products of SwMppP with L-Arg was also confirmed by mass spectrometry with electrospray ionization (ESI-MS), which detected peaks in the positive mode spectrum at m/z=146 and m/z=162. These masses correspond to the five-carbon products derived from 2 and 3, 4-guanidino-3(S)-hydroxybutyric acid (4) and 4-guanidinobutyric acid (5). The result was also verified by 13C-NMR (Figure 5-4). These products are the result of oxidative decarboxylation of 2 and 3, like catalyzed by H2O2 as has been observed for other 
α-keto acids 14, 15. This observation was the first suggestion that H2O2 might be a product of SwMppP-catalyzed oxidation of L-Arg. Therefore, the experiment was repeated, this time 
with catalase in the reaction mixture. The masses for both products are 174 and 190, corresponding to 3 and 2. The fully oxidized product 2 is produced at a ratio of ~1.7:1 compared to the partially oxidized product 3. Thus, once in every two to three turnover cycles, the enzyme loses its substrate to hydrolysis before it can be fully oxidized. This observation likely has important implications for the mechanism of this novel enzyme. Note that 2 is the same compound that MppR was able to cyclize to give the iminoimidazolidine ring of L-End observed in a crystal structure of MppR in the presence of 
2. MppP is therefore the first enzyme in L-End biosynthesis, reacting directly with L-Arg to create the substrate for MppR. 
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Figure 5-4: 13C-NMR spectrum of the reaction of 10 μM SwMppP with 2.0 mM L-Arg in 20 mM sodium 
phosphate pH 8.4 buffer. 
 
5.3.2 Ammonia is also a product of SwMppP with L-Arg and O2 
The 4-electron oxidation of L-Arg suggested by the results detailed above would require ammonia to also be a product of the reaction, since the PLP cofactor needs to be converted from the pyridoxamine form to the aldehyde (PLP) at the end of the reaction cycle. A glutamate dehydrogenase (GDH)-coupled assay was employed to determine whether or not the reaction of SwMppP with L-Arg produces ammonia. The assay takes advantage of 
the fact that GDH can be run in reverse, where α-ketoglutarate is reduced by ammonia and NADH to give glutamate, water, NAD+, and a proton.  By constructing a standard curve of 
the rate of loss of absorbance from NADH at 340 nm vs the concentration of ammonia, it is possible to estimate the concentration of ammonia in, for example, SwMppP reaction mixtures. The results of these experiments are shown in Figure 5-5. The correlation 
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coefficient (R2) of the standard curve is 0.9992, so the response of the GDH initial velocity to the ammonia concentration is linear. In the reaction of 20 μM SwMppP and different concentrations of L-Arg, after the GDH addition, the absorbance at 340 nm decreased and the rate of this decrease is proportional to the centration of L-Arg. In 15 min, 
approximately 80% of the L-Arg was consumed and an equal amount of ammonia was released. 
 
Figure 5-5: (A) The standard curve of NADH based GDH assay. (B) The ammonium formation is proportional to the L-Arg concentration according to the GDH assay. 
 
5.3.3 SwMppP is an oxidase and not an oxygenase 
Reactions of SwMppP with 3 concentrations of L-Arg were monitored using an oxygen electrode (Figure 5-6). When the reactions reached equilibrium, catalase was added. The addition of catalase resulted in the regeneration of dioxygen amounting to half of that originally consumed by SwMppP in each reaction. This result indicates that H2O2 is another formal product of the SwMppP reaction, and that each molecule of O2 consumed by 
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SwMppP is reduced to H2O2 during the catalytic cycle.  
 
Figure 5-6: O2 regeneration after adding catalase into equilibrated SwMppP with varied [L-Arg] solutions. The concentration of dioxygen was monitored in a Hansatech dioxygen electrode. The reactions were 
initiated by add 10 μM SwMppP into solutions containing 25 μM (, top), 50 μM ( , middle), and 100 μM ( , bottom) L-Arg in 50 mM BisTris Propane pH 9.0 buffer. When the reaction was equilibrated, 50 ng/mL catalase were added into the solution. As the table shown, the regenerated O2 is around half of the O2 consumed by SwMppP, which suggests that all O2 was consumed to form H2O2. 
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The observation that each molecule of dioxygen consumed is reduced to hydrogen peroxide logically dictates that none of the oxygen atoms incorporated into the products (2 or 3) can come from dioxygen. SwMppP is therefore an oxidase, and not an oxygenase. To confirm that the oxygen atoms incorporated into the products do indeed derive from water and not dioxygen, reactions of SwMppP with L-Arg were conducted with either 18O2 or H218O. Catalase was included in the reactions to prevent the H2O2-mediated decarboxylation of the products that would complicate the interpretation of the results. The products of these reactions were analyzed by ESI-MS. This analysis showed that in the presence of 18O2, the products were detected at m/z=174 and m/z=190, indicating that neither product contained 18O. When the reactions were run in H218O, the products were 
detected at m/z=176 and m/z=194. This is consistent with the incorporation of two atoms of 18O into the fully oxidized 2, and a single atom of 18O into 3 (Figure 5-7).  
 
Figure 5-7: Mass spectrometric analysis results. A) Spectrum of SwMppP with L-Arg in the presence of 18O2. The mass of both products did not change. B) Spectrum of SwMppP with L-Arg in H218O. The hydroxy oxygen atom of 2 product originated from H218O. And the keto oxygen atom of both products also came from the H218O by hydrolysis. 
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While other PLP-dependent enzymes are known to react with molecular oxygen, such as DOPA decarboxylase/aromatic L-amino acid decarboxylase 16, 17, and so-called “paracatalytic” reactions with O2 have been described 18, SwMppP is the first PLP-dependent enzyme to produce a hydroxylated product. Given the sequence similarity between SwMppP and more typical PLP-dependent aminotransferases, it would be particularly interesting to know how the structure of SwMppP differs, and why these differences result in the enzyme acting as an L-Arg γ-hydroxylase rather than a decarboxylase or aminotransferase. 
 
5.3.4 The structures of SwMppP 
The experiments described thus far show that SwMppP is an L-Arg oxidase. However, analysis of the primary sequence suggests that SwMppP likely has a very similar structure to the Fold Type I aminotransferases. So what structural features of SwMppP allow it to catalyze a very difficult reaction (oxidation of an unactivated carbon center) using a scaffold normally associated with simple aminotransfer chemistry?  To explore the relationship between the structure and function of SwMppP, we set out to determine its structure by X-ray diffraction. SwMppP crystallized by the hanging drop vapor diffusion 
method from 2 μL of protein solution at 15 mg/mL in 10 mM MES pH 6.7, 20 μM PLP and 1 
μL of crystallization solution (30% polyethylene glycol monomethyl ether 550 (PEG MME 550), 50 mM MgCl2, and 0.1 M HEPES (pH 8.0)). These crystals diffracted to 2.1 Å resolution. A number of aminotransferases, including the human kynurenine aminotransferase II (PDB ID 5EUN 19) had ~30% sequence identity to SwMppP, so we first 
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sought to obtain initial phases for the structure by molecular replacement. Numerous search models were tested, including those based on different aminotransferase structures, with separated domains (in case the domains had a different orientation in MppP), and ensemble structures built from superpositions of several models. None of these resulted in suitable phase estimates. We then attempted SAD phasing, but were stymied by the unusually low number of methionine residues (3 methionines of 376 AA) in the S. 
wadayamensis enzyme. Rather than attempt to soak in compounds with anomalously scattering atoms, we decided to target a highly similar homolog of MppP that had more methionine residues.  
The MppP from S. globisporus (SgMppP) was identified through BLAST searches of the 
SwMppP sequence and is XX% identical to SwMppP. This enzyme crystallized from XXX, but the crystals were not well ordered and only diffracted to ~3.5 Å resolution. However, this was sufficient to build a nearly complete model of the protein that was then used as the search model for successful molecular replacement phasing of the SwMppP data set. 
SwMppP crystallized in space group P212121 with the following unit cell dimensions: a = 
85.7 Å, b = 108.3 Å, and c = 195.4 Å. The asymmetric unit contained four molecules that formed two independent homodimers (Figure 5-8). The overall structure of SwMppP, as expected from the sequence analysis, is very similar to typical Type I aminotransferases like aspartate aminotransferase. As in AATase, there are also two domains in SwMppP: a large domain (A33-G272), a small domain (L23 – Q32 and G273 – R376) and an N-terminal extension (M1-E22).  The large domain contains a seven-stranded mixed β–sheet flanked by ten α–helices (α-β-α sandwich), while small domain has a mixed α-β topology. 
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Figure 5-8: (A) SwMppP dimer with one chain shown as a blue ribbon representation and the other shown as a wheat surface representation. The K221-PLP internal aldimine in the active sites is shown in yellow stick. The N terminus (1-22 aa) is disordered in the crystal.  (B) E. coli aspartate aminotransferase (PDB ID: 1ARS20) with one chain shown as a light green ribbon representation and the other shown as a wheat surface representation. The K258-PLP internal aldimine in the active sites is shown in yellow stick. The N terminus (1-30 aa) ordered and interacts with the large domain of the other chain.  
 
Three of the four chains in the asymmetric unit are missing 22 residues from the N-terminus, while the fourth (chain D) is missing only 10 residues. The extra 12 residues in chain D form a loop and α helix that points outward, away from the enzyme and interacts with a symmetry-related molecule (25 Å from the active site). There is nothing in these interactions to suggest that they are physiologically relevant. All four chains are missing one to three residues from the C-terminus. 
As alluded to above, and as shown in Figure 5-8, the tertiary structure of SwMppP is 
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similar to the type I aminotransferases (ATases)21. The E. coli aspartate ATase (PDB entry 1ARS20) superimposes well onto the structure of the SwMppP dimer. The root-mean-square deviation (rmsd) value obtained using secondary structure matching (SSM)22 of 3.4 Å for 567 of the 704 Cα atoms in SwMppP underscores the similarity of these two enzymes. For reference, different structures of the same protein can have rmsd values of more than 0.5 Å. The most obvious difference between the tertiary structures of SwMppP and AATase is that the N-terminal extension is disordered or points outward in SwMppP, which leaves the active sites open to the solvent, whereas this part of the AATase structure closes over the active site, covering the cofactor almost completely.  
As in the ATases, the active site is located at the interface between the large and small domains of each protomer. Unlike the ATases, however, there is minimal contribution from the other chain in the dimer. The position of the cofactor is also similar to that seen in all known Fold Type I aminotransferases, in a cleft formed by the central β-sheet and the N-
termini of helices α4 and α5 (Figure 5-8). In the absence of bound ligands, PLP is covalently attached to K221 by an aldimine linkage. The C5’ phosphate of PLP is held by fewer direct interactions than in other PLP-dependent enzymes. In SwMppP, the only direct interactions between the enzyme and the C5’ phosphate are an electrostatic interaction with K229 and a hydrogen-bonding interaction with S91. There may also be a weak hydrogen bond to H29. The remaining interactions constituting the C5’ phosphate-binding site are water-mediated hydrogen bonding interactions with D218 as well as Y88* and the main chain amide of L252* from the other protomer of the dimer (Figure 5-9). As in all fold type I aminotransferases, there is a negatively-charged residue, D188, placed near the pyridine N atom of the cofactor to stabilize the positive charge that forms during the catalytic cycle 23-
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25. The C3’ hydroxyl of PLP is involved in a hydrogen-bonding interaction with N160, which also makes a hydrogen-bonding interaction with R352, an absolutely conserved residue in the Type I aminotransferases. In the E. coli aspartate aminotransferase (EcAAT), for example, the equivalent Arg residue (R386) interacts with the α-carboxylate group of the substrate. Finally, the pyridine ring of PLP is clamped between F115 above and S190 below. Aminotransferases typically have an aromatic side chain packed against the “top” surface of the PLP ring, though the residue below the ring is more typically an Ala.  
While there are a number of similarities between the active sites of SwMppP and EcAAT, there are a number of interesting differences that likely play a role in the divergent activity of SwMppP. As mentioned above, the phosphate-binding site is anchored by Lys instead of Arg, and whereas most ATases have 2-3 Ser/Thr residues binding the phosphate group, and SwMppP has only one. One of the positions typically occupied by a Ser/Thr is taken by D218 in SwMppP. The carboxylate group of D218 is within hydrogen bonding distance of S190; this interaction is not observed in most other PLP-dependent enyzmes, most of which have Ala in the position occupied by S190. In many ATases, such as EcAAT, there is a Tyr residue that makes a hydrogen bond to the C3’ hydroxyl of PLP and affects the electron distribution in the cofactor 26. This residue is a Phe in SwMppP. The last unusual feature of the SwMppP active site is H29. This position is not conserved in other PLP-dependent enzymes, but is absolutely conserved among MppP homologs27. H29 is adjacent to the catalytic K221 and makes hydrogen bonding interactions with D27 and, perhaps, with the phosphate moiety of the cofactor. In two of the four molecules in the asymmetric unit, H29 takes on at least two conformations. 
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Figure 5-9: The active site of SwMppP. The stereoview of the SwMppP active site (A) shows the PLP covalently bound to enzyme, forming internal aldimine. The 2|Fo| - |Fc| electron density map contoured at 
1.0σ, is shown as magenta mesh, and the 2|Fo| - |Fc| composite omit map also contoured at 1.0σ, is shown as green mesh. The schematic view of the active site (B)  shows potential hydrogen bonding interactions as 
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green, dashed lines. Water molecules are shown as blue spheres. The chloride ion is shown as a green sphere. Panel A was generated using POVSCRIPT and POV-Ray. Panel B was created using a combination of MarvinSketch (https://www.chemaxon.com) and Adobe Illustrator CS6. 
 
5.3.5 The structure of the SwMppP•L-Arg complex 
The structure of SwMppP•L-Arg was obtained by soaking SwMppP crystals in a solution containing 10 mM L-Arg. Unlike the unliganded structure, where the N-terminus is disordered and leaves the active site exposed to the solvent, in the structure with L-Arg bound, the N-terminal extension orders and covers the active site (Figure 5-10). Superimposition of the unliganded SwMppP and SwMppP•L-Arg structures gives a root-mean-square deviation of 0.356 for Cα atoms in the SwMppP dimer, indicating that, except for the N-termini, there are no significant structural alterations as a result of ligand binding. So unlike many ATases, there is no closing movement of the small domain.  
Once the substrate binds in the active site, the α-amino group attacks C4’ of internal aldimine to form the external aldimine, displacing K221. Compared with the unliganded SwMppP, there are no significant changes in the active site, only a few subtle side chain movements, as shown in Figure 5-11. The Cl- ion bound to R352 is replaced by the α-carboxylate of L-Arg. T12 and E15 in the N-terminal helix form hydrogen bonds with guanidine group and carboxyl group of L-Arg, respectively. The guanidine group also forms hydrogen bonds with N117, S91, and the carbonyl groups of S248 and D249 from the other protomer. The side chains of H29, D27 and R31 are shifted towards the external aldimine. The ring of F115 rotates away from the PLP ring and is closer to L-Arg.  
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Figure 5-10: Ribbon representation of SwMppP (A) and SwMppPL-Arg (B) dimers. (A) Chain A is colored in grey, chain B is colored in light green. The N termini of both chains are disordered. The L23 Cα atoms in both chains are shown as blue spheres. (B) Chain A colored dark blue, chain B colored light green and the N-terminal helices colored purple. The PLP cofactors in the active sites are shown in stick. The N-terminal helix 
219 
ordered and covers the active site. The K8 Cα atoms in two chains are shown as blue dots. (C) Overlaying the active site of SwMppP and SwMppPL-Arg. The major change is the E15 and T12 interactions with L-Arg. Also, the rings of F115 and F191Y shift. 
 
Figure 5-11: The external aldimine structure in active site of SwMppPL-Arg. (A) SwMppPL-Arg active site showing the L-Arg covalently bound to the PLP as the external aldimine. The 2|Fo| - |Fc| electron density map contoured at 1.0σ, shown as magenta mesh, and the 2|Fo| - |Fc| composite omit map also contoured at 1.0σ, is shown as green mesh. (B), Schematic view of the active site showing potential hydrogen bonding interactions 
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as green, dashed lines. Water molecules are shown as blue spheres. Panel A was generated using POVSCRIPT and POV-Ray. Panel B was created using a combination of MarvinSketch (https://www.chemaxon.com) and Adobe Illustrator CS6. 
 
5.3.6 Structures of SwMppP•product complexes 
The structures of the SwMppP•2 complex (Figure 5-12) and the SwMppP•3 complex (Figure 5-13) have no big difference on the guanidine is bound from SwMppP•L-Arg structure, but the fact that the products are not external aldimine is a big difference. Also there are several residues side chain movements (overlay results are shown in Appendix F and Appendix G). S190 side chain shifted to hydrogen bond with D218. In the structure of SwMppP•2, 4HKA hydroxyl group made hydrogen-bonding interactions with the phosphate group and H29. 
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Figure 5-12: The active site of SwMppP•2. (A) SwMppP•2 active site showing the PLP covalently bound to the enzyme as the internal aldimine. E15 and T12 interact with 2 carboxylate group and guanidine group, respectively. His29 bonds to hydroxyl group of 2. The 2|Fo|-|Fc| electron density map contoured at 1.0σ, shown as magenta mesh, and the 2|Fo|-|Fc| composite omit map also contoured at 1.0σ, is shown as green mesh. (B) Schematic view of the active site showing potential hydrogen bonding interactions as green, dashed lines. Water molecules are shown as blue spheres. Panel A was generated using POVSCRIPT and POV-Ray. Panel B was created using a combination of MarvinSketch (https://www.chemaxon.com) and Adobe 
222 
Illustrator CS6. 
 
Figure 5-13: The active site of SwMppP•3. (A) SwMppP•3 active site showing the PLP covalently bound to the enzyme as the internal aldimine. E15 and T12 interact with 3 carboxylate group and guanidine group, respectively. The 2|Fo|-|Fc| electron density map contoured at 1.0σ, shown as magenta mesh, and the 2|Fo|-|Fc| composite omit map also contoured at 1.0σ, is shown as green mesh. (B) Schematic view of the active site showing potential hydrogen bonding interactions as green, dashed lines. Water molecules are shown as blue spheres. Panel A was generated using POVSCRIPT and POV-Ray. Panel B was created using a combination of MarvinSketch (https://www.chemaxon.com) and Adobe Illustrator CS6. 
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5.3.7 Characterization of N-terminus and active site residues 
The tertiary structure of SwMppP is very similar with type I aminotransferase, there are several residues differences in the active site, which probably results in the hydroxylase-deaminase activity rather than aminotransferase. Bioinformatic analysis27 showed that H29, F115, F191, and D218 are conserved in all of the MppP homologs but not in the Type I aminotransferases. To explore the specific roles of these different residues, site-directed mutagenesis was used to make point mutants that were characterized both structurally and kinetically. 
 
Figure 5-14: Different residues (colored in orange) in the active site of SwMppP•L-Arg. The 2|Fo| - |Fc| 
electron density map contoured at 1.0σ, shown as magenta mesh, and the 2|Fo| - |Fc| composite omit map also contoured at 1.0σ, is shown as green mesh. 
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5.3.8 Characterization of SwMppP and mutants  
5.3.8.1 Stability of SwMppP and mutants by differential scanning fluorimetry 
The Tm value for each mutant is listed in Table 5-2. Except SwMppP(F191Y), other mutants’ stability are same with that of wild-type SwMppP. The Tm value of SwMppP(F191Y) is so low that only flat curve was got. 
Table 5-2: Tm values of SwMppP and mutants 
Proteins Tm (oC) SwMppP 53.3 ± 0.1 SwMppP(E15A) 55.75 ± 0.1 SwMppP(E15Q) 53.3 ± 0.1 SwMppP(H29A) 47.5 ± 0.1 SwMppP(H29S) 46.6 ± 0.1 SwMppP(F115Y) 51.4 ± 0.2 SwMppP(F191Y) Not applicable SwMppP(D218S) 50.0 ± 0.1 SwMppPΔ1-22 50.2 ± 0.1 
 
5.3.8.2 C Determination of the reaction products of the mutants  
225 
To determine what reaction these mutants catalyzed, the 4.8 mL reaction contains ~65 
μM mutants protein and 2 mM L-Arg in 20 mM sodium phosphate pH 8.4 buffer were shaked at 25oC, 200 rpm overnight. Then the solutions were concentrated for 8 fold and analyzed by proton NMR. The results are summarized in Table 5-3.  
Table 5-3: The products of SwMppP and its mutants with L-Arg and O2 
 Products [2]/[3] SwMppP 2 and 3 1.7:1 SwMppP(T12A) 3 0:1 SwMppP(E15A) 3 0:1 SwMppP(E15Q) 2 and 3 1:2.4 SwMppP(T12A/E15A) 3 0:1 SwMppP(H29A) 3 0:1 SwMppP(H29S) 3 0:1 SwMppP(F115Y) 3 0:1 SwMppP(F191Y) 2 and 3 1.6:1 SwMppP(D218S) Trace 3 - SwMppPΔ1-22 Trace 3 -  
SwMppP catalyzes the oxidation of L-Arg and O2 into 2 and 3 in the ratio of 1.7 : 1. Except SwMppP(F191Y) and SwMppP(E15Q), all mutants lost the hydroxylase activity. 
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They only produce the side product 3.  The products ratio of variant F191Y is 1.6 :1, which is same with that of wild-type SwMppP.  However, because the Tm of F191Y is low, the amounts of substrate F191Y catalyzed are much less. Another mutant E15Q still have the hydroxylase activity, although it does make less hydroxylated products (with the [2] : [3] at 
the ratio of 1 : 2.4). The substitution of same residue E15 into alanine lost the hydroxylase activity. To figure out why the E15A variant lost the hydroxylase activity, I crystallized the E15A proteins and soaked the crystals with 10 mM L-Arg to get the E15AL-Arg structure (shown in Figure 5-15). In the structure of E15AL-Arg structure, L-Arg covalently bonds to PLP, forming external aldimine.  The N terminus still covers the active site when substrate binds. And T12 residue interacts with the guanidine group of L-Arg. The main chain of A15 is same with that of E15 in wild type protein. But the shorter side chain of A15 probably creates a void where water can be retained, and which could hydrolyze the quinonoid intermediate prematurely. 
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Figure 5-15: The active site of E15AL-Arg. The N terminus colored in purple. Chain A colored in blue, chain B colored in light green. PLP-L-Arg is shown in golden stick. The 2|Fo| - |Fc| electron density map contoured at 
1.0σ, shown as magenta mesh, and the 2|Fo| - |Fc| composite omit map also contoured at 1.0σ, is shown as green mesh. 
 
5.3.8.3 The steady state parameters monitored by O2 consumption 
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SwMppP reacts with L-Arg and O2 forming 2 and 3. The catalytic parameters (KM, kcat) of O2 usage were determined and are listed in Table 5-4.  
Table 5-4: Steady state parameters monitored by O2 consumption 
Proteins KM,L-Arg (µM) kcat (s-1) kcat/KM (M-1 s-1) 
SwMppP 26.5 ± 4.2 0.20 ± 0.006 7641.5 ± 1232.8 
T12A 105.8 ± 12.1 0.05 ± 0.0016 483.2 ± 57.4 E15A 28.0 ± 4.0 0.24 ± 0.006 8424.4 ± 1212.7 E15Q 19.0 ± 3.5 0.24 ± 0.007 12538.3 ± 2340.2 T12A/E15A 74.5 ± 7.7 0.035 ± 0.002 465.2 ± 54.3 
Δ1-22 234.8 ± 33.4 0.072 ± 0.002 306.0 ± 44.6 
H29A 25.4 ± 5.6 0.11 ± 0.004 4472.9 ± 1003.2 H29S 16.9 ± 3.6 0.07 ± 0.003 4327.6 ± 931.3 F115Y 66.5 ± 4.8 0.20 ± 0.003 2940.3 ± 217.7 F191Y* 8.9 ± 2.4 0.05 ± 0.003 4983.2 ± 1349.4 D218S 353.2 ± 53.5 0.07 ± 0.003 183.5 ± 28.7 * means inaccurate data due to the instability of protein F191Y. 
The KM of the T12A and T12A/E15A mutants were 3- to 5-fold higher than that of wild type. The turnover numbers (kcat) of the two mutants were also lower than the wild type, which makes the catalytic efficiency (kcat/KM) ~15-fold less than the wild type. In Figure 5-16, the spectra of both the T12A and T12A/E15A variants exhibit a shift from the external 
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aldimine peak (435nm) back to the internal aldimine peak (415 nm) as the reaction goes. The truncation mutant, however, showed an approximately 10-fold increase in KM and a 3-fold decrease in kcat, which reduced the pseudo-second order rate constant by almost 25-fold. The truncation mutant also produced only 2-ketoarginine. According to the spectrum of SwMppPΔ1-22 with L-Arg and O2 (Figure 5-16), the external aldimine also shifts into internal aldimine as the reaction goes.  The mutants E15A and E15Q have no effect on KM, kcat or catalytic efficiency. Interestingly, although the steady state kinetics (as measured by dioxygen consumption) is indistinguishable for the E15A and E15Q variants, the E15A variant does not produce 2, only the abortive product 3 based on the NMR results (Table 5-
4).  
Alteration of the N-terminus altered the ratios of products produced, but had no, or only a modest effect on the steady state kinetics as monitored by dioxygen consumption. However, as the spectra shown in Figure 5-16 demonstrate, the external aldimine peak 
(435 nm) gradually shifted to internal aldimine peak (415 nm) as reaction went, demonstrating that the N-terminal helix, especially T12, plays a key role in stabilizing the external aldimine and Quinonoid intermediate. 
230 
 
Figure 5-16: The spectrum (300 nm-600 nm) of SwMppP and its N terminus mutants with L-Arg.  The insets 
are the changes at 510 nm and 560 nm for each mutant. There are 3 major peaks (430 nm, 510 nm, 560 nm) for wt SwMppP with L-Arg. The blue lines from lighter to darker represents the data collect from 1.4 s to 300 s. The insets also describe the trends of these mutants reactions in a timer order in comparison with wt SwMppP. For the truncated N-terminal helix mutant SwMppPΔ1-22, the only peak (430 nm) shifted to 420 nm as the reactions goes. For SwMppP (E15A), there are only 2 peaks (430 nm, 510 nm). But for the mutant SwMppP (E15Q), there are three peaks (430 nm, 510 nm and small 560 nm).  
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In unliganded protein structure, H29 is close to the catalytic K221 and make hydrogen bonding with D27. In the product 2 bound structure, H29 hydrogen bonds to the hydroxyl group. To study the role of this special histidine residue, it was substituted into aliphatic alanine and polar serine. The steady state parameters on O2 consumption are very similar to wild type SwMppP (Table 5-4). The structures of H29A and H29S are both obtained. The structures and spectra of both mutants are identical, so only the spectrum of H29A is shown in Figure 5-17. Only the external aldimine and quinonoid I peak formed. No absorbance at 560 nm was observed. In the first 20 s, the Quinonoid I intermediate accumulated are more than wild type SwMppP (the inset in Figure 5-17A). However, the Quinonoid I intermediate accumulation rate and final amounts of H29A/S are less than those of wild type SwMppP. Overlaying the H29A structure with wild type SwMppP, (Figure 5-17B), there is no difference on the active site residues. However, in the H29A mutant active site, there are more water molecules around the PLP, which suggests that H29, together with F115 and F191, may be involved in the water exclusion in the active site. Given that H29 coordinates the hydroxyl group of 2 and the H29A/S mutants lose the hydroxylase activity, H29 may also be involved in positioning a water molecule for hydroxylation.  
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Figure 5-17: (A) The spectrum of H29A with L-Arg. The 700μl solution containing 30 μM H29A proteins with 
1.4 mM L-Arg were scanned on diode array spectrophotometer every second over 300 s. The blue color gets darker as time goes. The inset is the 510nm 560 nm change comparison between SwMppP and H29A. (B) 
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Superposition of the active sites of SwMppP (colored in grey) with H29A (dark blue). Water molecules all from H29A are shown in blue sphere. Cl- ion in SwMppP is shown as cyan sphere. In the active site, the H29A has more water molecules. 
The structure of H29A with L-Arg was obtained by soaking 5 mM L-Arg. The asymmetric unit contained four molecules that form two independent homodimers. Three of the four chains have L-Arg bound forming external aldimine with PLP, while there is nothing bound in the active site of chain D and PLP covalently bound to catalytic K221 that forms internal aldimine. As mentioned above, there are more water molecules in the active site of H29A mutant. When the substrate L-Arg bound into the active site, L-Arg covalently bonds to PLP and excludes the water molecules. The water molecules in Figure 5-18A are from H29A internal aldimine structure. The ring of F151 moves close to L-Arg and packed with the Cα of L-Arg. The ring of F191 rotates about 90 degree and packed to the oxygen atom of carboxylate group. Except these two residues, other residues in the active site are same with apo enzyme SwMppP. Overlaying theH29AL-Arg structure with SwMppPL-Arg, the active site residues are exactly same (Figure 5-18B). However, the short side chain of A29 cannot exclude the water molecules from the active site, so there are two water molecules close to A29 that are not found in the structure of wild-type SwMppP with L-Arg bound. 
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Figure 5-18: (A) Overlaying the active site of H29A (chain A colored in blue) and H29AL-Arg (chain A colored in grey). Both chain B colored in light green. Upon the substrate bound, N terminus cover the active site. E15 and T12 interact with the carboxylate group and guanidinium group of L-Arg, respectively. The ring of F115 and F191 moves closer to the L-Arg. (B) Overlaying the active site of SwMppPL-Arg (chain A colored in blue) and H29AL-Arg (chain A colored in grey) demonstrates that there is no difference between them except two more molecules in the active site due to the short side chain of A29. Both chain B colored in light green.  
 
F115 is another conserved residue in MppP homologs. To study the specific role of F115 play in the mechanism, it was mutated into tyrosine. The KM of F115Y mutant were 3 folds higher than that of wild type SwMppP. The turnover numbers (kcat) of F115Y is same with that of swMppP, which makes the catalytic specificity (kcat/KM) were ~3 fold less than the wild type SwMppP protein. As time goes, the external aldimine peak shifted back to internal aldimine peak (Figure 5-19A). The quinonoid I intermediate peak firstly accumulated, then decayed gradually. These features suggest that mutated Y115 probably  
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Figure 5-19: (A) The spectrum of F115Y with L-Arg. The 700μl solution containing 30 μM F115Y proteins 
with 1.4 mM L-Arg were scanned on diode array spectrophotometer every second over 300 s. The blue color gets darker as time goes. The inset is the 510nm 560 nm change comparison between SwMppP and F115Y. (B) Superposition of the active sites of SwMppP (colored in grey) with F115Y (dark blue). Water molecules all 
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from F115Y are shown in blue sphere. Cl- ion in SwMppP is shown as cyan sphere. In the active site, the F115Y has more water molecules. 
 
disrupts the stability of Quinonoid I and external aldimine, thus the equilibrium shifted into internal aldimine. The quinonoid II intermediate did not accumulate. Overlaying the F115Y structure with wild type SwMppP (Figure 5-19B), there are no differences in the active site residues with the exception of H29. In the structure of SwMppP(F115Y), H29 only adopts one conformation. Water molecules align differently between the active site of chain A and chain B. In chain B, one water molecule mediates the interaction between OH of mutated Y115 side chain and NE2 of H29. 
S190 and F191 are two adjacent conserved residues in MppP homologs. To study the specific role of S190 and F191, they were mutated into alanine and tyrosine, respectively. The purification of S190A failed because this mutant does not fold correctly and forms inclusion bodies. The mutant F191Y is also not stable due to the low Tm value mentioned above. The turnover numbers (kcat) of F115Y is much slower than that of SwMppP. The KM of F191Y mutant were 3 folds lower than that of wild type SwMppP. which makes the catalytic specificity (kcat/KM) were ~2 fold less than the wild type SwMppP protein. These parameters are based on the enzyme concentration, but the accurate concentration of active F191Y enzyme in the solution is unknown due to the instability property. The F191Y mutant is not stable, so I did not get the protein crystallized. As shown in Figure 5-20, there are four small peaks (358 nm, 430 nm, 510 nm, 560 nm) formed in the reaction of F191Y with L-Arg. The Quinonoid I intermediates accumulate much less than that in SwMppP, 
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while the Quinonoid II intermediates accumulates much more than that in SwMppP (Figure 5-20 inset). The peak with maximum absorbance at ~358 nm probably corresponds to 
ketimine intermediate that forms in aminotransferase (Figure 4-5). This peak first accumulated and then decreased as time goes. The position of F191 is usually tyrosine in 
aminotransferase (Figure 4-7C). These facts suggest that F191 is probably involved in exclusion of water close to C5. Substitution of F191 into tyrosine, the water may exist close to C5 and results in the ketimine intermediates formation. 
 
Figure 5-20: The spectrum of F191Y with L-Arg. F191Y enzyme (30 μM) was mixed with 1.4 mM L-Arg and recorded every second in 300s. There are 4 small peaks (358 nm, 430 nm, 510 nm, 560 nm) formed. Based on the thermo-Fluor assay results, F191Y mutant is not stable, which probably resulted in the small peaks. 
 
In the PLP bound internal aldimine structure of SwMppP, D218 hydrogen bonding to 
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the OH of S190, C5 of PLP and the main chain amine of T219 and G220. In the substrate bound external aldimine structure, D218 also interacts with the free K221. The SwMppP protein is yellow with PLP bound. However, the color of mutant D218S is less yellow even they are stored in the same buffer. The structure of D218S with poor electron density map showed that there is no PLP in the active site. The crystallization condition needs to be optimized for better diffraction. The spectrum of D218S demonstrates that there are three 
peaks (maximum absorbance at 340 nm, 430 nm and 510 nm) formed. As shown in the 
 
Figure 5-21: The spectrum of D218S with L-Arg. D218S enzyme (30 μM) was mixed with 1.4 mM L-Arg and recorded every second in 300s. There are 3 peaks (344 nm, 430 nm, 510 nm). The inset is the 510 nm and 560 nm comparison with wild type SwMppP.  
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inset in Figure 5-21, the external aldimine and Quinonoid I peaks decrease as time goes, 
while the peak with maximum absorbance at 340 nm keeps increase. This peak range from 310 nm to 370 nm may be pyridoxamine phosphate (PMP) or ketimine. Given that no PLP bound in the D218S active site and little products formed by NMR, the peak probably represents PMP (or both by hydrolyzing ketamine into PMP). If PMP cannot be hydrolyzed into PLP and form internal aldimine with K221, the PMP may dissociate out of the active site. So the D218 probably participates in PMP hydrolysis or internal aldimine formation.  
 
5.3.9 Full oxidation of L-Arg requires two equivalents of O2 
The stoichiometry of O2 consumed and L-Arg added was explored by O2 electrode (Table 5-5). For wild type SwMppP producing 2 and 3 in the ratio of 1.7:1, the ratio of [O2] consumed to [L-Arg added] is 1.4:1. The variant E15A, which only produces one product 3, only needs 1 equivalent of O2. But for E15D that producing both products, the ratio of [O2] consumed to [L-Arg added] is >1, suggesting that the 2 branch requires more than one (probably two) equivalent of O2 and the 3 branch only needs one. The ratios for mutants T12A, T12A/E15A and SwMppPΔ1-22 were lower than 1:1, which was probably due to the lower catalytic efficiency as shown in Table 5-4.  
For wild-type SwMppP, E15Q and F191Y, producing both products, the ratio is > 1:1. And for those mutants only forming keto-Arg as the product, the ratio is ≤ 1:1.  Because both 3 and 2 are the products of SwMppP with L-Arg and O2, we assumed that 3 pathway only consumed one equivalent of O2 and 2 pathway consumed two equivalents of O2. 
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Table 5-5: The ratio of [O2 consumption]/[L-Arg added] of SwMppP and its mutants reactions 
[L-Arg]/μM SwMppP T12A E15A E15Q T12A/E15A H29A H29S F115Y F191Y D218S SwMppPΔ1-22 
25 1.40:1 0.64:1 1.05:1 1.44:1 0.76:1 0.70:1 0.84:1 0.85:1 1.54:1 little activity 
0.61:1 
50 1.43:1 0.54:1 0.95:1 1.28:1 0.65:1 0.77:1 0.82:1 0.77:1 1.38:1 0.45:1 
100 1.38:1 0.59:1 0.95:1 1.29:1 0.72:1 0.81:1 0.80:1 0.80:1 1.37:1 0.47:1 
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5.3.10 Substrate specificity 
Reacting with L-Arg and O2 showed the Cγ-hydroxylation activity of SwMppP27. To check if the L-Arginine precursors L-ornithine and L-citrulline are the possible substrates, the hydroxylation reaction was determined by spectrometric scan of the intermediates and MS analysis of the products. No intermediate peak formed by spectroscopy (Figure 5-22), even the external aldimine peak. As shown in Figure 6A, when SwMppP reacted with L-ornithine, the broad internal aldimine peak became smaller and a new peak at ~320 nm showed up. When SwMppP reacts with L-citrulline, the broad internal aldimine peak got 
smaller and red shifted (~425 nm to ~410 nm) as shown in Figure 5-22B. To detect the substrate specificity in more detail, the reactions of SwMppP with L-Arg derivatives L-canavanine, methyl-L-arginine and D-arginine were also determined (Figure 5-22). Upon D-Arg addition, the external aldimine formed and gradually shifted back holoenzyme (internal aldimine). There is no intermediate and product formed by NMR and MS (data not shown). The inhibitory constant (Ki) of D-arginine is 325 μM by monitoring the 
fluorescence signal at 415 nm on stop-flow. But for the L-canavanine reaction, the intermediate quinonoid I, which has maximum absorbance at 510 nm, accumulated when O2 was used up in the cuvette. And there is one species formed at ~370 nm and decayed when another species formed which have broad absorbance around 330 nm. After several hours, the quinonoid I intermediate peak disappeared and two broad peaks at ~330 nm 
and ~425 nm still exist. For the reaction of SwMppP with methyl-L-arginine, quinonoid I peak quickly accumulated and gradually decreased. The NMR results showed that only keto-methyl-L-arginine formed. SwMppP did not catalyze the hydroxylation of methyl-L-arginine. Apparently, SwMppP exhibits very strong substrate specificity for hydroxylation. 
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Figure 5-22: The spectrum of SwMppP with L-arginine (A), L-ornithine (B), L-citrulline (C), L-canavanine (D), methyl-L-arginine (E) and D-arginine (F). The spectrum of enzyme only was shown as dash line. After compounds addtion, the spectrum was recorded (from light grey to black). 
 
243 
5.3.11 The structure of SwMppP with D-Arg 
As shown in Figure 5-22F, D-Arg is not the substrate of SwMppP, but it can bind to PLP forming external aldimine (peak shiftment from internal aldimine to external aldimine). Based on this, SwMppP crystals were soaked in 35 mM D-Arg to obtain the SwMppPD-Arg external aldimine structure (Figure 5-23). The active site explains why D-Arg is not a substrate: the α-proton points toward the bulk solvent and away from any suitable general base catalyst (probably K221). Except the aldimine covalent bond, the carboxyl group of D-Arg forms salt bridges with R352 (Figure 5-23B). The guanidine group interacts with D27 and D227 and located in the position of N-terminal helix lid, which disrupts the N terminus covering the active site. Hence, unlike the L-Arg binding, N terminus disorders in the structure of SwMppP•D-Arg. Comparison of the SwMppP•L-Arg (Figure 5-11) and SwMppP•D-Arg (Figure 5-23), there are less interactions from the other chain in SwMppP•D-Arg. Because the side chain of L-Arg well aligned in the active site, the S248* 
and D249* from the other chain interacts with the guanidinium group of L-Arg. And the S91 also interacts with the guanidinium group. However, the side chain of D-Arg points away from the active site, so it loses these interactions. 
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Figure 5-23: The active site of SwMppP•D-Arg. (A) SwMppP•D-Arg active site showing the PLP covalently bound to the enzyme as the internal aldimine. The 2|Fo| - |Fc| electron density map contoured at 1.0σ, shown as magenta mesh, and the 2|Fo| - |Fc| composite omit map also contoured at 1.0σ, is shown as green mesh. (B) Schematic view of the active site showing potential hydrogen bonding interactions as green, dashed lines. Water molecules are shown as blue spheres. Panel A was generated using POVSCRIPT and POV-Ray. Panel B was created using a combination of MarvinSketch (https://www.chemaxon.com) and Adobe Illustrator CS6. 
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D-Arg, as a competitive inhibitor, forms external aldimine with PLP in SwMppP active site. The dissociation constant of D-Arg  (Ki) is determined by both O2 probe assay and 
fluorescence change at 415 nm on stop flow. For O2 probe assay, 10 μM SwMppP firstly incubated with 0 μM, 250 μM, 500 μM, 1 mM, 2.5 mM, 5 mM and 10 mM D-Arg in 50 mM BisTris propane pH 9.0 buffer for 5 min. For each data set (e.g 10 μM SwMppP with 250 μM D-Arg), a series of L-Arg were added and the O2 consumption rate was determined. The result is shown in Figure 5-24. Each data set of rate vs L-Arg concentrations was fitted into Equation 2. Reciprocal plot of resulting vmax and L-Arg concentration gives a series of linear plot at different D-Arg concentrations. The slope is KM/vmax(1+[D-Arg]/Ki), and the intercept is 1/vmax. Linearly fitting the slope vs [D-Arg] data gives Ki of 253.4 μM. 
. 
 
Figure 5-24: The D-Arg dissociation constant (Ki) determination. (A) The reciprocal plot of Vmax and L-Arg concentration gives a series of linear plot at different D-Arg concentrations.  represents 0 μM D-Arg.   represents 250 μM D-Arg.  represents 500 μM D-Arg.   represents 1000 μM D-Arg. represents 2500 μM D-Arg.  represents 5000 μM D-Arg,  represents 10000 μM D-Arg. (B) The slope from (A) was plotted versus D-Arg concentration and the data is fitted linearly. The absolute x-intercept is the Ki (253.4 μM). 
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Fluorescence titration experiments were conducted to measure the kinetics of external aldimine formation step with D-Arg. SwMppP (10 µM after mixing) was mixed with different concentrations of D-Arg (40 μM, 80 μM, 160 μM, 320 μM, 640 μM and 1280 μM) and the total fluorescence was measured with excitation at 415 nm. The results are shown in Figure 5-25. The fluorescence data of SwMppP with different concentrations of D-Arg only have one phase and were fitted into Equation 3. The dependence of kobs were fitted 
into Equation 4 and gave Kd,app of 329.3 μM. 
 
Figure 5-25: Dissociation constant (Ki) determination of D-Arg into SwMppP by fluorescence determination 
excited at 415 nm. (A) Fluorescence signal fitting by first exponential. .  represents 40 μM D-Arg.  represents 80 μM D-Arg.  represents 160 μM D-Arg.   represents 320 μM D-Arg.  represents 640 μM D-Arg.   represents 1280 μM D-Arg. (B) The plot of kobs from data (A) versus D-Arg concentration gives the Kd,app value of 329.3 μM. 
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5.3.12 Presteady state kinetics of SwMppP 
Changes at the PLP center upon binding of L-Arg were monitored using stopped flow spectroscopy under anaerobic conditions, and exciting the internal aldimine at 415 nm. When the enzyme (10 µM after mixing) is mixed with various concentrations of L-Arg in the absence of dioxygen, there is a biphasic decay of fluorescence (Figure 5-26). The total amplitude change of the two phases is independent of the substrate concentration. The data were fitted to Equation 6 using Kinetic Studio (TgK Ltd.). The dependence of the observed rate constants k1 for the first phase (60% amplitude at 640 μM L-Arg) was fitted linearly (Figure 5-26B). The forward rate constant k1 and reverse rate constant k-1 of internal aldimine decay step are given by the slope and y-intercept, respectively. The external aldimine absorbs UV light at 425-430 nm, so the second decrease phase is probably corresponding to the step of internal aldimine to external aldimine. The dependence of the observed rate constants k2 for the second phase (40% amplitude at 640 
μM L-Arg) was fitted to the Equation 7. According to the hyperbolic fitting, Kapp for external aldimine intermediate formation equals to 17.7, while the maximum rate constant is 2.3 s-1. 
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Figure 5-26: (A) Fluorescence intensity change upon L-Arg binding. The data is fitted into two exponential. (B) The plot of rate constant (R1) generated by (A) versus L-Arg concentration.  represents 10 μM L-Arg.  represents 20 μM L-Arg.  represents 40 μM L-Arg.   represents 80 μM L-Arg.  represents 160 μM D-Arg.    represents 320 μM L-Arg.  represents 640 μM L-Arg. The data is fitted linearly and gives k1 equals 0.25 μM-1 
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s-1 and k-1 equals to 25.4 s-1. (C) The rate constant (R2) for the second phase generated by (A) has a hyperbolic dependence on [L-Arg], saturating at 2.3 s-1 with an apparent equilibrium constant of 17.7. 
 
The Quinonoid I intermediate accumulation was observed at the maximum absorbance at 510 nm under anaerobic condition. The experiment was set up similar with the method mentioned above, but collect the absorbance rather than fluorescence. The results are shown in Figure 5-27A. The Quinonoid I forms in a first order process with a ~100 ms lag that corresponding to the first phase and saturated when external aldimine totally decay observed in fluorescence data (Figure 5-29). The data are fitted into two exponential equation (Equation 6) using Kinetic studio (TgK Ltd.). The dependence of the observed rate constants k1 for the tiny phase was fitted hyperbolically (Figure 5-27B). So the calculated 
equilibrium constant for this step is 44.2 with the maximum rate constant is 2.5 s-1. The dependence of the observed rate constants k2 for the largest amplitude phase was fitted to the Equation 7 (Figure 5-27C). In the equation, Kapp and kmax are the apparent equilibrium constant and rate constant for the step of external aldimine into Quinonoid I intermediate, which match that in the second phase in the fluorescence experiment above. According to the hyperbolic fitting, Kapp in this absorbance data for external aldimine to Quinonoid I intermediate equals to 36.8, while the maximum rate constant is 9.8 s-1. 
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Figure 5-27: (A) Quinonoid I  (maximum absorbance at 510 nm) accumulation curves with different L-Arg concentrations under anaerobic condition.  represents 10 μM L-Arg.  represents 20 μM L-Arg.  represents 
40 μM L-Arg.   represents 80 μM L-Arg.  represents 160 μM D-Arg.    represents 320 μM L-Arg.  
represents 640 μM L-Arg.   represents 1280 μM L-Arg. The data is fitted into two exponential. (B) The plot of 
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rate constant (R1) generated by (A) versus L-Arg concentration. The amplitude of this data is negative and the rate constants show a hyperbolic fitting with equilibrium constant of 44.2. (C) The hyperbolic fitting of rate constant (R2) of the largest phase gives the rate constant of 9.8 s-1 with apparent equilibrium constant (Kapp) of 36.8 for external aldimine to Quinonoid I step. 
 
The reaction of Quinonoid I with O2 and Quinonoid II formation were monitored by double-mixing stop flow spectrophotometry. Prepared anaerobic SwMppP (40 μM) in 10 mM MES pH 6.7, 20 μM PLP buffer was firstly mixing with 1280 μM L-Arg in 100 mM BisTris Propane pH 9.0 buffer and sit for 20 s prior to the second mix of different defined concentrations of dissolved O2 in 100 mM BisTris propane pH 9.0 buffer. In future, to get a single turnover of Quinonoid I decay, more enzyme and less L-Arg should be used. Otherwise, the extra substrates would react with the recycled enzyme again, which would make the data too complicated to analyze. The dissolved O2 concentration in the buffer was defined by sparging an inverted syringe containing 100 mM BisTris propane pH 9.0 buffer for 5 min with blended N2 and O2 of known partial pressures supplied by a Maxtec Maxblend gas blender. The concentration of dissolved O2 was determined by firstly sparging the reaction chamber of a Hansatech dioxgen electrode filled with same buffer to define the equilibrium concentration of dissolved O2. Then the Quinonoid I intermediate observed at 510 nm and quinonoid II intermediate observed at 560 nm was recorded upon the second mixing with varied O2. 
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Figure 5-28: (A) Quinonoid I  (maximum absorbance at 510 nm) decay curves with different O2 concentrations by double mix.  represents 20 μM O2.  represents 40 μM O2.  represents 78 μM O2.   represents 158 μM O2.   represents 296 μM O2.  represents 465 μM O2. The data is fitted into two exponential and the fitting line colored in red. The first mix was obtained by mixing 40 μM SwMppP with 2560 μM L-Arg. The second mix is mixing the first mixture (Quinonoid I) with different concentrations of O2. (B) The plot of rate constant (k1) generated by (A) versus varied O2 concentrations. The data is fitted linearly and gives k equals to 0.0573 μM-1 s-1. (C) The amplitude of this tiny phase cannot be fitted meaningfully. 
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The absorbance at 510 nm was monitored for 100 s and the curve first decay as the reaction goes, then it accumulated again due to the extra L-Arg catalyzed by recycled enzyme. The first 15 s data corresponding to one turnover was fitted to Equation 6. The dependence of the observed rate constants k1 for the largest amplitude phase (99% at 465 
μM O2) was fitted linearly. The rate constant k of Quinonoid I react with O2 step is the slope (0.0573 μM-1 s-1). The first phase of Quinonoid I decay is the step before the Quinonoid II formation by overlay the figure of Quinonoid I decay and Quinonoid II formation (Figure 5-29). Hence, Quinonoid II only accumulates after Quinonoid I has decayed. The second phase rate constants with tiny amplitude change cannot be fitted meaningfully (Figure 5-28C).  
 
 
Figure 5-29: The phase comparison of Quinonoid I decay (A510) and Quinonoid II formation (A560). The Quinonoid I decay data colored in blue in a gradient of low O2 concentration (20 μM, lighter blue) to high O2 concentration (465 μM, darker blue). The Quinonoid II formation data colored in green in a gradient of low O2 concentration (20 μM, lighter green) to high O2 concentration (465 μM, darker green). The reaction of 
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Quinonoid I with O2 is mostly complete before QII begins to appear at 560 nm. 
 
The formation and decay with different concentrations of O2 of Quinonoid II (maximum absorbance at 560 nm) was monitored for 100 s with same setting with the data of Quinonoid I decay at 510 nm. The absorbance at 560 nm first accumulated then decay, followed by a linear decrease, whose slope and time course depend on the O2 concentration (Figure 5-29). Because the extra L-Arg exists, the absorbance at 560 nm goes up again. The first 15 s data (Figure 5-30A) probably corresponding to one turnover was fitted to Equation 8. The dependence of the observed rate constants k1 for the increased, largest amplitude phase was fitted linearly (Figure 5-30B). The forward rate constant k1 and reverse rate constant k-1 of Quinonoid II formation step are 0.0036 μM-1 s-1 and 0.9215 s-1, respectively. The dependence of second phase rate constants was fitted linearly (Figure 5-30C). The rate constant k of Quinonoid II with O2 step is 0.0032 μM-1 s-1. The dependence of third phase rate constants (Figure 5-30D) was fitted to Equation 7. According to the hyperbolic fitting, Kapp in this absorbance data for VII to VIII intermediate equals to 53.7, while the maximum rate constant is 1.5 s-1. 
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Figure 5-30: (A) Quinonoid II  (maximum absorbance at 560 nm) formation curves with different O2 concentrations by double mix stop flow.  represents 20 μM O2.  represents 40 μM O2.  represents 78 μM O2.   represents 158 μM O2.   represents 296 μM O2.  represents 465 μM O2. The data is fitted into two exponential and the fitting line colored in red. (B) The plot of rate constant (k1) generated by (A) versus varied O2 concentrations. The largest amplitude phase corresponding to the Quinonoid II formation is fitted linearly and gives k1 equals to 0.0036 μM-1 s-1 and k-1 equals to 0.9215 s-1. (C) The plot of rate constant (k2) generated by (A) versus varied O2 concentrations. The data is fitted linearly and gives k equals to 0.0032 μM-1 s-1. (D) The plot of rate constant (k3) generated by (A) versus L-Arg concentration gives the Kapp of this phase equals to 53.7 with the maximum rate constant is 1.5 s-1. 
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Table 5-6: Summary of kinetic and equilibrium constant of SwMppP with L-Arg calculated above 
Reactions 
k+ 
(μM-1 s-1) 
k- or k 
(s-1) 
Kd,app (μM) Kapp 
kmax 
(s-1) 
E + L-Arg = EL-Arg (I) 
EL-Arg (I) = EA (II) 
0.25 a 25.4 a 101.6 a   
EA (II)=Q1    17.7b 36.8 c 2.3b 9.8 c 
Q1 + O2 = IV 0.0573d     
IV = V    ND ND 
V = Q2 + H2O2 0.0036e 0.9215e    
Q2 + O2 = VII 0.0032f     
VII = VIII    53.7 g 1.5 g 
a represents the results from fluorescence data under anaerobic condition shown in Figure 5-26B. b represents the results from fluorescence data under anaerobic condition shown in Figure 5-26C. c represents the results from absorbance at 510 nm under anaerobic condition shown in Figure 5-27C. d represents the results from absorbance at 510 nm under aerobic condition shown in Figure 5-28B. e represents the results from absorbance at 560 nm under aerobic condition shown in Figure 5-30B. f represents the results from absorbance at 560 nm under aerobic condition shown in Figure 5-30C. g represents the results from fluorescence data shown in Figure 5-30D. 
Note: The Roman labels correspond to those in Scheme 5-3 below. E represents wild type SwMppP here. EA represents external aldimine. Q1 represents Quinonoid I. Q2 represents Quinonoid II. ND: not determined. 
 
5.3.13 Proposed mechanism of SwMppP 
Based on all structural and kinetics studies shown above, we proposed the mechanism 
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of SwMppP with L-Arg and O2 (Scheme 5-2). Upon the L-Arg bound, it attacks the internal 
aldimine, forming external aldimine. The free Lys221 on the enzyme would attack the H at 
Cα position, resulting in the formation of Quinonoid I (Q1) intermediate, which has maximum absorption at 510 nm. Those un-conserved residues probably contribute to stabilize the e--rich intermediate Q1. In the presence of O2, the H at β position is attacked by O2 radical. After rearrangement, it would branch into 2 ways. If the water molecule closes to the hydroperoxide anion (HOO-), the anion would attack the H from water and release H2O2 and 3. Final hydrolysis leads to the regeneration of PLP and release of ammonia. In 
 
Scheme 5-2: Proposed mechanism of SwMppP. 
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the 2 pathway, the hydroperoxide anion would attack the H at γ position, which results in the release of H2O2 and the formation of Quinonoid II (Q2). Another dioxygen molecule is involved in the oxidation of Q2. After several steps, 2 is formed and the second H2O2 molecule is released. The PLP is regenerated by hydrolysis of PMP. 
 
5.3.14 Presteady state kinetics of SwMppP(H29A) 
As shown in Figure 5-31, the first phase of SwMppP(H29A) is longer than that in wild type SwMppP. The 510 nm absorbance peak of H29A accumulated faster than that in wild type SwMppP, but accumulated much lower amounts of Q1. 
 
259 
Figure 5-31: The phase comparison of fluorescence intensity data and absorbance at 510 nm of SwMppP with L-Arg (10, 25, 50, 125, 250, 500, 1000 μM)(top) with H29A with L-Arg (25, 50, 100, 150, 200, 400, 600, 800, 1200 μM) (bottom). Both 415 nm data sets colored in magenta in a gradient of low L-Arg concentration (lighter magenta) to high L-Arg concentration (darker magenta). Both 510 nm data sets colored in blue in a gradient of low L-Arg concentration (lighter blue) to high L-Arg concentration (darker blue). The first phase (internal aldimine to external aldimine) of H29A lasts longer than that of wild type SwMppP. However, the quinonoid I accumulated at very close time. 
 
 The fluorescence and the absorbance at 510 nm data for SwMppP (H29A) was fitted to the mechanism depicted in Scheme 5-2 using KinTek Explorer simultaneously to obtain the dissociation constant and equilibrium constant for the four-step reactions under anaerobic condition. The global fitting figure is shown in Figure 5-32. The kinetic and equilibrium constants are summarized in Table 5-7.  
 
Figure 5-32: Fluorescence excited at 415 nm (A) and absorbance at 510 nm (B) of H29A mutant (10 μM) with varied L-Arg substrate (  25,  50,  100,  150,  200,  400,  600,  800 μM) under anaerobic condition were fitted globally in KinTek Explorer. The data were shown in dots with different colors, while the fitting was shown in lines with same color with the data. 
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Table 5-7: Summary of kinetic and equilibrium constant of SwMppP(H29A)with L-Arg under anaerobic condition 
Reactions k+ (μM-1 s-1) k- (s-1) Kd (μM) 
E + L-Arg = EL-Arg 0.252 79.8 316.7 
EL-Arg = EA 121 2.07  EA=Q1 1.84 0.0682  Note: E represents SwMppP (H29A) here. EA represents external aldimine, while Q1 represents Quinonoid I 
 
5.3.15 Presteady state kinetics of SwMppPΔ1-22 
The fluorescence data for SwMppPΔ1-22 was shown in Figure 5-33. The amplitude of fluorescence intensity is much lower than wild type SwMppP and SwMppP(H29A). I try to fit the data in Origin/Klaidagraph/KinTek Explorer with the mechanism depicted in Scheme 5-2, but it does not fit well. The global fitting figure is shown in Figure 5-33.  
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Figure 5-33: Fluorescence excited at 415 nm of SwMppPΔ1-22 with L-Arg substrate under anaerobic condition. The fluorescence data (dots) of SwMppPΔ1-22 (10 μM) versus different L-Arg concentrations (  25,  50,  75,  100,  150,  200,  400,  600,  800 and  1200 μM) was fitted globally (lines with different colors) to the same model mentioned above.  
 
5.3.16 Independent binding between two binding sites of SwMppP 
The structures of SwMppP or mutant H29A/S with L-Arg shows two different states in the two binding sites within one dimer. For example, in the two active sites of SwMppPL-Arg, chain A has the L-Arg bound to PLP while chain B has the product 2 bound. Some structures have 3 bound and internal aldimine state in chain A and chain B, respectively. In 
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the structure of H29AL-Arg, chain A has L-Arg bound but chain B has PLP covalently bound to catalytic lysine.  So to check if the two binding sites within one dimer are independent or not, ITC and fluorescence experiment that monitoring the internal aldimine decay was determined. SwMppP would form Quinonoid I eventually under anaerobic condition, which make the data harder to analyze. D188 hydrogen bonds to the NH of PLP ring, which is important for Quinonoid I formation. After mutated D188 into alanine, the variant D188A reacts with L-Arg to form external aldimine. So this mutant was used to study the dependence binding of two binding sites. 
ITC is a physical technique that works by determining the heat released or absorbed during a binding event. Before the experiment, the system is chemically calibrated. The 
sample cell containing 300 μl of 90 μM dialyzed, degassed SwMppP(D188A) protein in 15 
mM MES pH 6.7 buffer was incremental titrated with 2.5 μl of 800 μM L-Arg in the same buffer each titration. After load both sample cell and the burret with L-Arg, the system would keep equilibrate the system with stirrer on, which usually takes 1.5 h to get acceptable heat change deviation.  And the later titration experiment takes about 1 hour. The titration heat rate curve has a shifted baseline due to the instability of D188A protein. After continuous agitating for 2.5 h, the protein D188A precipitated and the baseline 
shifted upwards. I tried to decrease the temperature to 4oC, the baseline is almost flat but periodic noise peak show up at this low temperature. Then I tried 10oC, 12oC and 18oC, they all have shifted baseline. After many attempts, the ITC results are not satisfactory. So fluorescence experiments with short time and gentle treatment was used to monitor the internal aldimine decay and determine the binding relationship. The reaction containing 1.5 mL of SwMppP (D188A) (14 μM) and equal volume of different concentrations of L-Arg 
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(0 - 2560 μM) in 100 mM BisTris propane buffer was incubated for 8 min before excitation 
at 415 nm. As shown in Figure 5-34A, there are two species changing during the experiment. As substrate concentration increases, the peak with maximum absorbance at 
480 nm decreased, while the peak with maximum absorbance at 542 nm increased. Hence, 
the species that emissions maximally at 480 nm corresponds to internal aldimine, and the 
species that emissions maximally at 542 nm corresponds to external aldimine. According to the data, SwMppP (D188A) is almost saturated with 1280 μM L-Arg. Both 480 nm and 542 nm delta fluorescence data are not fitted into Hill equation, which suggested independence binding between two binding sites. The plot of calculated [D188AL-Arg] complex versus [L-Arg] at 480 nm was fitted to Equation 4 and the Kd for internal aldimine decay is 92.8 
μM (Figure 5-34B).  
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Figure 5-34: (A) Fluorescence change of SwMppP (D188A) with different concetrations of L-Arg (0, 5, 10, 20, 
40, 80, 160, 320, 640, 1280 and 2560 μM). There are two major peaks changing as the substrate 
concentration increases. The peak with maximum absorbance at ~480 nm decreased as [L-Arg] increases, 
which suggests this species is internal aldimine. The other peak with maximum absorbance at ~542 nm corresponds to external aldimine increases as substrate increases. (B) The fitting data of enzyme and L-Arg 
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complex versus [L-Arg] at 480 nm was fitted hyperbolically, rather than Hill plot. The inset is the zoomed initial data points and fitting. The data fits hyperbola pretty well, rather than a sigmoid curve. 
 
5.4 Discussion 
The nonproteinogenic amino acid L-enduracididine is a critical component of the mannopeptimycins, a family of cyclic glycopeptide antibiotics with potent activities against drug-resistant pathogens like MRSA. Creating derivatives of mannopeptimycin and other L-End-containing natural products is hampered by the limited availability of L-End. We are investigating the L-End biosynthetic pathway in order to develop an efficient enzymatic or chemo-enzymatic route to produce this unusual amino acid. Recently, we found that MppP is a PLP-dependent L-Arg oxidase in L-End biosynthesis in S. wadayamensis, not an aminotranferase as the sequence suggested. The quaternary structure of SwMppP shares high similarity with Type I aminotransferases. The major difference is the N-terminus. For type I aminotransferases, N-terminal helix interacts with the small domain of the other chain, and the small domain shifted towards the large domain forming a “closed” conformation when the substrate bound20, 28, 29. However, SwMppP mainly exists as homodimer with the active site exposed to the solvent in unliganded state. The fluorescence data of SwMppP (D188A) with L-Arg demonstrated that the two active sites within SwMppP dimer are independence binding. Upon the substrate binding, the N-terminal helix of SwMppP is ordered to cover the active site and interacts with L-Arg. In addition, there is no small domain movement. PLP-dependent cystathionase MalY in E. coli (PDB entry: 1D2F30) and some aminotransferases (PDB entry 4DQ6 and 3DZZ) have high 
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structural similarity with SwMppP. Overlaying SwMppP structure with them demonstrates that the small domain of SwMppP is closer to the large domain, demonstrating the small domain and large domain arrangement of unliganded SwMppP is more likely a “closed” conformation. 
In E. coli aspartate aminotransferase, the small domain inward movements push the repulsion interaction between G38 and Y225, which results in a lower pKa of the aldimine and enhanced catalysis28. The lower imine pKa of the internal aldimine is mainly due to the 90° torsion angle of C3-C4-C4’-Nζ bond and the repulsive interactions between G38 and Y22528, 31. However, the corresponding torsion angle of SwMppP is ~9°. And SwMppP has a higher catalysis activity at higher pH27, which indicates a pronated internal aldimine form in SwMppP. 
SwMppP reacts with L-Arg and dioxygen to yield two products, 3 and 2 in a ratio of ~1.7:1. The 2 is the products that can be cyclized by MppR (Figure 4-4B). The 3 side pathway may be one approach for self-resistance by limiting the antibiotics level. L-Arg is an important amino acid, which is involved in many pathways and serves as carbon and nitrogen source32. MppQ can catalyze 3 into L-Arg, which seems to be a way to regulate L-arginine level in the cells.  
The two N-terminal residues, T12 and E15, interact with L-Arg in the active site. To understand what roles these two residues and the N terminus play, we made mutations on the two residues as well as truncation on the N terminus (Δ1-22 aa). The N-terminal variants T12A, E15A, T12A/E15A and SwMppPΔ1-22 only produce 3, which indicates the N-terminal helix is essential for hydroxylation. In addition, T12A, T12A/E15A and SwMppPΔ1-
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22 have lower catalytic efficiency. As the spectrum shown in Figure 5-16, external aldimine 
peak (435 nm) gradually shifted to internal aldimine peak (415 nm) as reaction went, demonstrating that N-terminal helix, especially T12, plays a key role on stabilizing external aldimine. The mutant E15A has similar KM and kcat values with wild type SwMppP but is deficient in the hydroxylase activity. In the structure of E15A•L-Arg, the N terminus also orders and covers the active site. T12 in N terminus still interacts with the guanidine group of L-Arg.  But the short side chain of Ala15 creates more room for water retainment, which probably disrupts the hydroxylation pathway. E15Q variant still produced 3 and 2, although it does make less of the hydroxylated product. Hence, the N terminus interaction is crucial for the stability of external aldimine and later hydroxylation activity.  
The reaction of SwMppP with L-Arg and O2 forms two quinonoid intermediates (Q1 at 510 nm and Q2 at 560 nm). Under anaerobic conditions, the accumulated Quinonoid I is very stable, which suggests this carbanion is stabilized by SwMppP to some extent. When the O2 is present, Quinonoid I quickly reacts with O2, which is similar to the PLP-dependent DOPA/aromatic L-amino acid decarboxylases33. When the substrate covalently bonds to PLP, the free catalytic K221 forms a hydrogen bonding with D218, which is similar in DOPA/aromatic L-amino acid decarboxylases (PDB ID 1JS334). To study the role of this residue, D218 was substituted into Ser. There is a PMP peak accumulated in the reaction of D218S with L-Arg and D218S mutant only produced little products.  In addition, there is no PLP in the low quality structure of D218S. These results suggest that D218 probably participates in the PMP hydrolysis. In the structure of H29A, F115Y and H29A•L-Arg, there are more water molecules retaining in the active site. In the reaction of F191Y with L-Arg, there is a ketimine intermediate formed. The ketimine formation needs a water to provide 
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H to imine. In conclusion, the water molecule is an important factor to regulate the product pathway. In addition, E15, H29, F115 and F191 are all involved in water exclusion. In SwMppP with L-Arg spectrum, QII firstly accumulate and then quickly decay. But according to the spectrum of F191Y with L-Arg, QII keeps the accumulation, which suggests that F191 is also involved in the reaction of QII with O2.  
According to the spectra of all proteins mentioned above, QII only accumulates in the enzymes producing both products. For those mutants producing 3 only, no QII intermediate peak was observed. These facts suggest that QII formation belongs to the hydroxylation pathway. Pre-steady state data of Quinonoid I decay and Quinonoid II formation shows that Quinonoid II only forms after Quinonoid I decay.  
The portion of O2 consumed to form H2O2 was determined by adding catalase after the reaction attained equilibration. Catalase catalyzes 2 moles of H2O2 into 1 mole of O2, and the ratio of O2 consumed over O2 regenerated is 2:1, which indicated that each equivalent of O2 consumed is converted to 1 equivalent of H2O2. In addition, the products mass of SwMppP with L-Arg and O2 conducted in H218O demonstrates that the hydroxyl O atom of 2 comes from water. So SwMppP is an oxidase. 
The mutant E15A, producing 3 only, has similar catalytic efficiency with wild type. The ratio of [O2 consumed] over [L-Arg added] for variant SwMppP (E15A) that produces 3 only is 1:1, which suggested that 3 formation only requires one equivalent of O2. For the other mutants (T12A, T12A/E15A, SwMppPΔ1-22, H29A/S and F115Y) that producing 3 only, the ratios of [O2 consumed] over [L-Arg added] are smaller than 1. The ratio is based on the amounts of L-Arg added, not L-Arg consumed, so the mutants with lower catalytic 
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efficiency would give a smaller ratio value. The ratios of [O2 consumed] over [L-Arg added] of wild type SwMppP, E15Q and F191Y, producing both 3 and 2, is 1.4:1, which suggested that 2 formation requires 2 equivalents of O2.  
The dissociation constant for Quinonoid I with O2 is 52.6 μM by presteady state kinetics, while the dissociation constant for Quinonoid II with O2 is 418 μM. So Quinonoid II has a weak binding affinity.  
The structural and kinetic characterization of the wild-type and several variants of SwMppP allowed us to propose a model where the oxygen atom incorporated in the 2 product is derived from water rather than from dioxygen. And 2 formation requires 2 equivalents of O2, while the abortive product, 3, requires only 1 equivalent. 
Based on the model, the H29A fluorescence data and absorbance data at 510 nm were globally fitting in Kintek Explorer. The apparent dissociation constant of L-Arg to SwMppP 
is 101.4 μM, while the Kd of L-Arg to H29A is 316.7 μM. 
As described above, SwMppP catalyzes the Cγ-hydroxylation of a non-activated methylene moiety on L-Arg with very high stereospecificity. The stereochemistry of the Cα 
atom is crucial for the reaction. The α proton of D-arginine is located opposite to the general base catalyst for the Q1 intermediate formation27, and the external aldimine conformation is not stabilized by the interactions in the active site. Hence, the external aldimine gradually shifted into internal aldimine by the K221 attack. In addition, the position of guanidinium group is essential for the hydroxylation activity. The guanidinium group of L-Arg is hydrogen bonding with PLP phosphate group, T12, S91 and the carbonyl 
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groups of S248 and D249 from the other chain. The L-Arg homologs, L-citrulline, L-canavanine and methyl-L-arginine, disrupt the coordinations and resulted in the loss of hydroxylation. The side chain of D-Arg pointed away from the PLP cofactor and disrupted the N terminus interaction, which also leads to the inactivity. The length of the substrate is also important for SwMppP activities. Shorter L-Arg analog, L-Orn cannot be deaminized or hydroxylated.  
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Appendices 
Appendix A: Crystallographic data collection and refinement statistics. 
 RitR(C128S) 
(5U8K) RitRox (5U8M) 
RitR(C128
D) 
(5VFA) 
rdlv rd2lv 
Space group C121 P212121 C121 C121 P21212 Cell dimensions      a, b, c (Å) 141.1, 60.1, 53.3 74.3, 74.8, 102.8 142.8, 59.7, 52.5 93.9, 50.0, 63.0 40.2, 115.3, 125.4 
α, β, γ (°) 90.0, 96.0, 90.0 90.0, 90.0, 90.0 90.0, 96.3, 90.0 90.0, 121.4, 90.0 90.0, 90.0, 90.0 Resolution (Å) (last shell)a 40.33-1.69 (1.75-1.69) 50.00-2.10 (2.14-2.10) 50.00-1.45 (1.48-1.45) 50.00-1.83 (1.86-1.83) 50.00-2.60 (2.64-2.60) Wavelength (Å) 0.97872 0.97872 0.97857 0.97857 0.97872 No. of reflections      Observed 276131(24
543) 206898(8842) 396912(14482) 81689(3266) 263987(10059) Unique 49527(4856) 33913(1667) 76689(3384) 21809(1033) 18645(919) 
Completeness (%)a 99.6 (97.9) 99.9 (99.6) 99.0 (89.1) 99.1(97.0) 100.0 (100.0) Rmerge (%)a,b 0.090 
(0.340) 0.071 (0.586) 0.046 (0.498) 0.082 (0.436) 0.147 (0.890) Multiplicity 5.6 (5.1) 6.1 (5.3) 5.2 (4.3) 3.7 (3.2) 14.2 (10.9) 
<I/σ(I)>a 16.6 (8.1) 25.2 (2.5) 28.6 (2.9) 13.3 (2.6) 16.9 (3.3) 
Model Refinement Statistics Reflections in work set 91682 64031 76664 23890 17730 
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Reflections in test set 3718 3805 2000 1204 1770 Rcryst (Rfree) 0.1435 (0.1685) 0.1881 (0.2309) 0.1641 (0.1854) 0.2357 (0.2767) 0.1976 (0.2886) No. of residues 459 458 443 234 499 No. of solvent atoms 733 185 610 242 49 Number of TLS groups 18 17 16 1 1 Average B-factor (Å2) c      Protein atoms 12.9 46.3 25.9 24.1 43.3 Solvent 27.4 40.7 36.4 30.5 38.0 RMS deviations      Bond lengths (Å) 0.010 0.011 0.008 0.012 0.015 Bond angles (°) 1.021 1.053 0.976 1.311 1.474 Coordinate error (Å) 0.11 0.26 0.14 0.22 0.40 Ramachandran statistics (favored/allowed/outliers) 
98.5/1.5/0.0 98.0/2.0/0.0 97.0/3.0/0.0 95.7/3.0/1.3 91.3/4.7/4.0 
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Appendix B: Crystallographic data collection and refinement statistics. 
 
 a Values in parentheses apply to the high-resolution shell indicated in the resolution row. b R = Σ(||Fobs|-scale*|Fcalc||) / Σ |Fobs|. c Isotropic equivalent B factors, including contribution from TLS refinement. d In the structure of Q15Z91, “ligands” refers to c-di-GMP and citrate.  In the structure of Q15Z91GTP, “ligands” refers to c-di-GMP and GTP. 
  Q15Z91 Q15Z91GTP Space group  P212121 P212121 Cell dimensions    a, b, c (Å)  82.1, 116.0, 167.6 82.9, 116.5, 167.3 
α, β, γ (°)  90.0, 90.0, 90.0 90.0, 90.0, 90.0 Resolution (Å)  (last shell)a  50.00-1.85 (1.88-1.85) 50.00-1.95 (1.98-1.95) Wavelength (Å)  0.97872 0.97857 No. of reflections        Observed  797511(33484) 720622(28138)     Unique  135739 (6671) 117445(5618) 
Completeness (%)a  100.0 (99.8) 98.8(95.6) Rmerge (%)a,b  0.090 (0.613) 0.103 (0.540) Multiplicity  5.9 (5.0) 6.1 (5.0) 
<I/σ(I)>a  17.9 (2.7) 13.5 (2.7) 
Model Refinement Statistics Reflections in work set  135607 117218 Reflections in test set  2000 1996 Rcryst (Rfree)  0.1662 (0.1833) 0.2616 (0.3161) No. of residues  1192 1073 No. of solvent atoms  931 427 Number of TLS groups  8 9 Average B-factor (Å2) c        Protein atoms  38.2 56.8     Ligandd           25.4     41.5     Solvent  41.8 45.1 RMS deviations        Bond lengths (Å)  0.011 0.013     Bond angles (°)  1.259 1.667  Coordinate error (Å)  0.17 0.27 Ramachandran statistics (favored/allowed/outliers)  96.8/2.5/0.7 90.1/6.2/3.8 
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Appendix C: Crystallographic data collection and refinement statistics. 
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  SwMppP SwMppP·D-Arg SwMppP·L-Arg SwMppP·2KA SwMppP·4HKA 
Space group  P212121 P212121 P212121 P212121 P212121 
Cell dimensions       
a, b, c (Å)  85.7, 108.3, 195.4 86.8, 109.1, 194.8 85.8, 108.4, 196.2 85.9, 108.8, 195.5 86.0, 108.4, 196.5 
α, β, γ (°)  90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0 
Resolution (Å)  
(last shell)a 
 
41.45-2.10 
(2.14-2.10) 
44.53-2.25 
(2.29-2.25) 
50.00-2.20 
(2.24-2.20) 
44.59-1.83 
(1.87-1.83) 
50.00-1.93 
(1.96-1.93) 
Wavelength (Å)  0.97852 (D) 0.97856 (G) 0.97872 0.97849 0.97856 
No. of reflections       
    Observed  1532933(60186) 256371 (12494) 408941 (15090) 1055413 (53434) 650654 (25173) 
    Unique  106188 (5236) 79816 (3984) 85820 (3839) 160466 (7902) 135654 (6682) 
Completeness (%)a  100.0 (100.0) 90.2 (91.2) 91.6 (84.1) 99.9 (100.0) 98.4 (98.3) 
Rmerge (%)a,b  0.106 (0.734) 0.106 (0.726) 0.057 (0.193) 0.074 (0.567) 0.066 (0.488) 
Multiplicity  14.4 (11.5) 3.2 (3.1) 4.8 (3.9) 6.6 (6.8) 4.8 (3.8) 
<I/σ(I)>a  30.7 (5.2) 10.0 (1.9) 24.7 (6.1) 14.4 (3.3) 21.8 (2.3) 
Model Refinement Statistics  
Reflections in work set  100876 76747 85724 160326 135549 
Reflections in test set  5256 3015 1999 2000 2000 
Rcryst (Rfree)  0.148 (0.177) 0.162 (0.197) 0.145 (0.195) 0.151 (0.175) 0.156 (0.178) 
No. of residues  1417 1404 1458 1434 1454 
No. of solvent atoms  903 693 745 1032 930 
Number of TLS groups  29 33 30 31 20 
Average B-factor (Å2) c       
    Protein atoms  32.0 34.1 28.8 31.2 32.4 
    Ligands  30.9 43.9 31.6d 37.6d 41.9d 
    Solvent  35.6 36.6 33.0 37.3 36.9 
RMS deviations       
    Bond lengths (Å)  0.013 0.015 0.010 0.010 0.011 
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    Bond angles (°)  1.395 1.565 1.141 1.140 1.155 
 Coordinate error (Å)  0.17 0.22 0.17 0.19 0.19 
Ramachandran statistics 
(favored/allowed/outliers) 
 
98.3 / 1.7 /0.0 98.4 / 1.6 / 0.0 
97.2 / 2.5 / 0.3 97.6/ 2.0 / 0.4 98.2/ 1.8 / 0 
a Values in parentheses apply to the high-resolution shell indicated in the resolution row. 
b R = Σ(||Fobs|-scale*|Fcalc||) / Σ |Fobs|. 
c Isotropic equivalent B factors, including contribution from TLS refinement. 
d In  L-Arg complex structure, “ligands” refers to the L-Arg-PLP unit; in the 2KA complex structure, 
it refers to the 2KA and  L-Arg-PLP molecules; and in  the 4HKA complex structure, it refers to 
the 4HKA molecules. In the protein only, “ligands” refer to Cl- ion. 
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  E15A·L-Arg H29A H29S H29A·L-Arg H29S·L-Arg F115Y 
Space group  P1 21 1 P212121 P212121 P212121 P212121 I121 
Cell dimensions        
a, b, c (Å)  
64.4, 200.5, 
139.9 
85.9, 108.3, 
195.7 
85.8, 108.0, 
195.6 
85.8, 108.0, 
195.7 
85.5, 107.7, 
195.5 
111.62, 63.25, 
243.10 
α, β, γ (°)  90.0, 103.3, 90.0 90.0, 90.0, 90.0 
90.0, 90.0, 
90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 90.29, 90.0 
Resolution (Å) 
(last shell)a 
 50.00-2.20 (2.28-2.24) 
50.00-1.90 
(1.93-1.90) 
50.00-1.95 
(1.98-1.95) 
50.00-2.30 
(2.34-2.30) 
50.00-2.10 
(2.14-2.10) 
60.77-1.92 
(1.96-1.92) 
Wavelength (Å)       0.97872 
No. of reflections        
Observed  977686(170041) 837303(143854) 252515(12536) 494009(79839) 726298 (27943) 433940 (18551) 
Unique  36991(8030) 35984 (7049) 131339(6470) 17981(3685) 104882 (5113) 128901 (6294) 
Completeness (%)a  97.0 (92.2) 99.4 (99.1) 99.8 (99.3) 97.8 (92.3) 99.8(98.9) 99.7 (98.7) 
Rmerge (%)a,b  0.110 (0.588) 0.076 (0.555) 0.083 (0.551) 0.078 (0.369) 0.088 (0.460) 1.162 (3.647) 
Multiplicity  5.7 (4.6) 5.8 (5.1) 7.1 (6.8) 6.2 (4.9) 6.9 (5.5) 3.4 (2.9) 
<I/σ(I)>a  14.9 (2.1) 21.7 (2.8) 22.9 (3.1) 20.5 (3.7) 22.6 (3.4) 1.9 (0.3) 
Model Refinement Statistics 
Reflections in work set  156239 143740 131221 79748 104781 120037 
Reflections in test set  2001 2000 1999 1999 2000 1827 
Rcryst (Rfree)  0.2054(0.2656) 0.1503(0.1818) 0.1508(0.1838) 0.1607(0.2183) 0.1562(0.1989) 0.2620(0.3453) 
No. of residues  2839 1421 1421 1456 1455 1441 
No. of solvent atoms  1432 1072 943 472 688 468 
Number of TLS groups  72 30 25 26 30 18 
Average B-factor (Å2) c        
Protein atoms  46.5 29.1 30.4 41.4 37.8 23.1 
Ligands  38.0d 25.1d 28.1d 38.8d 35.4d - 
Solvent  39.0 37.5 36.9 39.2 40.1 23.1 
RMS deviations        
Bond lengths (Å)  0.012 0.009 0.010 0.011 0.011 0.014 
Bond angles (°)  1.255 1.055 1.108 1.181 1.173 1.411 
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Coordinate error (Å)  0.29 0.17 0.15 0.22 0.17 0.38 
Ramachandran statistics 
(favored/allowed/outliers) 
 97.2 / 2.5 / 0.3 98.1 / 1.6 / 0.4 98.2 / 1.5 / 0.4 97.1/ 2.6 / 0.3 97.2/ 2.4 / 0.4 90.6 / 7.4 / 2.0 
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Appendix D: Proton NMR spectra for the products of SwMppP and its N-terminal 
mutants with L-Arg.  
(A) Pure L-Arg (2.0 mM, ); (B) a reaction mixture containing 10.0 μM SwMppP and 2.0 mM L-Arg ( ),; (C) a 
reaction mixture containing 50.0 μM SwMppPΔ1-22 and 2.0 mM L-Arg ( ); (D) a reaction mixture containing 
50.0 μM SwMppPT12A and 2.0 mM L-Arg ( ); (E) a reaction mixture containing 50.0 μM SwMppPE15A and 2.0 mM L-Arg ( ); (F) a reaction mixture containing 50.0 μM SwMppPE15Q and 2.0 mM L-Arg ( ); (G) a reaction mixture containing 50.0 μM SwMppPT12A/E15A and 2.0 mM L-Arg ( ). All in 20 mM sodium 
phosphate buffer (pH 8.4). 
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Appendix E: Proton NMR spectra for SwMppP active site mutants with L-Arg.  
(A) L-Arg (2.0 mM) with MES (2.0 mM); (B) a reaction mixture containing 10.0 μM SwMppP(H29A) in MES pH 6.7 (2 mM, final concentration) buffer and 2.0 mM L-Arg; (C) a reaction mixture containing 10.0 μM SwMppP(H29S) in MES pH 6.7 (2 mM, final concentration) buffer and 2.0 mM L-Arg; (D) a reaction mixture 
containing 10.0 μM SwMppP(F115Y) in MES pH 6.7 (2 mM, final concentration) buffer and 2.0 mM L-Arg; (E) 
a reaction mixture containing 10.0 μM SwMppP(F191Y) in MES pH 6.7 (2 mM, final concentration) buffer and 2.0 mM L-Arg; (F) a reaction mixture containing 10.0 μM SwMppP(D218S) in MES pH 6.7 (2 mM, final concentration) buffer and 2.0 mM L-Arg. 
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Appendix F: Overlay the structure (A) and active site (B) of SwMppPL-Arg with 
SwMppP2 
 
 
 
Appendix G: Overlay the structure (A) and active site (B) of SwMppPL-Arg with 
SwMppP3 
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